tsawon lokacin da alamun cutar suka kasance?
kuma duk wani ciwon kirji dole ne a kula dashi domin ya tsira da wannan yanayin don shekarunka
kuma tare da zazzabi
kuma ya kamata a duba yawan cholesterol naka
kuma kana da zazzabi yanzu?
kuma kana da ciwon kirji a yanzu?
kuma kana da wahalar numfashi
kuma za ku iya gaya mani wasu alamun da kuke da su tare da wannan?
kuma yaya zazzabinka yake
kuma ina da tari kuma
kuma ina da ɗan sanyi a cikin tari
kuma yanzu ina da ciwon kirji mai tsanani
kuma wannan lokaci ne da za a cire zafin ciyayinka
kuma ya zo a kirji
kuma ina tsammanin ina da zazzabi kadan
kuma ina so ka bayyana min inda ciwon kirji yake
kuma suna da zazzabi mai sauƙi kuma
da kuma tarihin ciwon sukari
kuma ka san abin da yake yi saboda ƙirjina zai karye
Kuma kamar mutane suna zubo min dukkan tsire-tsire
kuma kana da ciwon kirji
kuma ka ce wannan nauyi ne a kirji
wani a cikin iyali yana da ciwon zuciya, bugun zuciya hawan jini
Shin kun lura da wasu alamun ko matsalolin ciwon jijiyoyin jiki?
Shin wasu a cikin iyalinka suna da irin wannan cututtuka?
kuna da wasu alamun cutar?
kana numfashi a hankali?
kana ci gaba da ciwon kirji
saboda wannan shine lokacin mura
kuma ba za a iya watsi da ciwon zuciya wanda ke haifar da ciwon kirji ba
amma babbar matsalar yanzu shine ciwon kirji
amma da ciwon numfashi
amma na san mutane da yawa da zasu yi min aiki
amma dole ne muyi la'akari da ciwon kirji da ciwo mai tsanani
amma yanzu da ka numfasa da kyau haka?
dalilin ciwon kirji a cikin cikakkiyar rashin fahimta
kamar wani ya tsotse ka a kirjinka
kamar numfashi ne kawai
Shin suna fama da cututtuka iri ɗaya?
kuna da wata cuta mai tsanani kamar hawan jini ko wani abu makamancin haka?
Shin kana da wata cuta mai tsanani kamar ciwon sukari?
kuna da ciwon numfashi tare da wannan ciwon kirji?
kana da hawan jini?
Kuna da ɗan gajeren hutu tare da wannan?
Shin ka san irin cututtukan da ta yi?
Kuna ganin inuwa?
sha ruwa da yawa yau
amma taimaka wa testis don ciwon sukari
amma a yanzu alamun sun yi kama da na yau da kullum
Yaya yawan zafin jikinka yake?
Yaya karfin jini naka yake?
idan ka ci gaba da jin zazzabi ya tashi
idan kana da zazzabi mai ɗari biyu ko sama
idan ka yi zaton alamun cututtukanka sun zama matsala kana bukatar a duba su sosai
ina da zazzabi jiya
ina da wata zazzabi
ina da zazzabi jiya
Ina da ciwon bacci a cikin kirji
Ina jin zafi sosai kuma na yanke shawarar numfashi
ta hanyar aiko maka da hoton
Ina jin ciwon kirji a yau
Na ji wani yana zazzabi yau
daga yadda na gani yana da mura
daga yadda na gani wannan dan kadan mura ne
Shin kana jin kamar wani babba yana zaune a kan kirjinka?
duk ya fara da zafi da zazzabi a lokaci guda
yana da tsayi a tsakiyar kirji
yana da matsawa kamar ciwon kirji
yana cikin kirji
yana cikin tsakiyar kirji
yana cikin tsakiyar kirji
ina jin zafi a kirji
Ina jin tsoron wannan ciwon kirji
Ina so ka yi mini bayani game da ciwon kirji
cutar hawan jini ko ciwon sukari
kamar yadda na yanka a tsakiyar kirji
yanzu ki zabi zazzabi ki sha tachipirina mai zaki
yanzu mary kwana nawa kika ji alamun
yanzu ka ce kana da ciwon kirji
wani lokacin ina jin ciwon kirji
Na ga, wannan shine lokacin da kake jin wasu alamun bayyanar cututtuka ban da ciwon kirji
Ko kuwa wani ya zauna a cikin ƙirjinka?
daidai yake da mutum yana fama da zazzabi, tari, tari, ciwon tsoka
kawai a tsakiyar kirji
nuna min a cikin wannan inuwa inda kake jin zafi
idan kana da zazzabi
Shin kuna tsammanin akwai wasu alamun bayyanar cututtuka masu saurin faruwa saboda kuna da ciki?
Shin yaranku suna da alamun rashin lafiya kamar wannan?
Ka faɗa mini ciwon kirjinka
zazzabi yakan yi tsanani da dare
zazzabin da na yi a cikin kwanaki biyu da suka shige
zazzabi ya fara tashi a daren jiya
a nan ne dakin likita porter da kuma cibiyar gaggawa
To, za ka iya gaya mani game da ciwon kirjinka?
su, ina da ciwon gaban jiki a cikin kirji
ni, ina jin zafi sosai a kirji
su, lokacin da nake da wannan ciwon a kirji
wane irin ciwo kake da shi a kirjinka?
lokacin da ciwon kirji ya fara?
A ina kake jin wannan ciwon a kirji?
ina kake jin wannan ciwon kirji a wannan kirjin
kana jin kamar kirjinka yana toshewa
ka san ina da ciwon sukari da sauran abubuwa
ka ce kana jin ciwon kirji
Yawan masu kamuwa da cutar coronavirus (COVID-19) ya karu sosai a Turai/Yankin Tattalin Arzikin Turai da Ingila daga 1 ga Janairu zuwa 15 ga Maris, 2020
Idan aka yi la'akari da cewa duk mutanen da ke fama da cutar coronavirus (COVID-19) suna nuna alamun cutar iri ɗaya a cikin Turai / Yankin Tattalin Arzikin Turai da Ingila, hakan yana nuna cewa, kodayake akwai bambance-bambance a cikin yanayin ƙasa zuwa ƙasa, cutar COVID-19 tana yaduwa cikin sauri a duk ƙasashe.
Dangane da abubuwan da suka faru a Italiya, ƙasashe, asibitoci da cibiyoyin kulawa da gaggawa suna buƙatar kasancewa cikin shiri don karɓar ƙarin masu cutar COVID-19 waɗanda ke buƙatar kulawa ta musamman, musamman a cikin ICU.
A ranar 31 ga Disamba, 2019, an gano mutane da yawa da ke fama da cutar numfashi a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairun 2020, Cibiyar Kula da Cututtuka ta kasar Sin ta bayyana cewa cutar ta samo asali ne daga wani sabon nau'in kwayar cutar coronavirus wanda yanzu ake kira SARS-CoV-2.
Tun daga wannan lokacin, cutar da ke haifar da SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
Bayanai da muke da su a yanzu sun nuna cewa kashi 80% na mutanen da ke da cutar COVID-19 suna da yanayin rashin lafiya mai sauƙi, kamar rashin lafiya na numfashi ko kuma wahalar numfashi, kuma yawancin su suna rayuwa.
A cikin kashi 14 cikin ɗari na mutane, COVID-19 yana haifar da rashin lafiya mai tsanani wanda ke buƙatar asibiti, yayin da kashi 6 cikin ɗari ke haifar da rashin lafiya mai tsanani wanda ke buƙatar kulawa mai tsanani.
Yawan mutuwar da ke faruwa a asibiti saboda COVID-19 ya kai kashi 4 cikin ɗari.
A cikin wannan binciken, za a bincika yanayin COVID-19 a kowace ƙasa a cikin Turai / Yankin Tattalin Arzikin Turai da Ingila (UK) kuma a kwatanta shi da na lardin Hubei, China.
Za mu kuma kwatanta yawan sabbin cututtukan COVID-19 a cikin Turai / Yankin Tattalin Arzikin Turai da Ingila da Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
An samu wasu cututtukan COVID-19 a Turai/Yankin Tattalin Arzikin Turai da Ingila
Kamar yadda ya faru a China, COVID-19 ya bazu zuwa wasu ƙasashe kuma cutar COVID-19 tana yaduwa a wasu ƙasashe kamar yadda ta faru a wannan ƙasar.
A ranar 11 ga Maris, 2020, Babban Daraktan Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin cutar da ke yaduwa.
A ranar 5 ga Maris, rahoton Eurosurveillance 2020, Spiteri da abokan aikinsa, sun ba da rahoton farkon yanayin COVID-19 na Turai bisa ga ma'anar WHO.
A cikin Turai / Yankin Tattalin Arziki na Turai, an fara samun wasu mutane uku a Faransa a ranar 24 ga Janairu, 2020; an dawo da su daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an sami wasu cututtukan COVID-19 a cikin ƙasashe 30 na Turai/Yankin Tattalin Arzikin Turai da Ingila (UK), kuma daga 31 ga Disamba, 2019, an sami ƙididdigar kamuwa da cutar 39,768 da mutuwar 1,727 tare da aƙalla 17,750 a Italiya da mutuwar 1,441.
Samun cikakken adadin mutane da suka kamu da COVID-19
Cibiyar Kula da Cututtuka ta Turai (ECDC), ta sabunta ƙididdigar COVID-19 a kowace ƙasa, wanda kawai ya dogara da tushen hukuma kamar ma'aikatun kiwon lafiya na duniya, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana da ƙarfe 8 na safe.
An yi amfani da wannan bayanin don ƙayyade yaduwar COVID-19 a cikin Turai / Yankin Tattalin Arzikin Turai da Ingila, kuma an kwatanta shi da Italiya.
A cikin yanayin cutar COVID-19, muna la'akari da yanayin cutar COVID-19 na kwanaki 14, wanda ke haifar da ci gaban COVID-19 a kowace ƙasa a cikin Turai / Yankin Tattalin Arzikin Turai da Ingila, a lokacin daga 1 ga Janairu zuwa 15 ga Maris 2020.
Mun kuma ba da jimlar adadin masu kamuwa da cutar a kowace ƙasa a ranar 15 ga Maris, 2020 da ƙarfe 8:00 na safe, idan aka kwatanta da adadin Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Yawan kamuwa da COVID-19 a Turai/Yankin Tattalin Arziki na Turai da Ingila
Yanayin cutar COVID-19 na kwanaki 14 a cikin Turai / Yankin Tattalin Arzikin Turai da Burtaniya zai kasance daidai da na lardin Hubei (China) (Figure 1).
Ga ƙasashen Turai/Yankin Tattalin Arzikin Turai da Ingila, cutar COVID-19 ta fara fitowa a ranar 21 ga Fabrairu sannan ta fara fitowa a ranar 28 ga Fabrairu, 2020 (Ƙarin bayani).
Wannan ya kasance ne saboda yawan adadin masu kamuwa da cutar a Italiya, amma a duk ƙasashen Turai/Yankin Tattalin Arzikin Turai, yawan masu kamuwa da COVID-19 ya kasance daidai (Ƙarin Bayani).
Adadi na 2 ya nuna jimlar adadin masu kamuwa da COVID-19, a cikin Turai / Yankin Tattalin Arzikin Turai da Ingila idan aka kwatanta da Italiya daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Wannan yana nuna cewa, a ranar 15 ga Maris da ƙarfe 8:00 na safe, wasu ƙasashe 15 na Turai / Yankin Tattalin Arzikin Turai da Ingila suna da adadin adadin masu cutar kamar Italiya makonni 3 ko ƙasa da haka da suka gabata.
Sakamakon bincikenmu ya nuna cewa yawan masu kamuwa da COVID-19 zai karu sosai a cikin Turai / Yankin Tattalin Arzikin Turai da Ingila.
Bayanan da aka samu game da yawan masu kamuwa da cutar COVID-19 sun nuna cewa cutar ta yadu daidai a wasu ƙasashe.
Ko da yake akwai bambance-bambance a cikin ƙasashe, ƙwararrun likitoci za su iya ba da magani daban-daban, kuma a wasu lokuta ma'anar cututtuka ta bambanta tsakanin ƙasashe da ƙa'idodi don zaɓar marasa lafiya waɗanda za a gwada su don COVID-19, har ma da gwajin gaba.
A farkon watan Maris na 2020, likitocin Italiya a cikin yankin sun ba da rahoton cewa kashi 10% na masu cutar COVID-19 suna buƙatar kulawa mai tsanani kuma kafofin watsa labarai sun ba da rahoton cewa asibitocin yankin suna cike da marasa lafiya.
Bayanai na asibiti da/ko kulawa mai tsanani na COVID-19 a halin yanzu suna samuwa a cikin Turai / Yankin Tattalin Arzikin Turai don kashi 6% da 1% na yawan jama'a (ba a nuna bayanai ba).
Duk da haka, dole ne a haɗa su da kyau don su dace da sabon bayanin da ya fi dacewa game da yawan masu cutar da mutuwar.
Wani bincike da aka yi a 2010-11 ya nuna canji mai yawa a cikin cibiyoyin kulawa da ke da tsananin kulawa da matsakaici a Turai, tare da gado 29.2 a Jamus da gada 4.2 ga kowane mutum 100,000 a Portugal.
Wannan yana nufin cewa ƙasashe na iya samun ƙarin ko ƙasa da Italiya (12.5 cibiyoyin kulawa da ke da tsananin kulawa da matsakaitan gadaje ga kowane mutum 100,000 a 201011).
Inganta yanayin kula da marasa lafiya ya wuce likita, saboda ƙididdigar kusancin Turai / Yankin Tattalin Arziki na Turai da Burtaniya dangane da yawan asibitocin COVID-19 da kuma &gt; 90% na haɗarin rashin gado a cikin ICU, an ba da su a cikin sabon tsarin ECDC na shida don kimanta haɗarin COVID-19.
Saboda yawan marasa lafiya a wasu sassan Turai/Yankin Tattalin Arziki na Turai da Ingila, kuma asibitoci a cibiyoyin kulawa mai tsanani galibi ana amfani da su don ɗaukar yawan jama'a na yanki, dole ne a samar da bayanai game da cututtuka da gadajen kulawa mai tsanani a cikin wani yanki da ake kira Nomenclature of Level 2 Information Units (NUTS-2).
Bayanai na yanzu da na gaba daga Italiya da sauran ƙasashe sun nuna cewa cutar COVID-19 tana yaduwa cikin sauri a cikin Turai / Yankin Tattalin Arzikin Turai da Ingila.
Kasashe, asibitoci da cibiyoyin kulawa da hankali suna buƙatar shirya yadda za su magance ƙarin kamuwa da SARS-CoV-2 da kuma karuwar yawan masu cutar COVID-19 da ke neman magani, musamman a cikin cibiyoyin kulawa da hankali, kamar waɗanda ke cikin yankunan Italiya da ke fama da cutar.
Kamar yadda aka nuna a cikin sabon binciken gaggawa na ECDC, ana buƙatar saurin, ingantaccen tsari da ingantaccen tsari don hana yaduwar SARS-COV-2, janye hankalin mutane daga kamuwa da cutar da kuma mai da hankali kan rage yawan kamuwa da cutar; saboda ƙididdigar yawan kamuwa da cutar ba zai taimaka wa yanke shawara ba kuma asibitoci ba za su sami lokacin fahimta, yarda da kuma shirya don kulawa ba idan ba a gwada su ba.
Binciken gaggawa na haɗarin zai kuma tattauna kan matakan kiwon lafiya na jama'a don rage yaduwar cutar.
Akwai ɗan gajeren lokaci a lokacin da ƙasashe ke da damar ƙara sarrafa ƙoƙarin da suke yi don rage yaduwar SARS-CoV-2 da matsa lamba kan likitoci.
Idan ba a yi hakan ba, cibiyoyin kiwon lafiya a wasu ƙasashen Turai/Yankin Tattalin Arzikin Turai za su sami ƙarin mutane da ke fama da cutar da za su bukaci kulawar mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar kwayar cutar coronavirus ta 2019 (COVID-19), wacce ke haifar da cutar sankarar bargo mai saurin kamuwa da cutar (SARS) coronavirus 2 (SARS-CoV-2), ta riga ta kashe mutane sama da 3,000 kuma ta shafi mutane sama da 80,000 a China da sauran sassan duniya, wanda ya zama babbar barazana ga lafiyar ɗan adam.
A cikin yanayin da ya dace da cutar SARS-CoV, wanda ya haifar da dubban kamuwa da cutar SARS a 2003, SARS-CoV-2 na iya samo asali ne daga ƙuda kuma yana da alamun bayyanar cututtuka iri ɗaya da kuma kamuwa da cuta iri ɗaya.
Koyaya, COVID-19 ba ta da ƙarfi kuma ba ta da haɗari kamar SARS amma tana yaduwa sosai kuma tana shafar tsofaffi fiye da matasa kuma tana shafar maza fiye da mata.
Yayin da wallafe-wallafen da ke tattare da cutar ke ci gaba da ƙaruwa, manufar wannan labarin shine samar da bayanai masu dacewa da kuma nazarin ayyukan bincike a wannan fannin.
Za a tattauna muhimman bayanai game da cututtuka, cututtuka masu tasowa, cututtuka, yadda za a gane su, yadda za a bi da su, yadda za a yi hasashen cutar, da kuma yadda za a kāre kansu.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba tukuna, muna fatan wannan talifin zai taimaka maka ka san da kuma magance wannan muguwar cuta.
Bikin bazara na ranar 25 ga Janairun 2020 ya zama na musamman kuma abin tunawa ga duk Sinawa, saboda an hana su fita waje a duk lokacin bikin da kuma makonni da yawa bayan haka saboda barkewar cutar.
Wannan kwayar cutar tana da alaƙa da kwayar cutar coronavirus (CoV) wacce ta kasance cutar sauro mai saurin kamuwa da cuta (SARS) a cikin 2003; an sake ta da SARS-CoV-2 ta Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020, kuma cutar da ta haifar da ita an sake ta da CoV Disease-19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma ta bazu cikin sauri a kasar Sin da kuma kusan ƙasashe 50 a duniya.
A ranar 2 ga Maris, 2020, cutar ta haifar da ƙarin kamuwa da COVID-19 sama da 80,000, tare da warkewa da sake dawowa sama da 40,000 da mutuwar sama da 3,000.
Hukumar Lafiya ta Duniya ta yi gargadin cewa COVID-19 shine "magabcin lamba 1 na ɗan adam" kuma yana iya zama mafi muni fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, mata sun buga labarai sama da 200 game da COVID-19 gami da ilimin ƙwayoyin cuta, cututtukan cututtuka, ilimin cututtuka, ganewar asali, da hanyoyin magani, tun lokacin da aka fara ba da rahoto a ranar 7 ga Janairu 2020 game da yadda cutar ke yaduwa.
Wannan talifin zai yi ƙoƙari ya taƙaita abin da za a yi a wannan sabon abu da ke yaɗuwa da sauri.
Idan za ta yiwu, za a gwada kwatancen COVID-19 da SARS da kuma cutar CoV, cutar murar Gabas ta Tsakiya (MERS, wanda ya bayyana a cikin 2012).
Za mu kuma tattauna abin da muka koya game da yadda za a magance cutar da kuma yadda za a magance ta da kuma wasu tambayoyi masu muhimmanci.
An ce CoVs ba su da haɗari sosai, galibi suna haifar da 15% na yawan kamuwa da mura.
Duk da haka, a wannan karni, mun sami wasu CoVs masu cutar mutum sau biyu, kamar SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar daga China a 2003 da Saudi Arabiya a 2012, kuma sun bazu cikin sauri zuwa wasu ƙasashe tare da kamuwa da cuta da kashe mutane da yawa.
Saboda haka, COVID-19 na yanzu shine CoV na uku da ya bayyana a tarihin ɗan adam.
Kamar yadda aka nuna a cikin adadi. An fara bayyana cutar ta numfashi mai lamba 1.1 a Wuhan a ranar 31 ga Fabrairun 2019 ta Hukumar Kula da Kiwon Lafiyar Jama'ar Sin.
Bayan kwana bakwai, an gano yadda CoV ke tasowa.
A ranar 15 ga Janairun 2020, an samu mutuwar farko a Wuhan.
A lokacin, cutar tana yaduwa cikin birane da yankuna da kuma ƙasashe da ke kusa da su.
A ranar 20 na watan, likitoci sun gano cewa cutar tana da haɗari sosai.
A ranar 23 ga Janairu, an rufe birnin Wuhan kuma an dakatar da zirga-zirgar jama'a.
A ranar 24 ga Janairu, lokacin da aka fara binciken cutar, mutane 21 daga cikin mutane 41 da aka gano sun isa kasuwar kifin Wuhan inda cutar ta samo asali ne daga wani dabba da ba a sani ba.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta ayyana cutar a matsayin babbar matsalar duniya.
A lokacin da ake wallafa wannan rahoton, cutar ta bazu ko'ina cikin China da kuma kusan ƙasashe 50 a duniya (Fig. 2).
Da yake sun yi saurin canjawa, ba a san iyakar girman su da kuma ƙarfin su ba tukuna.
A ranar 11 ga Fabrairu, 2020, binciken da aka yi akan marasa lafiya 8,866, gami da mutane 4,021 da ke da cutar COVID-19 sun nuna sabon yanayin cutar kamar yadda ke ƙasa (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana shafar mutane a kowane zamani, amma galibi yana shafar mutane masu shekaru 30-65.
Kusan rabin (47.7%) na masu cutar sun wuce shekaru 50, kusan kusan kusan kusan 20 ne, kuma kawai 14 daga cikin masu cutar sun kasance ƙasa da shekaru 10.
SARS-CoV-2 ya fi kamuwa da maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya bazu cikin al'ummomi musamman a Hubei da kewayenta.
COVID-19 ya ɗauki matsakaicin kwanaki 5 (2-9) daga farkon zuwa ranar ganowa.
Matsakaicin lokacin bayyanar cutar shine kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin farawa zuwa mutuwa shine kwanaki 9.5 (4,8-13).
Yawan haifuwa (R0) shine 3.77 (95% CI: 3.51-4.05), kuma canjin R0 shine 2.23-4.82.
Yawan masu kamuwa da cutar ya karu sosai kafin ranar 23 ga Janairu, 2020, daidai da lokacin da aka yi amfani da sufuri sosai a lokacin bikin bazara na kasar Sin.
Matsakaicin mutuwar ya kasance 1.44% (95% CI: 1.10-1.86%), kuma canjin yawan mutuwar ya kasance 3.06% (95% CI: 2.02-4.59%).
Abubuwa uku masu haɗari na COVID-19 sune jinsi (maza), shekaru (≥60), da wahalar numfashi.
CoVs suna cikin babban iyali na ƙwayoyin cuta kuma suna cikin ƙwayoyin cuta waɗanda ke da alaƙa da RNA.
Ana iya rarraba su zuwa rukuni huɗu, misali, alpha, beta, gamma, da delta, kuma an san alpha- da beta-CoVs don cutar da mutane.
A cikin wannan yanayin, ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta ta hanyar ƙwayar cuta.
Ana samar da kwayar RNA ta hanyar cytoplasm; bayan yaduwar kwayar cutar, kwayar RNA tana shiga cikin ambulaf na glycoproteins da nucleocapsid proteins don samar da vesicles na virion, wanda ke haɗuwa da plasma don samar da kwayar.
An gano kwayar halittar SARS-CoV-2 ta farko a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV tare da daidaito na jini na kashi 99.98% a cikin samfuran 10 da aka tattara daga inda aka fara fitowa, kasuwar kifin Huanan da ke Wuhan.
A cikin wannan yanayin, cutar SARS-CoV-2 ta fi dacewa da cutar SARS-CoV fiye da MERS-CoV.
A cikin yanayin fashewar lantarki ta hanyar microscope, ana iya gano ɓangarorin SARS-CoV-2 a cikin jikin mutum ta hanyar numfashi.
An gano cewa ACE2 na ɗan adam shine mai ɗaukar SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 ba shi da ƙarfi sosai ga ACE2 na ɗan adam fiye da na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 ba zai haifar da cututtuka masu tsanani ga ɗan adam kamar SARS-CoV ba.
SARS-CoV-2 na iya samar da sabon ƙaramin furotin daga orf3b kuma ya samar da furotin daga orf8.
Hakanan, a cikin SARS-CoV-2 an gano cewa cutar ta SARS-CoV-2 tana da alamun cutar da ke haifar da cutar.
A ranar 18 ga Fabrairu, 2020, Zhou, da abokan aiki, sun bayyana cewa jikin ACE2 na mutum mai tsayi a cikin 2,9 Å mai rikitarwa yana dauke da amino acid mai ɗaukar B0AT1.
An gano cewa waɗannan ƙwayoyin cuta, waɗanda ke buɗewa da rufewa, sun haɗu kuma ƙwayoyin cuta na ACE2-B0AT1 na iya haɗuwa da sunadarai biyu na S, wanda zai ba da hujja don gano CoV da cutar.
Hakanan, a cikin waɗannan lokuta, cutar SARS-CoV-2 tana da alamun cutar.
Tushen da Kuma Wurin Da Aka Ɗaukaka
An san cewa SARS-CoV da MERS-CoV sun samo asali ne daga ƙuda kuma an watsa su ga mutane ta hanyar ƙuda da raƙuma.
Idan aka kwatanta SARS-CoV-2 da sauran CoVs, SARS-CoV-2 a cikin mutane ya fi na ƙuda saboda sabon ƙwayar cuta yana da kusan kashi 96% na kama da CoVs da ke da alaƙa da SARS guda biyu da aka samo daga ƙuda mai suna SL-CoVZX45 da SL-CoVZX21.
Amma, ba a san ainihin abin da ya sa cutar ta fito daga dabbobi zuwa mutane ba, kuma ba a san yadda ta shiga ba.
Ji da abokan aikinsa sun ce macizai ne suka kawo kwayar daga ƙuda zuwa mutane, kuma sun haɗa ta da furotin S.
A wani bincike, masu bincike a Guangzhou, China, sun gano cewa pangolins - dabbobi masu shayarwa da ake amfani da su a matsayin magungunan gargajiya a China - na iya zama wuri na biyu na SARS-CoV-2 bisa ga 99% na kamawar jini da CoV da aka gano a cikin pangolins da SARS-CoV-2.
Duk da haka, bambancin kashi 1% tsakanin ƙwayoyin cuta biyu har yanzu babban bambanci ne; saboda haka, za mu ci gaba da jira don tabbataccen ƙarshe (Lambar 33).
An gano cewa cutar SARS-CoV-2 ta kamu da cutar a cikin shekaru biyar da suka gabata.
SARS-CoV da MERS-CoV na iya rayuwa a waje da yanayin su na tsawon awanni 48 a cikin yanayin bushewa da har zuwa kwanaki 5 a ƙasa da 20 °C da 40%-50% a yanayin sanyi.
Hakanan, SARS-CoV-2 yana iya zama mai kama da juna.
An ce SARS-CoV-2 ba zai iya jurewa da hasken ultraviolet da zafin jiki na 56 °C ba a cikin minti 30; ko kuma, 75% ethanol, maganin kashe ƙwayoyin cuta mai ɗauke da chlorine, parasitic acid, chloroform, da sauran magungunan kashe ƙwayoyin cuta, amma ba chlorhexidine ba, na iya kashe kwayar cutar sosai.
Dukkanin mutane ba su da ƙwayoyin cuta ga SARS-CoV-2, don haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, babu wani bincike mai zurfi game da yadda za a magance SARS-CoV-2.
Saboda haka, za a iya yin la'akari da binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
Yawancin lokaci, lokacin da kwayar cuta ta shiga cikin kwayar halitta, kwayar cuta tana gano ta ta hanyar gano wasu abubuwa (PRRs) gami da nau'in mai ɗaukar hoto na C, mai ɗaukar hoto mai kama da Toll (TLR), mai ɗaukar hoto mai kama da NOD (NLR), da mai ɗaukar hoto mai kama da RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da ciwo, yana haifar da ƙwayoyin cuta, kuma yana haɗuwa da gajeren lokaci na interferon-like I (IFNs) wanda ke hana yaduwar kwayar cutar kuma yana saurin samar da ƙwayoyin cuta.
Amma, ƙwayar cuta ta SARS-CoV ta N na iya taimakawa kwayar cutar ta guje wa tasirin rigakafin cutar.
A kwanan nan, ƙwayoyin cuta suna haɗuwa don su yaƙi ƙwayoyin cuta.
T lymphocytes da kuma CD4+ da CD8+ T cells suna da tasiri a cikin tsarin rigakafi.
Kwayoyin T na CD4+ suna motsa ƙwayoyin B don samar da ƙwayoyin cuta, kuma ƙwayoyin T na CD8+ suna kashe ƙwayoyin cuta da ke cikin kwayar cutar.
Kwayoyin T masu taimakawa suna samar da cytokines da ke haifar da ƙwayoyin cuta don taimakawa ƙwayoyin cuta.
Koyaya, CoV na iya hana ƙwayoyin T suyi aiki a cikin tsarin mutuwar T.
Kwayoyin cuta masu haɗuwa kamar C3a da C5a da ƙwayoyin cuta suna da mahimmanci don yaƙar wannan kwayar.
Alal misali, an cire ƙwayoyin cuta daga mutanen da suka warke daga cutar MERS-CoV.
Amma, idan ƙwayarmu ta hana mu kamuwa da cuta, za ta iya sa mu yi rashin lafiya kuma hakan zai iya sa mu yi rashin lafiya.
A cikin cutar SARS-CoV-2, cutar ta farko ta kamuwa da cutar ta fi shafar tsofaffi da ke da wasu cututtuka da kuma mata masu ciki.
Mutane da ke da ƙwayoyin cuta da yawa ko kuma waɗanda ke da ƙarancin rigakafi suna da haɗarin kamuwa da cutar fiye da sauran mutane.
Matsakaicin lokacin bayyanar cutar SARS-CoV-2 shine kwanaki 1-14, mafi yawa kwanaki 3-7 bisa ga binciken da aka yi akan mutane 425 da aka fara ganowa a Wuhan.
Amma, binciken da aka yi a kan mutane 1,099 ya nuna cewa aƙalla kwanaki 3 ne cutar take bayyana kuma daga kwanaki 0 zuwa 24.
Wani bincike da aka yi kwanan nan, kamar yadda aka ambata a sama, ya nuna cewa tsawon lokacin bayyanar cutar ya kai kwanaki 4.8 (3.0-7.2) bisa ga mutane 8,866 da aka bi.
Yana da mahimmanci ga likitoci su daidaita lokacin keɓewa don daidaita ainihin lokacin bayyanar cutar, don haka hana mutane masu alamun cutar daga yada kwayar cutar ga wasu.
Kamar yadda yake a al'ada, mutanen da ke da alaƙa da cutar ko waɗanda ke da cutar suna buƙatar keɓewa na kwanaki 14.
Shin ya kamata a keɓe mutane na kwanaki 24?
Zazzabi shine mafi mahimmancin alamun bayyanar COVID-19, wanda zai iya kasancewa da kansa ko tare da wasu alamun kamar tari mai tsanani, numfashi, ciwon jijiyoyi, zazzaɓi, zafi, ciwon makogwaro, ƙwanƙwasa hanci, ciwon kirji, zawo, tashin zuciya, da amai.
Wasu marasa lafiya suna fama da ciwon numfashi da kuma/ko kuma rashin numfashi na ɗan lokaci a cikin mako ɗaya bayan kamuwa da cutar.
A cikin yanayi mafi tsanani, marasa lafiya suna da ciwon numfashi da kuma bugun zuciya, da kuma rashin jini.
Ya kamata a gwada mutanen da ke da zazzabi da/ko wahalar numfashi da zazzabi mai tsanani, koda kuwa ana tsammanin suna da ciwon huhu.
Binciken da aka yi a ƙarshen Disamba 2019 ya nuna alamun cutar a kashi 98% na zazzabi, 76% na tari, 55% na zazzabi, da 3% na zawo; 8% na mutane suna buƙatar taimakon iska.
An sami sakamako iri ɗaya a cikin sababbin bincike biyu da aka yi kan masu kamuwa da cuta da kuma masu yaduwar cutar ga marasa lafiya.
Amma, binciken da aka yi a shekara ta 2012 ya nuna cewa yawan mutanen da ke fama da cutar MERS-CoV suna da zazzabi (98%), tari mai tsanani (47%), da kuma numfashi mai wuya (55%).
Amma kashi 80% na waɗannan sun buƙaci taimakon iska, wanda ya fi yawan masu cutar COVID-19 da MERS da ke da lahani amma ba kamar COVID-19 ba.
Ana kuma samun zawo (26%) da ciwon makogwaro (21%) a cikin mutanen da ke da cutar MERS.
A cikin mutanen da ke da cutar SARS, zazzabi (99%-100%), tari mai tsanani (29%-75%), jiri (40%-42%), zawo (20-25%), da ciwon makogwaro (13-25%) sun kasance manyan alamun bayyanar cututtuka kuma kusan 14%-20% na buƙatar taimakon iska.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2 cikin ɗari yayin da adadin mutuwar duniya ya kai 66,576.
Idan aka gwada, yawan mutanen da suka mutu daga SARS a watan Nuwamba na shekara ta 2002 ya kai kashi 10 cikin ɗari na mutane 8,096 da suka kamu da cutar.
A cikin mutane 2,494 da suka kamu da cutar, kashi 37 cikin ɗari ne suka mutu a sakamakon wani bincike da aka yi a watan Yuni na shekara ta 2012.
A cikin binciken farko, R0 na SARS-CoV-2 ya kasance 6.47 da 95% dogara (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance daga 2 zuwa 4.
Ana kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamomi, yawan mutuwa, da R0 a cikin Tebur na 1.1.
Hakanan, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Saboda haka, cutar SARS-CoV-2 ta fi rikitarwa fiye da MERS-CoV da SARS-CoV.
Sau da yawa ana tura kaya daga gida ko kuma wani wuri ko kuma a kawo su ta jirgin ruwa.
Yawanci, masu kamuwa da cutar sun haɗa da mutanen da suka yi tafiya zuwa ko sun zauna a ko kuma sun kamu da cutar a cikin makonni biyu kafin barkewar cutar.
Koyaya, akwai yiwuwar mutane su iya ɗaukar kwayar cutar ba tare da nuna alamun cutar ba har tsawon makonni biyu kuma waɗanda suka warke daga asibiti suna iya sake kamuwa da cutar, don haka ana buƙatar ƙara kwanakin keɓewa.
Marasa lafiya waɗanda ke da ƙarancin ƙwayoyin farin jini ko ƙarancin ƙwayoyin jini (musamman ƙwayoyin lymphocytes) a farkon cutar.
Misali, an gano cutar lymphopenia a cikin adadin farin jini &lt; 4×109/L tare da ƙididdigar ƙwayoyin lymphocyte &lt; 1×109/L, da kuma ƙimar aspartate aminotransferase da viremia a cikin marasa lafiya 1,099 na COVID-19.
Wasu marasa lafiya suna da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
A cikin marasa lafiya masu tsanani, yawan dimer D, wato, ƙwayar jini da ke da ƙarfi, ya ƙaru, kuma ƙwayoyin lymphocyte sun soma raguwa.
An lura da ciwon kirji a cikin mutane da yawa da ke fama da COVID-19 kuma suna nuna bambancin yanayin duhu ko wuraren duhu a cikin huhu.
Sau da yawa marasa lafiya suna fama da ciwon huhu, ciwon huhu, da kuma ciwon numfashi mai tsanani (ARDS).
A lokacin ARDS, ciwo mai tsanani, hawan jini, da kuma lalacewar fibrosis suna sa numfashi ya yi wuya.
Rashin aiki na nau'ikan I da II na ƙwayoyin cuta yana rage matakin surfactant kuma yana haɓaka yanayin ciwo, don haka yana rage damar buɗewa na huhu kuma yana ƙara haɗarin cutar huhu.
Saboda haka, yawan ciwon huhu da suke fama da shi yana da nasaba da ciwon da ke sa su baƙin ciki.
A ranar 18 ga Fabrairu, 2020, binciken farko na COVID-19 ya nuna lalacewar ƙwayoyin cuta, ɓarkewar hyaline, da ɓarkewar ƙwayoyin lymphocytes na ciki, da ƙananan ƙwayoyin cuta a cikin ƙwayoyin huhu na mutanen da suka mutu daga cutar; wanda ya dace da yanayin cutar da ARDS kuma yayi kama da na SARS da MERS.
Ana amfani da gano SARS-CoV-2 RNA ta hanyar RT-PCR a matsayin muhimmin ma'auni don gano COVID-19.
Duk da haka, saboda yawan bayanan da ba daidai ba, wanda zai iya haifar da cutar, an fara amfani da alamun gano cutar (ba a iyakance ga RT-PCR kawai ba) a China a ranar 13 ga Fabrairu, 2020.
An yi irin wannan binciken a cikin binciken SARS.
Saboda haka, tattara bayanan cutar, yanayin cutar, gwaje-gwajen gwaje-gwaje, da bayanan radiography yana da mahimmanci kuma zai taimaka wajen tabbatar da ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wata dabara ta amfani da tsarin gano SARS-CoV-2 na CRISPR SHERLOCK, don gano SARS-CoV-2 RNA a cikin 20 × 10-18 mol/L ko 200 × 10-18 mol/L (ƙididdiga 10-100 a cikin microlit) ta amfani da ma'auni a ƙasa da awa ɗaya ba tare da yin aiki mai rikitarwa ba.
Da fatan, wannan sabon tsarin zai iya canza yanayin da kuma ingancin amfani, idan an yarda da shi bayan an sake dubawa.
Saboda rashin sanin sabon CoV, likitoci na iya ba da magani kaɗan ga masu cutar COVID-19, yayin da suke jiran ƙarin magunguna da ake amfani da su a cikin mata ko waɗanda aka yi la'akari da su a baya don magance wasu CoVs kamar SARS-CoV da MERS-CoV da cututtukan ƙwayoyin cuta (Table (Table2).2).
Waɗannan magungunan sun haɗa da sababbin magunguna da za a iya amfani da su waɗanda suka ƙunshi magungunan 'ya'yan itace, masu hana rigakafi, steroids, jini, maganin gargajiya na kasar Sin, da kuma magani.
An ce za a iya yin amfani da jini na mutum a matsayin magani.
Kamfanonin harhada magunguna za su yi aiki tuƙuru don samar da magunguna da alluran rigakafi don cutar.
SARS-CoV-2 yana da tasiri sosai akan huhu da kuma wasu ƙananan ƙwayoyin cuta waɗanda ke da tasirin ACE2, kamar hanji da kodan.
Duk da haka, ciwon numfashi da rashin hankali suna da haɗari ga yawancin marasa lafiya kuma suna da lahani mafi girma.
Saboda haka, taimakon numfashi yana da mahimmanci don rage alamun cutar da kuma warkarwa kuma ya ƙunshi samar da iskar oxygen, ƙarin iskar oxygen, iskar oxygen mai sauƙi, da kuma iskar oxygen mai mahimmanci.
An yi amfani da maganin ECMO don taimaka wa marasa lafiya da ke fama da ciwon numfashi mai tsanani, wani sabon tsarin sakawa na zuciya da aka yi amfani da shi don magance cututtukan zuciya ko kuma rashin numfashi.
Bugu da ƙari, kiyaye daidaiton wutan lantarki, rigakafi da warkar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An san cewa haɓakar cytokine yana haifar da halayen rigakafi na mutum a cikin mutane da ke fama da SARS da MERS.
Cytokine shine nau'in ciwo wanda yawancin cytokines ke haifar dashi kamar TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Cytokines suna motsa ƙwayoyin cuta don samar da wasu ƙwayoyin cuta daban-daban waɗanda galibi ke haifar da ARDS da lalacewar gabobin jiki.
Magungunan rigakafi suna da mahimmanci don ceton cytokines, musamman a cikin marasa lafiya.
An yi amfani da maganin cututtukan jiki da kuma tocilizumab, IL6, wanda ke hana kamuwa da cuta.
Wasu magungunan rigakafin rigakafin cytokine suna amfani da ƙwayoyin T-cell masu haɗuwa da ƙwayoyin cuta; toshe IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; mai hana cytokine mai nuna 4; da masu hana HDAC.
Ana amfani da kwayoyin cuta, kamar masu hana rigakafi, a matsayin maganin SARS don rage ciwo.
Duk da haka, ba a taɓa yin amfani da allurai masu yawa don cutar huhu a cikin marasa lafiya da ke fama da SARS da COVID-19.
Amma, yana iya jawo wasu matsaloli, musamman a cikin jini, kuma yana shafan yanayin da ake ciki.
Koyaya, ana ba da shawarar yin amfani da ƙananan allurai na corticosteroids a hankali ga marasa lafiya masu cutar COVID-19 waɗanda ke fama da rashin lafiya mai tsanani.
A lokacin da muke rubutu, babu wani magani da aka sani don cutar.
Duk da haka, yin amfani da maganin remdesivir, wanda shine analog na nucleotide, ya tabbatar da cewa yana da tasiri sosai a cikin Amurkawa da ke fama da COVID-19.
Remdesivir magani ne na rigakafin cutar da aka fara samarwa a Gilead don magance cutar Ebola da Marlburg.
Daga baya, an nuna cewa remdesivir na iya magance wasu ƙwayoyin cuta na RNA ciki har da MERS da SARS.
Bisa ga waɗannan ƙididdigar, Gilead ta ba da waɗannan kayan aikin a China don gwaji a kan mutane da ke fama da cutar SARS-CoV-2, kuma ana jiran sakamakon da ake tsammani.
Bugu da ƙari, an ba da shawarar cewa baricitinbe, interferon-α, lopinavir/ritonavir, da ribavirin, na iya taimakawa marasa lafiya da ke fama da ciwon numfashi mai tsanani.
Za a iya samun zawo, tashin zuciya, amai, cutar hanta, da sauran halayen da ba su dace ba idan an haɗa wannan magani da lopinavir/ritonavir.
Idan aka haɗa waɗannan magunguna da wasu magunguna da aka yi amfani da su a wasu marasa lafiya, dole ne a lura da su sosai.
Jinin da ke cikin jini da kuma rigakafi
Yin amfani da jini daga waɗanda suka tsira daga cutar don magance wasu masu cutar ko don kare lafiyar mutane daga kamuwa da cutar ya kasance tarihi ne.
Hakika, mutane da suka warke sau da yawa suna da ƙwayoyin cuta masu ƙarfi a cikin jinin su.
Kwayoyin rigakafi sune immunoglobulin (Ig) wanda kwayoyin B ke samarwa don magance ƙwayoyin cuta da sauran ƙwayoyin cuta kuma suna gano kwayoyin da ke cikin ƙwayoyin cuta sannan su kashe su.
Bisa ga waɗannan ƙididdigar, ana yawan karɓar jini daga marasa lafiya da suka warke daga COVID-19 kuma an karɓa daga mutane 10 da ke da ciwo mai tsanani.
Sun warke bayan sa'o'i 24. Ciwon da suke yi ya ragu kuma sun daina samun iskar oxygen a cikin jinin.
Duk da haka, tabbatarwa da kuma bayani suna da mahimmanci don ba da shawarar yin amfani da wannan hanyar don amfani da su kafin samar da magani na ainihi.
Bugu da ƙari, domin haɗarin da magani zai iya jawowa, ya kamata a yi la'akari da wasu haɗarin jini.
Alal misali, ƙwayoyin cuta suna iya ƙarfafa ƙwayoyin cuta kuma su sa a samu cytokines, wanda zai iya zama haɗari ga rayuwa.
Yawan maganin rigakafi a cikin jini yana da ƙananan, kuma ana buƙatar plasma don magance cututtuka.
Yana da wuya a samar da ƙwayoyin cuta na musamman don yaƙi da cutar.
Saboda haka, yana da mahimmanci kuma ya dace a rarraba ƙwayoyin B daga waɗanda suka tsira kuma a tantance ko kuma a ɗauki waɗannan ƙwayoyin don gano ko waɗannan ƙwayoyin suna iya yin yaƙi da ƙwayoyin cuta.
Hakan zai sa a yi maganin rigakafi da sauri.
An yi amfani da maganin gargajiya na gargajiya na gargajiya don magance cututtuka da yawa a kasar Sin shekaru da yawa.
Amma, haɗarin ya fito ne daga haɗuwa da abubuwa da yawa da ke da bambanci dangane da yanayin cutar ta hanyar TCM.
Yawancin abubuwan haɗin da ke taimakawa ba a san su ba ko kuma ba a san su ba saboda wahalar samarwa da tabbatar da su da kuma yadda za a haɗa su da kyau.
A halin yanzu, saboda rashin ingantaccen magani da ingantaccen magani don COVID-19, TCM ya zama mafi kyawun magani ga mutanen da ke da alamun rashin lafiya ko waɗanda suka warke daga mummunan cuta.
Misali, an gano cewa maganin Shu Feng Jie Du da Lian Hua Qing Wen sun kasance masu tasiri sosai wajen magance COVID-19.
An lura da mafi yawan warkewar COVID-19 a yawancin lardunan China da ke amfani da TCM tare da kashi 87% na masu cutar, kamar Gansu (63,7%), Ningxia (50%), da Hunan (50%), amma a lardin Hubei, wanda ke amfani da TCM tare da kusan kashi 30% na masu cutar COVID-19, kawai kashi 13% ne kawai suka warke.
Duk da haka, wannan kwatancen yana da wahala saboda wasu dalilai kamar yawan masu cutar da kuma tsananin cutar dole ne a yi la'akari da lokacin binciken.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike don kwatanta maganin gargajiya na Turai (WM) da kansa da maganin WM da TCM.
An lura cewa lokacin da ake bukata don rage zafin jiki, warkar da cututtuka, da kuma asibiti ya fi ƙasa a cikin rukunin WM+TCM fiye da rukunin WM kadai.
Abin mamaki, yawan ci gaba da alamun cutar (daga mai sauƙi zuwa mai tsanani) ya kasance ƙasa da ƙasa ga ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (7.4% vs. 46.2%) kuma mutuwar ta kasance ƙasa da ƙungiyar WM + TCM fiye da ƙungiyar WM kawai (8.8% vs. 39%).
Duk da haka, inganci da fa'idar TCM har yanzu suna jiran tabbatarwa bayan an gwada su a cikin mutane da yawa da kuma wurare da yawa.
Hakanan za a ba da hankali ga fahimtar tsarin aiki da kuma bayanin ingancin abubuwan da ke cikin maganin TCM ko yadda ake haɗa su idan ya yiwu.
Mutane da ake zargi da kamuwa da cutar COVID-19 ko kuma waɗanda ke da ita, galibi suna da tsananin tsoron cutar mai saurin mutuwa, kuma waɗanda aka keɓe suna da damuwa, kaɗaici da fushi.
Ƙari ga haka, alamun rashin lafiya kamar zazzabi, rashin iskar oxygen, da tari da kuma wasu cututtuka da ake samu daga shan magani kamar rashin barci da ake samu daga shan magungunan da ake kira corticosteroids suna iya sa mutum ya damu sosai kuma ya yi baƙin ciki.
A lokacin da cutar SARS ta fara, an ce mutanen sun nuna halaye da yawa kamar su damuwa, damuwa, fargaba, rashin hankali, mantuwa, rashin hankali, har ma da ƙoƙarin kashe kansa.
Binciken da ke tattare da hulɗa da ke tattare da keɓewa don kare COVID-19 na iya haifar da damuwa da alhakin kamuwa da cutar, keɓewa, da baƙin ciki ga dangi da abokai.
Don haka, ya kamata a ba da kulawa ta musamman ga mutanen da ke da cutar COVID-19, waɗanda ake tsammanin suna da cutar, da duk waɗanda ke buƙatar ta.
Kula da cututtukan mutum ya kamata ya haɗa da zaɓin ƙungiyar masu kula da cututtukan mutum da yawa, sadarwa ta yau da kullun da kuma samar da ingantaccen bayani game da barkewar SARS-CoV-2 da samar da magunguna da kuma amfani da na'urori da aikace-aikace don nisantar da mutane.
Alluran rigakafi na yau da kullun suna da mahimmanci don dakatar da yaduwar kwayar cutar daga dabbobi da mutane masu kamuwa da cuta da kuma sauran abubuwa kuma galibi suna aiki tare da maganin rigakafi don magance cututtukan da ke haifar da sabbin ƙwayoyin cuta.
An yi ƙoƙari don samar da allurar rigakafi daga furotin S don samar da ƙwayoyin cuta masu ɗorewa waɗanda zasu iya kashewa da / ko kare mutane daga SARS-CoV.
Mata sun gwada maganin rigakafin SARS a cikin kifi.
Koyaya, ba a san ainihin ingancin allurar rigakafi a cikin tsofaffi da marasa lafiya da kuma kariya daga ƙwayoyin cuta na dabbobi ba kafin a fara nazarin kwayoyin halittar mutum.
Wataƙila saboda SARS ya ɓace shekaru 17 da suka gabata kuma babu wani wanda ya kamu da cutar tun daga lokacin.
Akasin haka, mutane da ƙananan ƙungiyoyi za su ci gaba da kamuwa da cutar MERS a Gabas ta Tsakiya kuma za su ci gaba da yaduwa ta hanyar dabbobi.
Mata sun yi ƙoƙarin samar da allurar rigakafin MERS ta hanyar kashe kwayar cutar, DNA na kwayar halitta, masu ɗaukar hoto, ƙananan kwayoyin halitta, abubuwan da ke kama da kwayar cutar da ƙwayoyin cuta na kwayar cuta da sauran gwaje-gwaje na dabbobi.
Samun ingantaccen allurar rigakafi mai ƙarfi da ke aiki da ƙarfi don yaƙar SARS-CoV-2 ga mutanen da ba su da rigakafi yana da mahimmanci da aiki mai wuya don hana yaduwar cutar.
Amma, yana da wuya a shawo kan matsalolin saboda yawan lokaci da ake bukata (kimanin watanni 18) don samar da allurar rigakafi da kuma saboda yawancin nau'ikan CoVs.
A matsayin sabon kamuwa da cuta, COVID-19 yana nuna ƙarfinsa ne kawai a cikin ƙananan mutane.
A yawancin lokuta, waɗanda suke da wannan cutar suna iya warkewa a hankali ba tare da nuna alamun cutar ba.
Amma kamar SARS da MERS, COVID-19 yana da haɗari da kuma mutuwa a cikin mutane masu fama da cutar.
Saboda haka, ƙirar ƙirar ƙirar ƙirar ƙirar ƙirar ƙira yana da mahimmanci ga likitoci don sanya ƙwarewar su a gaba, musamman a wuraren da ƙwarewar ƙwarewa ta iyakance.
Dangane da binciken da aka yi a kan kwayoyin halitta, waɗannan abubuwan da ke gaba suna iya tasiri ko kuma alaƙa da gano cutar COVID-19 (Table (33)):
Ruwa: Ruwa yana da mahimmanci wajen tantance cutar SARS, wanda kuma ya shafi COVID-19.
COVID-19 ya fi bayyana a cikin mutane masu shekaru 30 zuwa 65 saboda kashi 47.7 cikin ɗari na masu cutar sun haura shekaru 50 a cikin binciken da aka yi da mutane 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun nuna alamun rashin lafiya da ciwo da kuma tsawon rai fiye da marasa lafiya (a matsakaita shekaru 66 da 51), wanda ke nuna cewa shekaru yana da tasiri mai tasiri a kan lafiyar mai cutar COVID-19.
Jima'i: SARS-CoV-2 yana da yawa ga maza fiye da mata (0.31/100,000 vs. 0.27/100,000), kamar yadda aka bayyana a sama.
Sauran cututtuka da cututtuka: Masu cutar COVID-19 da ke buƙatar kulawa mai tsanani suna iya fuskantar ciwon numfashi da bugun zuciya.
Cutar zuciya ta kasance babban dalilin mutuwa a cikin mutanen da ke fama da SARS.
An yi hasashen cewa SARS-CoV-2 na iya zama kama da ACE2 cholangiocytes, wanda zai iya haifar da rashin aiki na hanta a cikin mutane da ke fama da COVID-19.
Yana da kyau a lura cewa shekaru da kuma ciwo na dindindin suna da nasaba kuma suna iya shafar juna.
Rashin lafiyar gwaji: Matsayin jini na CRP yana nuna girman ciwo ko ciwon jijiya kuma an ce yana da tasiri a cikin ciwon, wanda ke taimakawa wajen warkarwa, kuma a ƙarshe, rayuwa.
An kuma tattauna alaƙar matakan CRP da tsinkayen COVID-19.
Bugu da ƙari, matakan lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen tantance lafiyar mutum.
Ana samun waɗannan ƙwayoyin a cikin gabobin jiki da yawa, musamman a zuciya da hanta, kuma ana samun su sa'ad da ƙwayoyin jiki suka lalace.
Saboda haka, sau da yawa wannan ne ke jawo ciwon zuciya ko kuma hanta.
Alamun cututtuka masu tsanani: Ana buƙatar yin la'akari da hotunan kirji da ƙananan ci gaban alamun cutar tare da wasu dalilai don tantance yiwuwar tsira daga COVID-19 da kuma yiwuwar haɗarin cutar.
Amfani da steroids: Kamar yadda aka ambata a sama, steroids sune magungunan rigakafi da aka saba amfani dasu don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Saboda yawan amfani da kwayoyin cutar a cikin marasa lafiya da ke fama da SARS, yawancin waɗanda suka warke sun kamu da cutar anemia da lahani na rayuwa da rashin lafiya.
Saboda haka, idan ya cancanta, ana buƙatar amfani da ƙananan allurai na steroid na ɗan gajeren lokaci a cikin marasa lafiya da ke fama da COVID-19.
Rashin kwanciyar hankali: Kamar yadda aka ambata a sama, lokacin da cutar COVID-19 ta ɓarke, mutane da yawa sun kamu da rashin kwanciyar hankali saboda keɓewar kansu na tsawon lokaci da rashin haƙuri da kuma ganin mutuwar dangi da sauran masu cutar.
Yana da muhimmanci a ba da shawara da kuma kula na dogon lokaci don a taimaka wa marasa lafiya su daina damuwa kuma su koma rayuwarsu ta yau da kullum.
Bisa ga binciken da aka yi a cikin mata, COVID-19 yana da alamun bambance-bambance da SARS.
Bugu da ƙari, SARS-CoV-2 yana iya zama mai saurin kamuwa da cutar ta hanyar numfashi na ƙasa kuma yana iya haifar da alamun rashin lafiya ko rashin alamun bayyanar cutar a farkon lokacin kamuwa da cutar, kamar sauran CoVs masu saurin sanyi.
Saboda haka, mutane da ke da cutar a farkon lokacin cutar ko kuma a lokacin da cutar ta fara, suna iya haifar da ƙarin kamuwa da cutar a cikin aikin yau da kullun, wanda ke sa ya zama da wahala a magance cutar.
Amma, SARS-CoV yana iya kamuwa da cutar a lokacin da mutum ya kamu da cutar sosai, amma ba a taɓa samun yaduwar cutar ba a farkon lokacin.
Saboda haka, cutar COVID-19 ta yanzu ta fi ƙarfin gaske kuma ta fi wahalar shawo kanta fiye da SARS.
Za a ci gaba da yin ƙoƙari a China don hana zirga-zirgar mutane zuwa Wuhan da biranen da ke kewaye da shi da kuma ci gaba da keɓewar ƙasa gaba ɗaya don fatan hana SARS-CoV-2 yaduwa.
Duk da irin wannan ƙoƙarin da ya shafi tattalin arziki da kuma al'umma, ƙaruwar yawan sababbin cututtuka zai nuna cewa annobar ta ragu.
Mafi kyawun kimantawa shine cewa wannan fitowar zata ƙare a watan Maris kuma lokacin da za'a rage shi zai ɗauki watanni 3-4.
Amma, wasu masana ba su yarda da hakan ba.
Paul Hunter, da abokan aikinsa sun yi imanin cewa COVID-19, wanda ya fi SARS haɗari, ba zai ƙare a cikin 2020 ba.
Ira Longini, tare da abokan aikinsa, sun tsara samfurin don gano sakamakon cutar kuma sun kimanta cewa SARS-CoV-2 na iya kamuwa da kashi biyu cikin uku na yawan jama'ar duniya.
Wani rukunin bincike na Kanada ya ba da rahoton cewa an gano SARS-CoV-2 a cikin wasu ɓoyayyen turbinate da kuma bargo na masu haƙuri da suka warke kuma aka sallame su daga asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar na iya zama cutar da ke faruwa a cikin yanayi kamar mura.
Amma, akwai alamun da ke nuna cewa adadin sabbin masu cutar a China yana raguwa, kuma hakan ya nuna cewa matakan da ake ɗauka yanzu suna da amfani.
A dā, an yi hasashen cewa cutar Ebola za ta kashe mutane kusan miliyan ɗaya, kuma mutane miliyan biyar za su mutu.
Amma, da yake an saka mutane a cikin keɓewa da kuma ware mutane, an daina cutar.
Hakanan yana yiwuwa, kamar yadda ya faru da SARS-CoV, cewa ƙarfin SARS-CoV-2 zai iya raguwa kuma daga ƙarshe ya ƙare ko ya zama cutar da ba ta da ƙarfi ga ɗan adam.
An kwatanta kwatancen COVID-19 da SARS da MERS a ƙasa (Fig. (Fig.55).
SARS-CoV-2 yana yaduwa ta hanyar tari ko fitsari, kuma a wasu lokuta ta hanyar abubuwan da ke dauke da cutar.
An kuma gano kwayar cutar a cikin ƙazanta, wanda ke nuna cewa mai yiwuwa ta shiga cikin bakin ta hanyar ƙazanta.
Wani bincike da aka yi kwanan nan da aka yi da mutane 138 ya nuna cewa kashi 41 cikin ɗari na marasa lafiya ba su kamu da cutar asibiti ba, har da marasa lafiya 17 da ke da wata cuta da kuma likitoci ko ma'aikatan jinya 40.
Saboda haka, yana da muhimmanci mu ɗauki mataki don mu kāre mutane, musamman likitoci, masu kula da lafiya, dangi, abokai, har ma da maƙwabta da suka taɓa yin cuta.
Babban matakin kariya don rage haɗarin kamuwa da cuta shine sanya abin rufe fuska da hanci; amfani da abin rufe fuska na likita da abin rufe fuska na N95 (lambar lamba # 1860s) zai taimaka wajen hana yaduwar kwayar cutar.
Abun rufe fuska na likita yana hana ruwa daga cikin jiki daga fitar da iska ko kuma ya haɗu da abubuwa, inda zai iya shiga cikin jiki.
Koyaya, kawai masks na N95 (lambar lamba # 1860s) na iya karewa daga ƙarancin ƙwayar cuta a cikin 10 zuwa 80 nm, kuma kashi 5% na kwayar cutar tana iya shiga cikin jiki; SARS-CoV-2 yayi kama da SARS-CoV a cikin girman kuma duka suna kusan 85 nm.
Don hana ɓarkewar ɓangarorin ta hanyar haɗa masks na likita guda biyar, ana buƙatar likitocin da ke hulɗa da marasa lafiya su sa masks na N95 (lambar lamba # 1860s) maimakon masks na likita.
Baya ga abin rufe fuska, dole ne likitoci su sanya takunkumin da ya dace don rage damar kamuwa da ƙwayoyin cuta.
Kwayoyin cutar za su iya kamuwa da mutum ta hanyar idanu.
A ranar 22 ga Janairun 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; mai yiwuwa kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu ciwo.
Saboda haka, ya kamata likitoci su riƙa saka abin rufe ido ko kuma tabarau sa'ad da suke kula da marasa lafiya.
Ga duk waɗanda ke cikin wuri mai cutar ko kuma waɗanda ke da yiwuwar kamuwa da cutar, yana da mahimmanci cewa dukansu su wanke hannayensu da sabulu mai kashe ƙwayoyin cuta sau da yawa fiye da yadda suke yi, su kasance a gida ta hanyar keɓe kansu da kuma hulɗa da mutanen da ke da yiwuwar kamuwa da cutar.
Mita biyu shine mafi kyawun tazara tsakanin mutane da marasa lafiya.
Yin waɗannan matakan sune hanya mafi inganci don rage haɗarin kamuwa da cutar da hana cutar yaduwa.
Ko da yake SARS-CoV-2 ya bayyana a matsayin sabon kwayar cuta a cikin ɗan adam, yana da alaƙa da SARS-CoV kamar yadda aka bayyana a ranar 7 ga Janairu, 2020, ya kamata ya zama sanannen sanarwa ga jama'a a China saboda an san yadda cutar SARS ta ɓarke a 2003.
Amma har zuwa 19 ga Janairun 2020, darektan Cibiyar Kula da Cututtuka ta Wuhan ya ba da tabbacin cewa sabon kwayar cutar ba ta da saurin yaduwa da kuma saurin yaduwa a cikin mutane kuma yana da wahalar kamuwa da cutar.
Wannan labarin ya janyo rashin kulawa, musamman a lokacin da ake shirin bikin bazara a duk faɗin ƙasar, kuma an rasa wannan lokacin mai mahimmanci don hana cutar daga yaduwa a Wuhan.
Hukumar Kula da Cututtuka ta kasar Sin za ta iya koyon darasi daga wannan mummunar koyarwar kuma ta yi gyara mai kyau a nan gaba.
Alal misali, waɗannan shawarwari sun ƙunshi (1) yin hankali sosai sa'ad da suke magana a gaban jama'a don su sa mutane su amince da su kuma su yi tasiri a kan halinsu da kuma shawarwarin da suke yankewa; (2) yin hankali da kuma mai da hankali ga bayanin da aka bayar daga asibitoci maimakon na likitoci ko hukumomi; (3) yin amfani da shawarwari masu ƙarfi don magance cututtuka a farkon lokaci maimakon yin amfani da su don sa mutane su yi tunani; da kuma (4) samar da hanyoyin da za su taimaka wa mutane su san game da cututtuka da kuma yadda za su yi bincike da kuma magance su.
Cutar COVID-19 ta hanyar sabon SARS-CoV-2 ya fara a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, ya bazu ko'ina cikin ƙasar Sin da kuma kusan ƙasashe 50 a duniya a lokacin da muke rubuta wannan labarin.
Saboda irin wannan cutar ta yi kama da SARS-CoV kuma alamun bayyanar cututtuka sun yi kama da COVID-19 da SARS, barkewar COVID-19 ya haifar da sake dawowar SARS.
Amma, akwai kuma bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ke da mahimmanci don hana cutar da kuma ceton masu kamuwa da cutar.
COVID-19 yana shafar tsofaffi fiye da matasa da maza fiye da mata, kuma yana da haɗari da haɗari ga tsofaffi fiye da matasa.
SARS zai iya kashe mutane fiye da COVID-19 (10.91% vs. 1.44%).
Mutane da ke fama da COVID-19 sun yada kwayar cutar ko da ba su da alamun cutar, amma mutanen da ke fama da SARS suna yada cutar ne kawai a cikin yanayin rashin lafiya mai tsanani, saboda haka yana da wuya a hana yaduwar COVID-19 fiye da SARS.
Wannan yana ba da ɗan bayani game da dalilin da yasa SARS-CoV-2 ya fi yaduwa da kuma yaduwa fiye da SARS-CoV.
Idan aka gwada RNA na SARS-CoV-2 na yau da kullun, babu yiwuwar ƙarin mutane su kamu da COVID-19.
Amma, waɗanda suka warke suna iya sake kamuwa da cutar.
Waɗannan abubuwan suna ƙara haɗarin yaduwar cutar sosai.
Don ci gaba da bincike na COVID-19, akwai wasu mahimman abubuwan da za a inganta, gami da:
Ta yaya SARS-CoV-2 ya samo asali?
Ko da yake an gano kusan kashi 96% na kama tsakanin SARS-CoV-2 da ƙwayoyin cuta guda biyu na SARS CoVs, ba za a iya tabbatar da cewa SARS-CoV-2 ya samo asali ne daga ƙwari ba.
Daga waɗanne dabbobi ne cutar ta yadu daga mazauninta, kamar su ƙuda zuwa mutane?
Idan ba mu san amsoshin tambayoyi na farko da na biyu ba, ba za mu iya hana wannan matsalar ba, kuma za ta iya sake tasowa a kowane lokaci.
Ko da yake gyaran kwayoyin halitta da gwaje-gwaje na ilimin halittu sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, shin ba mu san ainihin yadda kwayar cutar ke shiga cikin ƙwayoyin cuta na sama na numfashi ba kuma yana haifar da canji?
Shin kwayar cutar tana da alaƙa da ACE2- a cikin ƙwayoyin sauran gabobin jiki?
Idan ba mu san amsoshin waɗannan tambayoyin ba, ba za mu iya sanin magani da ya fi dacewa ba.
Har yaushe ne za a ci gaba da wannan ciwon?
Ta yaya ƙwayoyin cuta suke yaduwa cikin jini a jikin mutane?
Shin zai zama annoba ta duniya, ko kuma zai zama na dindindin kamar SARS ko kuma zai zama na yau da kullun kamar mura?
Yana da muhimmanci amma yana iya ɗaukar lokaci don samun amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Amma duk da haka, duk abin da za mu yi, abin da ya kamata mu yi shi ne mu hana cutar da wuri kuma mu dawo da rayuwarmu.
Kwayar cutar korona ta ɗan adam ta samo asali ne daga dabbobi
Tsarin canji da rarrabuwa yana ba da damar ƙwayoyin cuta na coronaviruses (CoVs) da masu ɗaukar su, gami da mutane, su ci gaba da girma tsawon shekaru.
A cikin shekarun da suka gabata, cutar ta kamu da cutar a cikin mutane da yawa.
A cikin wannan yanayin, cutar SARS da MERS sun zama sanannun alamun cutar HCoV.
Cutar SARS-CoV-2 da ta ɓarke a tsakiyar China a ƙarshen 2019 ta sanya CoVs a cikin jerin sunayen da ke da ban mamaki kuma suna da saurin yaduwa amma ba su da haɗari sosai fiye da SARS-CoV.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Yawancin HCoVs sun samo asali ne daga ƙuda amma ba sa haifar da cuta.
An kuma gano wasu ƙwayoyin cuta na HCoVs.
Sanin dabbobi masu ɗauke da cutar yana da muhimmanci wajen magance cutar.
Binciken alaƙar da ke tsakanin masu ɗaukar CoV a cikin dabbobi na iya zama babban taimako don gano cutar CoV a cikin mutane.
A cikin wannan labarin, za mu taƙaita abin da muka sani game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da kuma asalin dabbobi da masu watsa su.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa a cikin kwayoyin halitta.
An yi magana game da cutar CoV ta 2019 (COVID-19) a wannan labarin.
Bugu da ƙari, ya kuma tattauna abubuwan da ake buƙata don samun nasarar canza abubuwan da ke haifar da cuta da kuma tasirin su yayin da ƙwayoyin cuta ke ci gaba da haɓaka da kuma haɓaka.
Kwayoyin cutar Coronaviruses (CoVs) suna cikin dangin Coronaviridae, wanda ya ƙunshi rukuni na ƙwayoyin cuta masu ƙarfi na RNA.
Kwayoyin cuta da ke da manyan kwayoyin halitta na 26 zuwa 32 kilobases a cikin RNA-virus sun sami sunan CoVs saboda suna da alama suna da kambi a cikin microscope na lantarki.
A cikin kwayoyin halitta, CoVs ba su da tsarin kwayoyin halitta mai daidaituwa.
Kimanin kashi biyu cikin uku na kwayoyin halitta suna da sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sassan sas
Ana kuma amfani da sunadarai da yawa don a samar da sunadarai 16 na ƙwayoyin cuta, da ake kira nsp1~16.
Sauran kwayoyin halitta suna da ORFs don jikin sunadarai, ciki har da ƙwayoyin cuta (S), fata (E), membrane (M) da nucleoproteins (N).
Wasu ƙwayoyin cuta na musamman suna da lambar a cikin jerin CoVs daban-daban.
A cikin yanayin da ya dace, ana iya rarraba CoVs zuwa manyan rukuni huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), kuma beta-CoVs suna da yawancin HCoVs kuma an rarraba su zuwa rukuni huɗu (A, B, C da D).
Bayanan kwayoyin halitta sun nuna cewa jemage da beraye sune tushen asalin asalin yawancin alpha-CoVs da beta-CoVs, amma tsuntsaye sune tushen asalin gamma-CoVs da delta-CoVs.
A cikin shekaru dubu, CoVs suna haɗuwa sau da yawa a cikin iyakokin abinci kuma wasu daga cikinsu sun zama ƙwayoyin cuta masu cutar ɗan adam.
A halin yanzu, an gano mutane bakwai da ke dauke da kwayar cutar CoV (HCoVs).
A cikin waɗannan, HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Wasu daga cikin waɗannan ƙwayoyin cuta sun haɗa da cutar coronavirus mai saurin kamuwa da cuta (SARS-CoV), cutar coronavirus ta Gabas ta Tsakiya (MERS-CoV), da kuma SARS-CoV-2.
A cikin waɗannan lokuta, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
A akasin wannan, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 sun fi ƙarfin gaske, suna haifar da mummunan lalacewar ƙananan hanyoyin numfashi a cikin yawancin marasa lafiya waɗanda ke da haɗarin kamuwa da cutar rashin ƙarfi ta numfashi (ARDS) da sauran cututtukan huhu.
An gano HCoV-229E na farko, B814, a cikin hancin masu cutar sanyi a tsakiyar shekarun 1960.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
A wasu lokuta, cutar ta iya zama sanadiyyar cututtuka da yawa.
Cutar SARS ta 2003 tana ɗaya daga cikin cututtukan da suka fi muni a zamaninmu, tare da kamuwa da mutane fiye da 8,000 da kusan kashi 10 cikin ɗari na mutuwar.
A cikin shekaru goma, cutar MERS ta zama cuta mai tsanani a yankin Larabawa kuma ta bazu a dukan duniya.
Wani sabon HCoV (2019-nCoV) na 2019, wanda aka sanya wa suna SARS-CoV-2, shine sanadin cutar coronavirus ta 2019 (COVID-19), wanda ya kashe mutane sama da 3,120 kuma ya kamu da mutane sama da 91,000 har zuwa 3 ga Maris 2020.
An ba da gargaɗi kuma duniya tana shirye don cutar SARS-CoV-2.
Dukkanin HCoVs guda bakwai sun samo asali ne daga dabbobi, kamar su barbashi, beraye, ko wasu dabbobin gida.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa a cikin jikin mutum, kuma a cikin waɗannan ƙwayoyin cuta, ƙwayoyin cuta na HCoVs suna da yawa a cikin jiki.
Cutar ta COVID-19 ta haifar da mummunan tasiri ga masana kiwon lafiya, masana kimiyya, da zamantakewar al'adu da al'adu na kasar Sin da na duniya.
A cikin wannan yanayin, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs, a cikin nau'in HCoVs.
Hakanan yana iya jagorantar ko taimakawa binciken yanayin zama, yanayin wucewa da ingantawa na ƙwayoyin cuta na SARS-CoV-2, da ƙoƙarin da ake buƙata don hana yaduwar cutar a nan gaba.
A cikin wannan labarin, an ba da taƙaitaccen bayanin asalin waɗannan ƙwayoyin cuta, yadda ake watsa su da sauran ƙwayoyin cuta da ƙwayoyin cuta na HCoVs.
A cikin yanayin da ya dace, yawancin masu amfani da maganin sun yi amfani da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin.
An kuma yi la'akari da yadda HCoV ke ci gaba da kuma yadda sau da yawa haɗuwa da wasu kwayoyin halitta yana rage yawan kamuwa da cuta.
An kuma yi amfani da maganin rigakafin cutar SARS-CoV-2 a cikin wannan labarin.
An san CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin a gano alamun farko na HCoV-229E, B814, a cikin hancin mutane masu sanyi, an riga an gano CoVs a cikin dabbobi da yawa, gami da turkey, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekaru da suka gabata, an gano wasu HCoVs guda bakwai.
A cikin wannan yanayin, a cikin yanayin da aka tsara, an yi amfani da nau'in HCoVs a cikin nau'in HCoVs.
An gano HCoV-229E a cikin kwayar cutar ta numfashi ta farko a cikin mutanen da ke fama da cutar ta cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan WI-38.
Hakanan, a cikin yanayin rashin lafiya, cutar ta iya haifar da ciwon kai da ciwon kai.
A cikin shekarun da suka gabata, cutar ta kamu da cutar a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
A cikin wannan yanayin, cutar ta kamu da cutar a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
A cikin wannan yanayin, cutar ta kamu da cutar a cikin gida, kuma a cikin gida, cutar ta kamu da cutar a cikin gida.
Sau da yawa, lokacin da ƙwayoyin cuta biyu ke bayyana a cikin mako ɗaya, sai mutum ya kamu da cutar a cikin makonni biyu.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Sai kawai wasu marasa lafiya marasa lafiya sun kamu da ciwon numfashi mai tsanani.
SARS, wanda aka fi sani da ciwon huhu, shine HCoV na farko da aka rubuta wanda ya haifar da annoba ta farko a tarihin ɗan adam kuma ya samo asali ne daga SARS-CoV, HCoV na uku da aka gano.
Wataƙila cutar SARS ta farko ta auku ne a shekara ta 2002 a lardin Guangdong na ƙasar Sin.
Cutar SARS ta yi sanadiyar kamuwa da mutane 8,096 da mutuwar mutane 774, kuma ta bazu zuwa ƙasashe da nahiyoyi da yawa.
Ban da abin da ke kawo cutar, an gano cewa mutane biyu ne kawai ke da cutar, kuma cutar tana bayyana a cikin kwanaki 4 zuwa 7 kuma tana daɗa tsanani a rana ta 10.
Mutane da ke da cutar SARS-CoV suna da ciwon jijiyoyi, zafin jiki, zazzabi, tari, da sanyi, sannan kuma suna fama da numfashi, tari da wahalar numfashi.
Rashin ƙwayoyin lymphocyte, lalacewar ayyukan al'ada, da haɓaka creatine kinase sune wasu daga cikin cututtukan SARS da suka fi yawa.
An kuma lura da lalacewar alveolar, fitowar ƙwayoyin epithelial da ƙaruwa na macrophages a cikin mutane da ke fama da SARS.
Kimanin kashi 20 zuwa 30 cikin ɗari na waɗanda suka kamu da cutar za su shiga sashin kulawa mai tsanani kuma za su buƙaci taimakon iska.
Hakanan, a cikin ƙananan hanyoyin numfashi, gabobin da yawa kamar hanji, hanji da kodan na iya lalacewa yayin da cutar ta yi tsanani, sau da yawa suna haifar da ƙaruwa na cytokines, wanda zai iya zama mai saurin mutuwa ga marasa lafiya.
An fara gano kwayar cutar ne a gwajin jini na wani dangin wanda ya kamu da cutar wanda ya zo daga Guangzhou zuwa Hong Kong.
An kuma gano cewa cutar ta kamu da cutar a cikin shekaru da yawa da suka gabata.
An gano HCoV-NL63 a cikin jariri mai wata 7 a Netherlands a ƙarshen 2004.
A dā, an gano cewa ana yawan samun cutar a tsakanin matasa da tsofaffi da kuma marasa lafiya da ke fama da ciwon huhu.
A cikin waɗannan lokuta, cutar ta iya zama mai saurin kamuwa da cutar ta hanyar cutar HCoV-NL63.
Wani bincike kuma ya nuna cewa an samo wannan kwayar daga hancin wani jariri mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano cutar a ƙasar Holland, amma ta yaɗu a ko'ina.
HCoV-NL63 yana da alamun kusan kashi 4.7 cikin ɗari na cututtukan cututtukan numfashi, kuma yawancin kamuwa da cutar sun faru ne a farkon lokacin bazara, lokacin damina, da kuma lokacin sanyi.
HCoV-NL63 yana haifar da cututtukan numfashi na laryngitis, wanda ake kira croup.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekaru 71 da haihuwa wanda aka kwantar da shi asibiti don cutar huhu da cutar sankarar bargo a Hong Kong.
Bugu da ƙari, a cikin cutar, cutar ta HCoV-HKU1 tana da alaƙa da cutar asma mai tsanani.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Dukkanin HCoVs huɗu suna da alaƙa da ɗan adam kuma galibi suna da wahala saboda rashin cutar mai tsanani, kodayake haɗarin ya faru ne saboda dalilai da ba a san su ba kuma a cikin ƙananan misalai na wani nau'in HCoV-NL63 mai saurin kamuwa da cuta, wanda kwanan nan aka ce yana haifar da ƙananan cututtukan numfashi a China.
A wasu lokuta, HCoVs da za su iya zama masu saurin yaduwa a cikin mutane kuma su kasance a cikin jiki na mutum, ba su da ƙarfi ko kuma ba su da tasiri sosai.
An fara gano MERS-CoV a cikin 2012 a cikin fitsarin wani mutum mai shekaru 60 da haihuwa wanda ke fama da ciwon huhu da ciwon koda a Saudi Arabia.
Ko da yake yawancin masu cutar sun fito ne daga Gabas ta Tsakiya, an sake yada su ta hanyar haɗuwa da wasu ƙasashen Turai da Tunisia.
Wani ƙaramin jirgin ruwa kuma da aka yi a Koriya ta Kudu a shekara ta 2015 ya kai mutane 186.
Alamun MERS sun yi kama da na SARS, wanda ke da alaƙa da cutar huhu mai tsanani.
A cikin wannan yanayin, cutar SARS ta haifar da ciwon koda mai tsanani, wanda ba shi da alaƙa da cutar MERS a cikin sauran cututtukan HCoV.
Fiye da marasa lafiya 30 sun nuna alamun cututtukan hanji, kamar zawo da amai.
A ranar 14 ga Fabrairu, 2020, an ba da rahoton sama da mutane 2,500 da suka kamu da cutar da kuma mutuwar 34.4%, wanda ya sa MERS-CoV ya zama ɗaya daga cikin cututtukan da ke haifar da mutuwa.
A ƙarshen Disamba 2019, an gano wasu mutane da ke fama da cutar sankarar bargo da aka gano a baya tare da cutar SARS-CoV-2 a Wuhan, Lardin Hubei, China.
Hukumar Lafiya ta Duniya ta bayyana cutar ta numfashi ta SARS-CoV-2 a matsayin gaggawa ta lafiyar duniya da ke damuwa da COVID-19.
A ranar 3 ga Maris, 2020, an samu mutum 90,053 da suka kamu da cutar a duk duniya, tare da mutuwar kashi 3.4 cikin ɗari.
Abin lura, adadin mutuwar a Hubei, China ya kai kashi 4.2 cikin ɗari, yayin da a waje da shi ya kai kashi 1.2 cikin ɗari.
SARS-CoV-2 yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV; yana nunawa ta hanyar zazzabi, tari da wahalar numfashi.
Wasu marasa lafiya ma suna da zawo.
Cutar huhu tana ɗaya daga cikin alamun cutar kuma tana iya saurin zama ciwon numfashi mai tsanani.
Ko da yake SARS-CoV da SARS-CoV-2 suna da kamanceceniya da kashi 82% na yawan nucleotides, sun bambanta da yawa a cikin nau'ikan cututtuka.
A cikin waɗannan lokuta, cutar SARS-CoV-2 tana da ƙananan ƙwayoyin cuta, amma yana da sauƙin yaduwa a cikin mutane idan aka kwatanta da SARS-CoV da MERS-CoV.
An kuma gano SARS-CoV-2 a cikin mutane marasa alamun cutar kuma mai yiwuwa hakan ya sa ya bazu cikin sauri a duniya.
A cikin wannan yanayin, SARS-CoV-2 yana da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Na farko, akwai bambanci sosai tsakanin kwanaki kafin kamuwa da cuta da kuma tsawon lokacin da cutar take ci.
A cikin wannan yanayin, SARS-CoV-2 yana da manyan kamanceceniya da sauran HCoVs shida.
A cikin waɗannan lokuta, cutar ta kamu da cutar ta hanyar cutar COVID-19 da ke haifar da cututtuka da yawa.
A wani ɓangare, SARS-CoV-2 yana nuna alamun da ke faruwa a cikin cututtukan HCoVs da aka gano a cikin mutane, gami da nuna alamun da ba a sani ba, kaɗan, ko babu alamun.
A wasu lokuta, ƙananan ƙananan cututtukan COVID-19 masu tsanani suna iya zama masu cutar SARS-CoV, kodayake ƙarancin adadin.
A cikin waɗannan lokuta, cutar ta SARS-CoV-2 ta fi yawa fiye da sauran cututtukan da ke cikin jikin mutum.
Hakanan, SARS-CoV-2 yana da yawa fiye da HCoVs a cikin mutane.
A wani ɓangare kuma, ya kamata a sake tantance ko yaduwar SARS-CoV-2 ta ragu bayan kamuwa da cutar kamar yadda ya faru da SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, SARS-CoV-2 ana iya gano shi a cikin ƙwayoyin cuta.
Ko da yake cutar SARS-CoV-2 ta kamu da cutar ta hanyar ƙwayoyin cuta yana da mahimmanci kamar yadda ya faru da SARS-CoV, ana buƙatar ƙarin bincike don bayyana shi a nan gaba.
A cikin wannan yanayin, cutar SARS-CoV-2 tana da tasiri sosai a cikin jikin mutum.
Koyaya, wasu halaye na SARS-CoV-2 da yanayin watsawa, bayyanar da yaduwar bayan kamuwa da cutar COVID-19 zasu iya tasiri ga yaduwar cutar.
Dukkanin HCoVs da ke cikin mutane suna nuna alamun alamun da ke daidaitawa da jikin mutum.
A wasu lokuta, yana iya zama gaskiya cewa mata sun saba da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyu suna iya zama masu kariya daga cutar HCoV a baya kuma su tsira.
An kuma gano cewa cutar ta kamu da cutar a cikin mutane da yawa.
Don yin hakan, HCoVs suna buƙatar haɓaka cikin jikin mutum don sababbin su fito don magance ƙuntatawa na yanayi.
A cikin wannan yanayin, mafi yawan SARS-CoV-2 da ke rayuwa da kuma yawan kamuwa da cutar, mafi yawan yiwuwar ya zama mai kama da mutum.
Idan an daidaita shi, mutane ba za su iya kamuwa da cutar ta hanyar keɓewa ko wasu hanyoyin watsawa ba.
A cikin shekaru da yawa, CoVs guda huɗu masu saurin kamuwa da cutar sun yi yawo a cikin mutane, suna haifar da sanyi a cikin mutane waɗanda ke da rashin ƙarfi.
Ba a buƙatar waɗannan ƙwayoyin cuta su ɓoye a cikin dabbobi.
A gefe guda, SARS-CoV da MERS-CoV masu saurin kamuwa da cuta ba su da daidaituwa ga jikin mutum kuma ba su da wata hanyar da za ta hana yaduwar su tsakanin mutane.
Zai ci gaba da zama a cikin dabbobi kuma ya nemi zarafin ya shiga cikin mutane, musamman ta hanyar abu ɗaya ko fiye da haka da zai iya ɗauke da shi.
Hakanan, a cikin waɗannan lokuta, cutar ta SARS-CoV-2 tana da alamun bayyanar cututtuka kamar SARS-CoV/MERS-CoV da sauran HCoVs guda huɗu da ke kama da mutane.
A wasu lokuta, cutar ta iya zama mai saurin kamuwa da cutar, amma a wasu lokuta, cutar ta iya zama mai saurin kamuwa da cutar.
A cikin waɗannan lokuta, cutar ta kamu da cutar ta hanyar cutar da ake kira SARS-CoV.
Za mu ga ko za su iya zama mutane kuma su yi tafiya a tsakanin mutane ba tare da masu ɗauke da su ko dabbobi ba.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
A cikin kwayoyin halitta, HCoVs suna girma a cikin kwayoyin halitta, wanda ke da alaƙa da ci gaban nucleotide.
Kwayar cutar ta kamu da cutar sosai kuma ba ta haifar da cutar ba a cikin wannan yanayin.
A cikin wannan yanayin, ƙwayoyin cuta na HCoV suna da ƙarancin ƙwayar cuta.
A cikin waɗannan misalai biyu, masu ɗaukar hoto suna ɗaukar cutar da wuri mai kyau don ɗaukar hoto na HCoV ko kwayar cutar da ke haifar da shi.
Amma, idan sabon HCoV ya shiga cikin wani wuri mai kyau kafin ko kuma a lokacin da ya shiga jikin mutum, ba zai iya daidaitawa da sabon wuri ba kuma sau da yawa yana haifar da cuta.
Wannan matsakaicin matsakaici na biyu na iya zama ƙwayoyin cuta na dabbobi kuma yana da tasiri sosai wajen ƙarfafa su ta hanyar ba da damar kwayar cutar ta haifuwa da shiga cikin jikin mutum da haɓaka haɓakar cutar.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Amma, HCoVs na iya daidaitawa da kuma rayuwa a cikin yanayin rayuwa na biyu.
A wannan misalin, wurin zama na biyu ya zama wurin da ya fi dacewa da shi.
Rahotannin cututtuka sun nuna cewa mutanen da ke fama da SARS suna da tarihin dogon lokaci na hulɗa da kayan wasa.
A cikin wannan yanayin, a cikin nau'in kwayoyin halitta, kwayoyin halitta suna da yawa fiye da kwayoyin halitta.
An gano kwayar cutar SARS-CoV a cikin dabbobi masu launin fata (Paguma larvata) da kuma karnuka masu rai a cikin kasuwar dabbobi don farko a cikin jerin sunayen SARS-CoVs.
An ba da wannan shawarar ne saboda an gano wasu sabbin SARS bayan an kashe duk civets a kasuwa.
Duk da haka, an gano cewa wasu ƙwayoyin cuta na Palm masked waɗanda aka samo daga daji ko gonaki ba tare da an kawo su a cikin kasuwar dabbobi masu rai ba sun kasance SARS-CoV, wanda ke nuna cewa waɗannan ƙwayoyin cuta na iya zama cibiyar watsawa ta biyu ta SARS-CoV amma ba cibiyar watsawa ba.
Abin sha'awa, saboda kashi 80% na dabbobin da ke kasuwar Guangzhou suna da ƙwayoyin cuta masu hana SARS-CoV, ana iya ɗauka cewa wasu ƙananan dabbobi sune tushen tushen SARS-CoV.
Duk waɗannan sune ƙarshen wuraren da SARS-CoV ke zaune.
Binciken da aka yi a cikin dabbobi masu ɗauke da SARS-CoV ya nuna alaƙa da ƙwayar cutar CoV, SARS Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke cikin ƙwayoyin cuta na kudan zuma na China.
A cikin waɗannan ƙwayoyin cuta, ƙwayoyin cuta sun haɗa da ƙwayar cuta da ƙwayar cuta.
Wannan ƙwayar cuta da ƙwayar CoVs suna da kusan kashi 88-92% na nucleotides da ke kama da SARS-CoV.
Wannan binciken ya taimaka wajen kafa sabon ra'ayi cewa ƙuda ce take ɗauke da cututtuka da ke shafan mutane.
An kuma gano cewa yawancin SARS-like CoVs (SL-CoVs) sun samo asali ne daga ƙudaje, amma WIV1 ne kawai daga cikin duka za a iya ɗauka a matsayin kwayar cuta mai rai.
An san cewa enzyme mai canza angiotensin na mutum 2 (ACE2) shine mai kare SARS-CoV.
WIV1 da aka samo daga ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
A cikin yanayin da ya dace, ƙwayar SARS ta iya kashe WIV1.
A halin yanzu, WIV1 shine mafi kusa da SARS-CoV a cikin jemage, saboda sun kasance kusan kashi 95% na nucleotides.
Duk da cewa akwai alaƙa tsakanin ƙwayoyin cuta biyu, an yarda cewa WIV1 ba shine tushen SARS-CoV na biyu ba kuma ƙwayoyin cuta ba shine tushen SARS-CoV ba.
An kuma gano cewa cutar ta kamu da cutar a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Kwayoyin cuta na CoV-HKU4 da MERS-CoV suna amfani da wani abu mai hanawa, dipeptidyl peptidase 4 (DPP4), don shigar da ƙwayoyin cuta.
RNA-related RNA polymerase mai kama da MERS-CoV shine ƙananan cututtukan da ke kusa da sauran ƙwayoyin beta-CoVs da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a gano wani MERS-CoV mai rai a cikin kwarkwata ba.
MERS-CoV da danginsa na kusa da CoV-HKU25 suna da kusan kashi 87% na nucleotide iri ɗaya.
Saboda haka, ƙuda ba za ta iya zama babban tushen MERS-CoV ba.
Amma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuma masu raƙumi suna da ƙwayar MERS-CoV mai hana rigakafi, kamar yadda raƙuma daga Gabas ta Tsakiya suke da yawa a Afirka.
An gano MERS-CoV mai kama da kwayar cutar da ke cikin mutane daga hancin raƙuma, wanda ke nuna cewa fitsari na raƙuma shine tushen MERS-CoV.
Hakanan yana da mahimmanci saboda sau da yawa ana samun alamun bayyanar cutar mai sauƙi amma mai mahimmanci a cikin raƙuman da aka gwada waɗanda ke dauke da MERS-CoV.
Abin lura, raƙuma masu cutar ba kawai sun yada kwayar cutar ta hanyar numfashi ba amma ta hanyar ƙazanta zuwa bakin, wanda shine hanyar da kwayar cutar ta shiga cikin mu daga ƙuda.
Amma, akwai wasu tambayoyi saboda yawancin mutanen da ke fama da cutar MERS ba su taɓa haɗuwa da raƙuma ba kafin barkewar cutar, ko dai daga wani mai watsawa ko kuma ba a san yadda aka watsa su daga dabbobi da ba a san su ba waɗanda ke dauke da MERS-CoV.
SARS-CoV-2 yana da 96.2% na nucleotide na kama da na CoV RaTG13 na ƙwari wanda aka samo daga ƙwari Rhinolophus affinis.
Kamar yadda yake tare da SARS-CoV da MERS-CoV, bambancin dake tsakanin SARS-CoV-2 da RaTG13 yana da ƙarfi sosai har ba zai yiwu a haɗa su ba.
Wannan yana nufin cewa ba za a iya samun kwari ko wasu wurare na biyu na SARS-CoV-2 ba sai dai idan an gano wani abu mai kama da kwari CoVs a nan gaba.
A bayyane yake, dabba mai ɗauke da SARS-CoV-2 na biyu ya kasance cikin abincin da aka sayar da shi da kuma kiwon kifin a Huanan, inda ake tsammanin yawancin ƙwayoyin cuta na COVID-19 suka samo asali, wanda ke nuna cewa wataƙila mutane sun karɓi cutar daga dabbobi.
Yawancin binciken metagenome sun nuna cewa wani nau'in dabbobi masu haɗari da ake kira pangolins (Manis javanica) na iya zama magabatan beta-CoVs masu alaƙa da SARS-CoV-2.
Hakanan, a cikin sabon tsarin kwayoyin halitta, SARS-CoV-2 yana da ƙananan ƙwayoyin cuta da ke tattare da kwayoyin cuta.
Amma, suna da kama da RaTG13 domin sun yi kama da juna da kashi 90 cikin ɗari a cikin ƙwayoyin nucleotide.
An haɗa shi da ƙananan ƙananan kwayoyin SARS-CoV-2 na tsire-tsire, waɗanda ke da alaƙa da asalin asali (RBD) tare da SARS-CoV-2, 97,4% na amino acid.
A cikin bambancin da ke tsakanin, SARS-CoV-2 da RaTG13 RBDs sun bambanta sosai, kodayake suna da kusancin kama a matakin kwayoyin halitta.
Wani bincike na farko da aka yi akan gawawwakin pangolin ya nuna cewa sun sami ƙwayoyin cuta a cikin huhu, wanda ya yi kama da SARS-CoV-2.
Wannan binciken yana amfani da wasu hanyoyin da aka haɗa da maganin don samar da tsarin halittar mutum wanda ya kai kashi 86.3% na tsawon tsarin halittar kwayar cutar.
An kuma gano cewa cutar SARS-CoV-2 ta kamu da cutar a cikin shekaru da yawa.
Duk da haka, akwai wasu maganganu da yawa da suka tabbatar da cewa SARS-CoV-2 ya samo asali ne daga pangolin saboda bambancin da ke tsakanin SARS-CoV-2 da pangolin SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Hakanan, bambanci tsakanin SARS-CoV-2 da RaTG13 ya fi ƙasa da bambanci tsakanin SARS-CoV-2 da SARS-CoV-2 daga bangolin beta-CoVs.
An gano cewa cutar SARS-CoV-2 ta kamu da cutar a cikin ƙudaje, pangolins da wasu dabbobi.
Ko da yake akwai alaƙa tsakanin RBDs da SARS-CoV-2 da pangolin, SARS-CoV-2 beta-CoVs, SARS-CoV-2 da RaTG13 suna da yawancin abubuwan da suka shafi kwayoyin halitta.
Ana iya cewa yawancin kamanceceniya tsakanin RBDs na pangolin SARS-CoV-2 na beta-CoVs da SARS-CoV-2 sun samo asali ne daga bambancin haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓ
An yi wasu maganganu game da alaƙar da ke tsakanin SARS-CoV-2 pangolin da beta-CoV da RaTG13 a cikin dabbobi masu rai na hudu.
A cikin yanayin juyin halitta, sake haɗuwa yana faruwa a cikin beta-CoVs.
A cikin wannan yanayin, a cikin nau'in SARS-CoV-2 da aka gano, an gano cewa cutar ta kamu da cutar a cikin dabbobi.
Bayan cutar da HCoVs ke haifarwa, mata sun kuma yi nazarin asalin HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1 daga dabbobi.
A cikin wannan yanayin, a cikin yanayin da aka tsara, ƙwayoyin cuta na HCoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV-CoV
An ba da rahoton cewa an gano cutar CoV ta ARCoV.2 (Appalachian Ridge CoV) a Arewacin Amurka, kuma ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwarƙun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
A gefe guda, HCoV-229E yana da alaƙa da wani CoV na bera, wanda aka kira Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, amma an ce matsakaicin matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakaiciyar matsakai
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa a cikin dabbobi.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
A cikin wannan labarin, an bayyana cewa HCoV-229E yana da ƙwayoyin cuta da yawa.
A cikin wannan yanayin, cutar ta kamu da cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar ta hanyar cutar.
A cikin waɗannan, an sami alpaca alpha-CoV guda ɗaya.
Akwai shaidu da yawa da suka nuna cewa kwayar cutar ta samo asali ne daga ƙuda kuma an watsa ta kai tsaye ga mutane.
Na farko, mutane ne suka haɗu da waɗannan ƙwari, ba alpacas ba.
Duk da haka, alpacas suna da dangantaka ta kusa da mutane.
A cikin wannan yanayin, ƙwayoyin cuta na alpaca sun fi yawa fiye da sauran ƙwayoyin cuta na alpaca.
A ƙarshe, alpha-CoV alpaca ba ya bayyana a cikin ƙwayoyin dabbobi.
Saboda haka, ba za a iya musanta cewa alpacas sun kamu da HCoV-229E na alpha-CoV daga mutane ba.
Hakika, ƙuda tana da alhakin ƙwayoyin cuta da yawa da ke kawo cuta ga mutane, kamar su ƙwayoyin cuta na ƙuda, Ebola, Nipah, da kuma Hendra.
Saboda haka, ba abin mamaki ba ne cewa ƙwayoyin cuta na HCoV-229E sun kasance daga ƙwari zuwa ga ɗan adam.
Ko kuma, kodayake alpha-CoVs na wannan bera sun ba da CoV-229E, alpacas da raƙuma na iya zama cibiyoyin watsawa na biyu waɗanda ke ɗaukar ƙwayoyin cuta ga mutane, kamar yadda ya faru da MERS-CoV.
MERS-CoV misali ne mai kyau na yadda kwayar cutar ta samo asali daga ƙuda zuwa raƙuma da kuma daga raƙuma zuwa mutane.
An gano asalin MERS-CoV daga ƙuda kamar yadda aka gano a baya kuma bayanan da aka samu sun tabbatar da hakan.
An san cewa malam buɗe ido suna da ƙwayoyin cuta da yawa da suke rarrabawa tsakanin halittu da yawa kuma suna iya zuwa daga wani halitta zuwa wani.
Numfashi, zama a cikin rukuni, kusanci da kuma iya tashi mai ƙarfi suna da kyau ga 'yan doki don yada kwayar cutar.
A gefe guda, MERS-CoV zai iya kamuwa da raƙuma na dogon lokaci.
Ta saba da raƙuman sosai har ba ta zama gida na biyu ba amma ta zama wurin da ta dace da ita.
MERS-CoV ba ya haifar da cututtuka masu tsanani kuma yana yaduwa sosai a cikin waɗannan dabbobi.
Wannan cutar ta kamu da cutar a cikin mutane kuma mutane za su ci gaba da sanya ta a matsayin ƙarshen saboda baza'a iya ci gaba da yaduwar MERS-CoV ba.
A cikin wannan yanayin, a cikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'
A cikin yanayin, beta-CoVs pangolin suna haifar da cututtuka da yawa a cikin pangolins.
A cikin waɗannan wurare, akwai wasu wurare da ke da kyau don yin amfani da su don yin amfani da su don yin amfani da su don yin amfani da su don yin amfani da su don yin amfani da su don yin amfani da su don yin amfani da su don yin amfani da su.
Akwai yiwuwar SARS-CoV-2 zai iya canzawa daga kwayar halitta zuwa kwayar halitta, daga dabba zuwa mutum, amma yana buƙatar ƙarin bincike don tabbatar da hakan.
A cikin waɗannan lokuta, cutar SARS-CoV-2 tana iya zama mai saurin kamuwa da cutar.
Mutane suna iya kashe waɗannan ƙwari ko kuma su yi amfani da su wajen haƙa kwal.
Da farko, pangolins na iya zama ɗayan manyan wuraren da SARS-CoV-2 ke iya shiga cikin nan gaba.
Mutane suna kamuwa da cutar ta hanyar kashe dabbobi da kuma cin naman dabbobi.
Hakanan, a cikin wasu lokuta, cutar SARS-CoV-2 tana iya kamuwa da ƙwayoyin cuta na gida.
Bincike a kan dabbobi da ke cikin gida da na daji don samar da ƙwayoyin cuta yana da amfani sosai.
A cikin waɗannan lokuta, a cikin nau'in SARS-CoV-2 da aka ambata a sama, an sami ƙarin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bambancin bamb
An yi bincike kan asalin SARS-CoV-2.
Baya ga waɗannan nau'ikan dabbobin da ke da alaƙa da juna, manyan abubuwa uku game da wannan kwayar cutar waɗanda ke da mahimmanci don magance CoVs suna cikin wasu ƙwayoyin halitta.
Na farko, suna da ƙwarewa wajen yin amfani da RNA da kuma haifuwa.
Ba kamar sauran ƙwayoyin cuta na RNA ba, ana iya ɗaukar yanayin CoVs a matsayin mai sauƙi da mai tsanani kuma yana ƙaruwa zuwa ~10-4 a kowace shekara a wurare 2, dangane da yadda CoVs ke daidaitawa da sabon yanayin.
CoVs suna da ƙwayoyin exoribonuclease, kashe su na iya haifar da ƙaruwa da rage ƙarfin su ko ma hana su girma.
Abin sha'awa, an san cewa mahimmin nucleotide na Remdesivir yana hana haɓakar CoV ta hanyar hana wannan exoribonuclease da RNA mai ƙarancin RNA.
Remdesivir yana ɗaya daga cikin mafi ingancin maganin SARS-CoV-2 da aka gwada akan ɗan adam.
Duk da haka, yawan maye gurbin CoVs ya fi kusan miliyan ɗaya fiye da inda suke.
Bugu da ƙari, yawan canjin kwayoyin halitta ya fi yawa idan CoVs ba su dace da sabon yanayin ba.
Idan aka kwatanta da SARS-CoV tare da yawan canjin halittar, an gano cewa yawan canjin halittar SARS-CoV-2 ya ragu, wanda ke nuna cewa yana da alaƙa da ɗan adam.
A wata sassa, ta saba da sabon wurin zama da ke kusa da mutane.
Bayan SARS-CoV-2, yana da alaƙa da MERS-CoV, wanda ya dace da raƙuma.
A zahiri, saboda canjin yanayin halitta zai haifar da allurar rigakafi da maganin rigakafi na SARS-CoV-2 don rage ƙarfinsa.
Na biyu, babban RNA na kwayoyin halitta wanda ke cikin CoVs yana da tasiri a kan juyin halitta da sake dawowa, don haka yana haɓaka haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar haɓakar
Wannan yana da nasaba da yadda tsarin kwayoyin halitta ya buɗe kuma aikin furotin ya haifar da 3 ƙarshen kwayoyin halitta.
Na uku, CoVs suna canza kwayoyin halitta ta atomatik kuma sau da yawa yayin da suke canza RNA ta hanyar fasaha mai ban mamaki na kopping-selection.
A cikin yanayin da ke tattare da shi da kuma aikinsa, ana canza sau da yawa yayin da ake tsara RNA na CoV.
RNAs masu tsayi iri ɗaya da ƙananan kwayoyin halitta na iya haɗuwa don samar da sababbin CoVs.
An gano alamun phylogenetic na daidaitattun haɗuwa a cikin HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabbobi kamar SL-CoV na malam buɗe ido da batCoV-HKU9.
Halin da ke tsakanin kwayar cutar da kuma yadda take yaduwa
Baya ga waɗannan abubuwa uku na ƙwayoyin cuta da aka ambata a sama, yanayin yanayin ƙwayoyin cuta yana da mahimmanci a cikin yanayin motsi na kwayoyin halitta.
A cikin wannan, an ba da misalin SARS-CoV mai haɗuwa, wanda ke nuna cewa yana yada cutar ta hanyar kamuwa da cuta daga kwayar halitta zuwa kwayar halitta.
A sakamakon binciken bambancin da aka yi tsakanin mutane da kuma dabbobi na SARS-CoVs, an nuna cewa SARS-CoV zai ci gaba da canzawa cikin sauri a cikin yanayin sa, musamman yayin da yake tafiya a cikin RBD na furotin S.
RBD na CoV S-protein yana da alaƙa da ƙwayoyin cuta kuma yana da zaɓi sosai ga ƙwayoyin cuta na gida.
A cikin SARS-CoV, RBD yana da amino acid 318 zuwa 510 a cikin S1 , wanda ke haɗuwa da ACE2 na ɗan adam da sauran wuraren kamuwa da cutar.
RBD na SARS-CoV na iya gano masu karɓar ACE2 na yawancin dabbobi, kamar su bera, civet, beraye da kyarketai, yana ba da damar kwayar cutar ta wuce daga kwayar halitta zuwa kwayar halitta.
A gaskiya ma, an gano sauran amino acid guda 6 ne kawai a cikin ɗan adam da kuma kwayar cutar civet da aka gano a cikin RBD kuma 4 daga cikinsu suna da alaƙa da mai karɓar ACE2.
Hakanan, a cikin SARS-CoV, an gano cewa cutar ta SARS-CoV ta haifar da wasu cututtuka da ke haifar da cututtuka na cututtuka na cututtuka na cututtuka.
A wasu kalmomi, waɗannan abubuwa biyu na amino acid suna iya zama muhimmiyar mahimmanci don ƙwayoyin cuta su daidaita da jikin mutum.
A cikin waɗannan lokuta, cutar SARS-CoV-2 tana da alamun cutar da ke haifar da cutar.
Bambanci tsakanin kashi 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein yana nuna cewa alaƙar S-protein da ACE2 na ɗan adam na iya canzawa.
A zahiri, binciken da aka yi na cryo-EM ya nuna cewa wannan haɗin gwiwar ya ninka na 10 zuwa 20 na haɗin gwiwar tsakanin ACE2 na ɗan adam da SARS-CoV na furotin S.
Hakanan yana da mahimmanci a gano ko akwai buƙatar ƙarin hanyar watsa SARS-CoV-2.
A cikin wannan yanayin, cutar ta kamu da cutar a cikin ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
Akwai wasu masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da 9-O-sialic acid acetyl mai karɓar HCoV-OC43.
Hakanan yana iya taimakawa wajen sarrafa CoVs waɗanda ke iya daidaitawa da jikin mutum bayan sun samo asali daga dabbobi.
Bugu da ƙari, a cikin yanayin da ya dace, ƙwayoyin cuta na HCoVs suna da yawa a cikin kwayoyin halitta.
A cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin, a cikin yanayin yanayi mai kyau, a cikin yanayin yanayi mai kyau, a cikin yanayin yanayi mai kyau.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
A wannan yanayin, ba a san ainihin hanyar gano kwayoyin halitta a cikin mahimman bayanai game da alaƙar kwayar cutar da yanayin ba kuma ana buƙatar bincike.
Ana iya samun ƙarin ƙwayoyin cuta da ƙwayoyin cuta na SARS-CoV-2 ta hanyar amfani da fasaha mai ƙarfi na CRISPR.
Ƙarin HCoVs: Komawa zuwa Farko
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa.
A cikin wannan yanayin, ƙwayoyin cuta na HCoVs suna da yawa fiye da yadda ake tsammani.
Hakanan, sauye-sauye da sauye-sauyen kwayoyin halitta suna taimakawa ci gaban HCoV kuma sune matakai biyu masu mahimmanci a wannan yanayin.
Alal misali, samun ko rasa lambar kwayar halitta na furotin yana iya canza yanayin haɗin kai tsakanin ƙwayoyin cuta.
A cikin abubuwan da ke tattare da furotin na SARS-CoV, ORF8 ya bayyana yana da mahimmanci don daidaitawa da jikin mutum, saboda ƙwayoyin cuta na SARS-CoV sun kasance a gefe amma an gano cewa sun kasance nau'ikan nau'ikan furotin na ORF8.
An gano cewa an kashe kwayoyin halittar 29-nucleotide na SARS-CoVs waɗanda ke da alaƙa da cutar a farkon lokacin kamuwa da cutar a cikin ɗan adam.
Wannan kashewa yana raba ORF8 daga ORF8a da ORF8b kuma ana tsammanin shine tushen da ke ba da damar shi ya motsa daga wani wuri zuwa wani.
Hakanan, SARS-CoV na iya haɗuwa da jerin alpha- da gamma-CoVs, inda aka gano yawancin ƙananan haɗuwa a cikin RNA mai ɗauke da RNA mai ɗauke da RNA.
An kuma gano wuraren haɗin gwiwa a cikin nsp9, yawancin nsp10, da kuma sassan nsp14.
Hakanan, cutar MERS-CoV ta bayyana a cikin jerin jerin, wanda ya samo asali daga raƙuman raƙuman Saudi Arabiya.
Bugu da ƙari, a cikin waɗannan lokuta, cutar ta kamu da cutar a cikin kwayoyin halitta, wanda ya haifar da rashin lafiyar jiki.
Hakanan ya kamata a yi hankali da cewa zaɓin da ba daidai ba na iya haifar da sauye-sauyen yanayin kwayoyin halittar ƙwayoyin cuta, wanda zai iya rage tasirin ƙwayoyin cuta, kamar ƙwayoyin cuta a cikin masu karɓar su.
Wani misali na wannan shine asarar ORF4 gaba ɗaya a cikin samfurin HCoV-229E, wanda ya haifar da kashe nucleotides biyu.
Ko da yake ana iya samun ORF4 mai tsabta a cikin ƙuda da ƙwayoyin cuta na raƙumi waɗanda ke da alaƙa da HCoV-229E, alpha-CoV alpaca ya nuna haɓakar nucleotide guda ɗaya, wanda ya haifar da canji a cikin tsarin.
A ƙarshe, amma ba mafi mahimmanci ba, haɓakar sabon HCoVs yana haifar da tasirin tasirin yanayin ƙasa.
Ba a lura da alamun cutar ko kuma alamu kaɗan lokacin da ƙudaje suka kamu da CoVs, wanda ke nuna bambancin CoVs da ƙudaje.
A cikin wannan yanayin, ƙwayoyin cuta na CoVs suna da yawa a cikin kwayoyin halitta.
Alal misali, ƙarancin ƙwayar cuta a cikin ƙwayoyin cuta ya rage yiwuwar cutar da CoVs ke haifarwa.
Ƙari ga haka, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
Bugu da ƙari, ƙwayoyin oxygen mai yawa (ROS) da ke haifar da ƙwayar ƙwayar cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta.
Yawancin cututtukan CoV na iya haɓaka ta hanyar haɗuwa, wanda ke haifar da sabon ƙwayoyin cuta ko ƙwayoyin cuta don daidaitawa da yanayin.
Saboda haka, ba zato ba tsammani ba ne cewa sababbin HCoVs uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba sa haifar da cututtuka ko ƙananan alamomi a cikin yanayin da suke rayuwa kamar su kwari da raƙuma.
Ana yawan haifuwa ba tare da amfani da kwayoyin da ke hana kamuwa da cutar ba.
A nan ne ake gano waɗanda ba su da alamun cutar da kuma abin da ke sa cutar ta fi tsanani.
Babban alamun cutar galibi ana haifar da haɓakar ƙwayoyin cuta da ƙwayoyin cytokines a cikin yanayin ƙarfin rigakafi, wanda ke haifar da lalacewar huhu.
A akasin wannan, a cikin marasa lafiya marasa alamomi, ƙwayar cuta ta CoV tana aiki sau biyu.
Hakanan, maganin SARS-CoV-2 yana da tasiri sosai a cikin maganin rigakafi.
Interferon yana da tasiri sosai a kan kwarkwata.
Saboda haka, ba da maganin cutar ta Interferon na farko a farkon lokacin kamuwa da cutar SARS-CoV-2 a cikin ɗan adam yana da tasiri sosai.
Bugu da ƙari, ba a iya yin amfani da NLRP3 a cikin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Bisa ga waɗannan ra'ayoyin, haɗuwa da NLRP3 zuwa ƙwayoyin ƙwayoyin cuta tare da MCC950 na iya taimakawa wajen magance COVID-19.
An kuma gano cewa cutar SARS-CoV-2 ta kamu da cutar a cikin shekaru biyar da suka gabata.
Ko da yake ana iya cewa beta-CoVs na malam buɗe ido suna da kusan kashi 95% na nucleotide kama da SARS-CoV, ba-CoVs suna da kashi 96% na nucleotides kama da SARS-CoV-2.
Ko da yake an gano cewa civets da sauran dabbobin da ke kasuwa suna da kwayar cutar da ke kama da SARS-CoV, sabbin wuraren da SARS-CoV-2 ke yawo sun yi kama.
A cikin waɗannan lokuta, cutar ta SARS-CoV-2 tana da alamun cutar ta SARS-CoV-2 da ke haifar da cutar ta SARS-CoV-2.
Ko da yake akwai tambayoyi, babu wata hujja da ta nuna cewa SARS-CoV-2 da mutum ya kirkira an yi shi ne da gangan ko kuma a ɓoye.
An sake yin magana game da CoVs a cikin sabon yaduwar SARS-CoV-2.
A cikin wannan yanayin, a cikin nau'in kwayoyin halitta, kwayoyin halitta suna da yawa, amma a cikin nau'in kwayoyin halitta, yawancin kwayoyin halitta suna da ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan ƙananan
A cikin waɗannan lokuta, cutar ta SARS-CoV ta fi yawa fiye da a cikin sauran kwayoyin halitta.
Saboda cutar SARS-CoV tana haifar da haɗuwa tsakanin mutane da civets a cikin kasuwanni, rufe kasuwanni da kashe civets na iya kawo ƙarshen cutar SARS.
A cikin wannan mahallin, ya kamata a cire pangolins daga kasuwannin dabbobi don hana su watsa cutar, saboda yawancin bayanan da aka bayar sun nuna cewa yawancin beta-CoVs daga pangolin suna da alaƙa da SARS-CoV-2.
Koyaya, binciken da za a yi a nan gaba zai taimaka wajen tabbatar da ko SARS-CoV-2 ya kamu da ɗan adam daga pangolins da sauran dabbobi.
A wani ɓangare kuma, MERS-CoV zai iya kamuwa da raƙuma na dogon lokaci.
Rakuma suna da muhimmiyar rawa wajen kai cutar ga mutane, kamar yadda nama, madara, fata, da kuma kayan ulu suke yi wa mutanen yankin.
Ana rarraba shi sosai a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a kashe raƙuma gaba ɗaya don yaƙi da MERS ba, kamar yadda aka yi a kasuwar dabbobi a Chinae don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana sake barkewar MERS, muna buƙatar ingantaccen bincike don samar da allurar rigakafi mai dacewa don MERS-CoV na raƙumi, da kuma sanya wasu matakan hana cutar.
Idan ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, sabon tsarin kwayoyin halitta na iya haifar da wasu cututtuka.
Yawancin CoVs suna yawo a cikin daji.
A cikin yanayin, CoVs na dabbobi na iya bayyana ta hanyoyi da yawa.
Akwai damar da yawa ga waɗannan CoVs na dabbobi su sake haɓaka da haɗuwa, samar da sababbin CoVs waɗanda zasu iya yaduwa da yawa da / ko kashe mutane a nan gaba.
A wasu wurare a ƙasar Sin, ana bukatar a daina cin kifi don a rage yawan haɗuwa da dabbobi.
A yayin da SARS, MERS da COVID-19 ke damunmu, muna buƙatar shirya da kuma tsara yadda za mu magance su.
Hakika, ƙwayoyin cuta da yawa sun daɗe suna duniyarmu.
Yana zama a inda yake har sai ya sami zarafin fita.
Ko da yake waɗannan ƙwari suna da halaye da yawa da suke sa ƙwayoyin cuta su yaɗu sosai, za mu iya rage haɗarin haɗuwa da su da kuma wasu dabbobin daji ta wajen koya wa mutane su nisanta kansu da waɗannan dabbobin.
Kulawa da dabbobi masu shayarwa yana da mahimmanci don gano yanayin CoVs da yanayin su, kuma yana taimakawa wajen hana dabbobi daga watsa ƙwayoyin cuta zuwa mutane da kuma sake farfadowa a nan gaba.
A ƙarshe, hanya mafi kyau ta hana ƙwayoyin cuta daga dabbobi ita ce nisantar da mutane daga wuraren da waɗannan dabbobin daji ke zaune.
Har zuwa yanzu, ba a san ainihin asalin SARS-CoV-2 na dabbobi ba.
Da farko, idan kwari sun ba da kwayar cutar SARS-CoV-2 ta asali ga pangolins, zai zama da amfani a fahimci yadda kwari da pangolins ke rayuwa tare.
Na biyu, idan ƙuda ce ta kai kwayar cutar ga mutane, muna bukatar mu san yadda mutane suka kamu da ƙuda.
Na uku, idan dabbobi masu shayarwa na uku sune ainihin cibiyar kwayar cutar, dole ne a bayyana yadda ta ke hulɗa da sauran halittu ciki har da mutane, jemage da pangolins.
A ƙarshe, saboda yawancin dabbobi masu shayarwa da dabbobin gida na iya ɗaukar SARS-CoV-2, ana buƙatar saka idanu da kuma bincika su don gano cutar.
Ko dai jemage, pangolin ko wasu dabbobi masu shayarwa, ana sa ran SARS-CoV-2 ko wasu ƙwayoyin cuta masu kama da su za a gano su a cikin yanayin da suke rayuwa a nan gaba.
Ana iya samun ƙarin bayanai game da cutar a cikin takaddun shaida na SARS-CoV-2 da aka yi amfani da su a cikin takaddun shaida na COVID-19.
Bayanan yau da kullun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrun wararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwararrunwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwarwar
A ranar 6 ga Fabrairun 2020, ƙungiyarmu ta ba da shawarar tallafi don ganowa da kuma magance cutar coronavirus ta 2019 (2019-nCoV), ta ba da ƙarin ƙwarewarmu da ƙwarewarmu don magance cutar ta duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) tana nan, kuma iliminmu da iliminmu game da ita yana ƙaruwa a hankali ta hanyar bayanan bayanan da aka samu da kuma kayan aikin asibiti da aka gano; saboda haka ana sabunta dabarun bincike da hanyoyin kulawa.
A cikin wannan wasiƙar, mun amsa ga wani bayani a cikin sabis ɗinmu kuma mun ba da ƙa'idodin ƙididdigar gaggawa don casuwan da aka ambata da casuwan da aka yarda a cikin sabon tsarin bincike na COVID-19 (siffa ta bakwai) wanda Kwamitin Kiwon Lafiyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, cutar coronavirus ta 2019, (2019-nCoV) ta haifar da cutar, wacce aka sani da cutar coronavirus ta 2019 (COVID-19) kuma an sake kiran kwayar cutar da cutar coronavirus mai saurin numfashi 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta haɓaka tallafin shawarwarin tsaro kuma an buga su a cikin Shafin Farko na Lafiya na Soja na 06 ga Fabrairu 2020.
Tun lokacin da aka wallafa shi, ya burge masu karatu da yawa.
Amma a matsayin mai kula da COVID-19, iliminmu da iliminmu game da shi yana ƙaruwa a hankali ta hanyar nazarin bayanan da aka samu da kuma kayan aikin asibiti da aka sani; saboda haka ana ci gaba da sabunta hanyoyin bincike da hanyoyin kulawa.
An wallafa samfurin bincike na farko na COVID-19 wanda Kwamitin Kiwon Lafiya na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ya fitar a tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, ya samar da bugu bakwai yayin da wasu yanayi ke canzawa sosai.
Yanzu da taimakonmu ya sami amsa daga Zhou et al., sun haɗa da tsarin da ya fi sauƙi na ƙididdigewa a cikin binciken da suka yi a asibiti.
Ayyukan su sun kara yawan alamun da ake samu na agaji kuma sun zama muhimmin tsari ga cutar a duniya.
Mun yi godiya da muhimmancin aikin da suka yi kuma muna gode musu.
Koyaya, aikin su yana buƙatar sabuntawa game da Ayyukan Ganowa da Kulawa na Gida don COVID-19 (Gwaji na bakwai) ƙaramin bincike.
A cikin fitowar ta bakwai (3 ga Maris 2020), zaɓin don karɓar ƙididdigar yana buƙatar haɗuwa da wani ɓangare na tarihin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututut
Bayanan cututtukan cututtuka: (1) rahoton tafiya ko zama a Wuhan da kewayenta, ko haɗuwa da wasu daga cikin shari'o'in COVID-19 da aka ruwaito kwanaki 14 da suka gabata kafin bayyanar cututtukan; (2) rahoton haɗuwa da wani daga cikin masu cutar SARS-CoV-2 (gwajin nucleic acid nucleic acid mai kyau); (3) rahoton haɗuwa da mai cutar zazzabi ko cututtukan numfashi daga Wuhan zuwa yankuna da ke kusa ko kuma yankuna inda aka ba da rahoton wasu daga cikin masu cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtukan; (4) rahoton haɗuwa da tarin masu cutar (≥ 2 lokuta tare da zazzabi da / ko cututtukan numfashi a cikin makonni 2 a cikin ƙananan wurare, kamar gida, makaranta, makaranta, ofis, da sauransu).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) alamun bayyanar cututtuka na COVID-19; (3) ƙididdigar ƙwayoyin jini da ƙwayoyin cuta na al'ada, raguwa, ko ƙimar ƙwayoyin lymphocyte a farkon farawa.
Binciken cutar da aka yarda da shi dole ne ya kasance a cikin yanayin da aka yi la'akari da shi a cikin kowane ɗayan abubuwan da ke cikin yanayin ko kuma shaidar serological kamar haka: (1) gwajin PCR na lokaci-lokaci mai kyau don SARS-CoV-2; (2) bin tsarin kwayoyin halitta wanda ke nuna haɓakar homogeneity a cikin coronavirus da aka sani; (3) tabbatacce ga ƙwayoyin IgM na musamman da IgG zuwa SARS-CoV-2 a cikin gwajin ƙwayar cuta; ko canji a cikin IgM na SARS-CoV-2-takamaiman IgG antibodies daga mara kyau zuwa tabbatacce, ko haɓaka mai girma ≥ 4 sau a lokacin farfadowa fiye da lokacin cutar.
Za mu lura cewa an ƙara gwajin PCR na lokaci-lokaci don gano acid nucleic ta hanyar numfashi ko samfurin jini a cikin bugu na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020).
An ƙara ganowar bambancin samfurin jini a bugu na huɗu (27 ga Janairu 2020) da na biyar (8 ga Fabrairu 2020); kuma an ƙara bayanan serology a bugu na bakwai.
Wadannan canje-canje a cikin tsarin bincike sun ci gaba da aiki don gano kayan aikin bincike na asali don gano mafi kyawun kwayar nucleic acid, tare da samfurin numfashi da samfurin jini, wanda ya haifar da rashin amincewa da ra'ayoyi daban-daban, kuma ya taimaka wajen kawo sakamakon ƙwayoyin cuta na musamman zuwa ƙwayoyin cuta masu mahimmanci.
Bugu da ƙari, akwai wasu shaidu da ke tunatar da mu cewa dole ne mu kula da marasa lafiya marasa alamun cutar a cikin marasa lafiya.
Don ci gaba, jadawalin Zhou et al. ya kamata a sabunta shi, kamar yadda aka sanya alamar rashin alamun asibiti a matsayin ƙananan haɗari.
Hakanan dole ne a tabbatar da tsarin maki tare da ƙarin kayan aiki da nazarin asibiti.
A ƙarshe, muna fatan cewa za a ƙara yawan bayanan da aka samu kuma muna gayyatar masu karatu su ba da ra'ayoyinsu.
Don ganewar asali na cas an tsara  kuma an yarda  duk masu buƙatar su bi da kuma bi da taimakon asibiti daga ƙasashensu.
Ƙungiyarmu za ta kuma sabunta lokacin da ya dace don tallafawa aikin agaji.
Bangladesh ta ba da rahoton mutuwar mutane uku daga COVID-19, fiye da kowane lokaci
A jiya, Bangladesh ta ba da rahoton mutuwar mutum biyar a rana ɗaya daga COVID-19.
Wannan shine mafi girman adadin mutuwar da aka samu daga wannan kwayar cutar.
A jiya, Cibiyar Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin masu kamuwa da cutar ya kai 114 kuma 33 daga cikin waɗanda ke zaune a gida sun warke.
Mutane 17 sun mutu.
A wata sanarwa da aka wallafa a shafukan sada zumunta, Daraktan IEDCR, Dakta Meerjady Sabrina Flora, ta ce mutanen da suka mutu maza biyu ne da mata biyu.
A cewar Dokta Meerjady, biyu suna da shekara 60, biyu suna da shekara 51 da wani kuma shekara 41 da wani.
Ya kuma ce biyu daga cikin mutanen da suka mutu sun fito ne daga Dhaka.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin cutar annoba a ranar 11 ga Janairu.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na kasar Anadolu cewa daya daga cikin wadanda suka mutu shine Jalal Saifur Rahman, darektan hukumar hana fashi, wanda ke asibitin Kuwait Maitree.
A ranar Asabar, a cikin wani bidiyo na labarai a kan layi, Ministan sufuri na Bangladesh Obaidul Quader ya ce za a dakatar da zirga-zirgar bas na kwanaki da yawa, har da ranar Asabar mai zuwa.
An fara aikin rufe bas ɗin a ranar 26 ga Maris kuma an shirya za a kammala shi a ranar Asabar, 4 ga Afrilu.
Ana iya kawo kayan aiki  magani, man mota da abinci .
An gano farkon kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris, tare da mutane biyu da suka zo daga Italiya da matar ɗaya daga cikinsu.
A ranar 19 ga Maris, an warkar da dukan mutane uku.
SARS-Cov-2 ya fi kamuwa da cuta miliyan ɗaya a duniya
A ranar Alhamis, adadin sabbin cututtukan da ke tattare da cutar coronavirus ta SARS-CoV-2 ya zarce miliyan ɗaya a duniya, in ji rahoton Johns Hopkins.
52 daga cikin mutuwar sun kasance daga COVID-19, cutar da ke haifar da coronavirus.
Wannan nasara ta zo ne a ranar da Malawi da Zambia suka sami sabon kamuwa da cutar coronavirus.
A ranar Alhamis, Koriya ta Arewa ta zama ƙasa ta farko a duniya da ba ta da cutar coronavirus.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton mutane 1,051,635 da suka kamu da cutar da kuma 79,332 a ranar 1 zuwa 10 na yamma agogon Turai (0800UTC) a ranar 4 ga Afrilu 4.
A Amurka, akwai sama da mutane 244,000 da suka kamu da cutar coronavirus, da kuma mutuwar 5,900.
Bayan Jami'ar Johns Hopkins, mutuwar cutar coronavirus ta kai 1,000 a ranar Laraba, in ji rahoton CBS.
A duk faɗin duniya, ƙasashe sun kafa tsauraran matakan hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya tsawaita dokar hana fita har zuwa ranar 1 ga Mayu.
A duk fadin kasar, Shugaba Vladimir Putin ya ce za a ci gaba da biyan albashi ga 'yan Rasha ko da kuwa sun bar aiki a ranar 30 ga Afrilu.
Majalisar dokokin Portugal ta amince da tsawaita dokar hana fita na kwanaki 15, ta wuce ta kuri'u 215, 10 sun ƙi, kuma ɗaya ya ƙi.
Saudi Arabiya ta tsawaita dokar hana fita a wuraren alfarma na Makka da Madina na tsawon yini guda; a baya, dokar hana fita ta kasance daga karfe 3 na yamma zuwa 6 na safe.
An sanya dokar hana fita a Thailand daga karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio Mike DeWine ya ce birnin zai fara dokar hana fita daga gida daga ranar 1 ga Mayu.
Shaguna a Australia sun rage yawan takarda da mutum zai iya saya
A ranar Lahadi da Asabar, manyan kantunan sayar da kayayyaki na Australiya Woolworths da Coles sun sanya dokar sayen takarda guda ɗaya ko biyu a kowane kantin sayar da kayayyaki a cikin ƙasa.
ALDI ya kafa dokoki guda ɗaya a rana ta farko.
An wallafa dokoki a cikin takarda a waje da shagon da kuma a shafin Facebook.
Mutane sun sayi kaya da yawa saboda tsoron cewa COVID-19 na iya sa mutane su kasance a gida.
A ranar Laraba, Woolworths ya ƙaddamar da ƙuntatawa kan sabis na isar da kaya zuwa gida tare da takaddun shaida.
An yi wannan umarni ne a ranar hudu da ta gabata a Woolworths a Coles a ranar 4 da 5 ga Maris.
Coles, a cikin sanarwar da ta yi a ranar 8 ga Maris, ta ce dokar ta mutum huɗu ta fara aiki, wasu kantunan sayar da kayayyaki suna ƙarewa cikin sa'a ɗaya bayan shigowar kayayyaki kuma ta kira bukatar mutane ta wucewa, yayin da ALDI, a shafin Facebook a ranar Talata ta kira shi ta wucewa.
Sayarwa ta ƙaru sosai a makon da ya gabata, in ji wani daga Woolworths.
Shagon Costo a Canberra ya kuma yi karo da mutum biyu a makon da ya gabata.
Don magance matsalar ƙarancin kayayyaki, Coles ya ba da umarnin kaya da yawa, Woolwoths ya ba da umarni da yawa, AlDI ya ba da umarnin kayayyaki na ranar Laraba da yawa da suka zo kwanakin baya.
Russell Zimmerman, darektan ƙungiyar masu sayar da kayayyaki ta Australiya ya ce, 'yan kasuwa suna ƙara yawan sayarwa, amma suna damuwa sosai game da dokokin ƙasar.
Mutane sun fahimci cewa dole ne a ƙara yawan samar da kayayyaki don a biya bukatun mutane.
A ranar Talata, ALDI ta sanar da cewa bayan fitar da kayayyaki a kwanakin baya, wasu shagunan ba za su sami Musamman na ranar Laraba ba.
A wani rahoto da aka bayar a shafin news.com.au, Dr. Gary Mortimer, masanin harkokin kasuwanci a Jami'ar Fasaha ta Queensland ya ce kantuna suna ba da damar shiga ga kowa.
Ya lura cewa takarda ta zama babban abu, saboda haka ba ta da yawa, kuma tana tafiya da sauri, ta cika wuraren shagon, wanda ya kara da damuwa game da rashin amfani.
Coles da Woolworths suna da gaskiya (wannan) idan akwai wadataccen kaya a cikin shagon, idan akwai wadataccen kaya kamar takarda da kayan wanke hannu, zai iya zama mai girma da ƙasa, in ji Russell Zimmerman a ABC News.
Wani mai yin takarda mai suna Who Gives a Crap ya ce a ranar Laraba da ta shige, ba su da kayayyaki.
Kamfanin Kimberly-Clark, mai kera takarda Kleenex, da kamfanin Solaris mai kera takarda Sorbent, sun ce suna aiki 24/7 don biyan buƙatun, a cewar rahoton news.com.au.
Domain.com, masu ba da sabis na gidaje sun ce wasu masu gidaje suna ba da kyauta ta kyauta ga mai biyan kuɗi na farko don sayen gida, yayin da mutane suka rage yawan sayayya saboda ba su da abin yi a ƙarshen mako na ranar aiki.
Labaran ranar Alhamis na NT News, wani yanki na Darwin, ya nuna takardu takwas da za a iya yankewa don taimakawa maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin.
Kafin a dakatar da dokar, ABC Australia ta ruwaito cewa a ranar 3 ga Maris, masu sayar da kayayyaki ba su da niyyar rage yawan sayayya.
Russell Zimmerman ya ce akwai bukatar wasu abubuwa, kamar su abin rufe fuska, magungunan tsabtace jiki, abinci mai ƙanshi, wanke hannu, da gari.
Kuma, a waje da Ostiraliya, a ranar Lahadi a wani kantin sayar da kayayyaki na Ocado a Ingila, an lura cewa mutane ba sa sayen takarda na Andre a cikin fakitin 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana yaduwar cutar COVID-19  Cutar da ke tattare da coronavirus SARS-CoV-2  a matsayin annoba.
Duk da cewa sunan annoba yana nuna irin cutar da ta fi tsanani, ba yadda ta ke da tsanani ba, WHO ta ga cewa akwai bukatar gwamnatoci su yi aiki:
Kowace ƙasa na iya kawo ƙarshen annobar.
Idan ƙasashe suka gano, gwada, ba da agaji, keɓewa da kuma kula da mutane, za su iya haɗa kai don yaƙi, in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
Muna cikin damuwa game da yadda cutar ke yaduwa da kuma yadda ba a yi komai ba.
In ji Dokta Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka da Kula da Amurka, cutar ta zama mamaki.
Ya ce, kamar yadda CNN ta ruwaito a watan Fabrairu, tun bayan barkewar cutar mura, babu wata cutar numfashi da ta yi tasiri ko kuma ta bazu a duniya.
Ghebreyesus ya yi magana iri ɗaya, yana cewa Wanene a cikinmu ya rage da zai ga cutar da ba ta da alaƙa da coronavirus.
Ya kara da cewa, kuma wanene ba zai taɓa ganin annobar da za a iya kawo ƙarshen ta ba.
An kira wannan annoba bayan shawarar da Hukumar Lafiya ta Duniya ta yanke a watan Janairu ta ayyana ta a matsayin babbar matsalar kiwon lafiya ta duniya.
Dr. Anthony Fauci na Cibiyar Kula da Magunguna da Cututtuka ta Amurka, ya ce "Abin da ya faru a baya zai iya zama mafi muni".
A ranar Alhamis, Rahoton Haɗin Kai ya ba da rahoton cewa daga cikin mutane 126,000 da aka gano da cutar COVID-19 a duniya, 4,600 sun mutu.
Cutar annobar coronavirus ta 2019-20 ita ce cutar sankarar cutar coronavirus ta 2019 (COVID-19), wanda cutar cututtukan numfashi ta coronavirus 2 (SARS-CoV-2) ta haifar.
An gano cutar a Wuhan, China, a watan Disamba na 2019, an bayyana ta a matsayin matsalar lafiyar jama'a a ranar 30 ga Janairu, 2020, kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an sami mutane miliyan 1.61 da ke da cutar COVID-19 a cikin yankuna 210 da yankuna, wanda ya haifar da mutuwar mutane 97,000.
Mutane 364,000 sun bar gidajensu.
Yawan mace-mace ya kai kashi 4 cikin dari a China, kashi 13.04 cikin dari a Algeria da kashi 0.08 cikin dari a New Zealand.
Alamun cututtuka sune zazzabi, tari da kuma numfashi.
Matsaloli sune ciwon huhu, wahalar numfashi.
Idan cutar ta kamu da yau, zai ɗauki kwanaki biyar zuwa 12 kafin bayyanar cututtuka ta fara.
Babu riga-kafi ko magani.
Don hana kamuwa da cutar, ya kamata ka wanke hannuwanka, rufe hanci ko bakinka lokacin da kake tari, ka nisanta kanka da mutane, kuma ka lura da waɗanda ke keɓewa saboda sun kasance kusa da mai kamuwa da cutar.
Gwamnatoci a duk faɗin duniya sun kafa dokar rufe hanyoyi, dokar hana fita, dokar hana fita, kayan aikin kariya, da kuma rufe wurare.
Cutar ta haifar da matsalar tattalin arziki a duniya, ta haifar da katse wasanni, coci, siyasa da nishaɗi, da kuma ƙarancin kayayyaki a duniya saboda yawan cin kasuwa.
An rufe makarantu da jami'o'i a duk faɗin duniya ko kuma a birane a ƙasashe 193, wanda ya shafi ɗalibai kashi 99.4 cikin ɗari na yawan jama'a.
Rashin fahimtar gaskiya game da cutar ya zama ruwan dare gama gari a kan intanet, kuma ƙiyayya da baƙi ta fi yawa a cikin ƙiyayya tsakanin Sinawa, da mutanen Gabas da kudu maso gabashin Asiya da ke kusa da su, da waɗanda ke cikin yankin da cutar ta kamu.
Bayan an rufe hanyoyin, an rage iskar carbon a cikin yanayi.
Hukumomi a Wuhan, China (babban birnin lardin Hubei) sun gano yawan kamuwa da cutar nimoniya a ranar 31 ga Disamba, 2019, kuma an fara binciken gano cutar a farkon Janairu, 2020.
Wadanda suka kamu da cutar sun fito ne daga kasuwar dabbobi ta Huanan kuma ana tsammanin cutar ta samo asali ne daga can kuma ta zoonotic.
Kwayar cutar da ke haifar da cutar an kira ta SARS-CoV-2, sabon kwayar cuta da ke da alaƙa da coronavirus na malam buɗe ido, coronavirus na al'ada da SARS-CoV. Mutumin farko da ya nuna alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma ba a san ko mutumin ya fito daga wannan kasuwa ba.
Daga cikin wadanda suka kamu da cutar a shekarar 2019, kusan rabin an gano su ne daga kasuwa.
A ranar 13 ga Maris, 2020, rahoton daga Kudancin China a cikin Morning Post ya bayyana cewa cutar ta fara ne a ranar 17 ga Nuwamba, 2019, tare da wani mutum mai shekaru 55 a Hubei.A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa an samu raguwar cutar a China amma an fara samun karuwa a Italiya, Iran da Koriya ta Kudu, inda aka samu karuwar masu cutar a China.
Yana iya nufin cewa ba mu san adadin mutanen da ke da cutar ba a cikin waɗanda ke da alamun rashin lafiya.
A ranar 26 ga Fabrairu, ƙananan masu cutar sun kasance masu launin toka, tare da ƙananan shekarun 19 da ke ƙasa da kashi 2.4% na ƙasashe.Babban masanin kimiyya na Burtaniya, Patrick Vallance, ya gano cewa kashi 60% na yawan jama'ar Burtaniya suna buƙatar kamuwa da cutar don rigakafin cutar ta fara aiki.
Yawan mutane da ke da cutar COVID-19 da aka tabbatar da cutar a cikin gwajin, bisa ga doka.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3% na yawanta, kuma yawancin ƙasashe sun ba da izinin yin gwaji ga mutanen da ke da alamun rashin lafiya, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka gudanar a China tsakanin 16 ga Maris da 23 ga Fabrairu ya nuna cewa kashi 86% na masu kamuwa da COVID-19 ba a gano su ba, kuma sun yada cutar a kashi 79% na waɗanda aka gano.
Wani rahoto da aka fitar a ranar 30 ga Maris ya nuna cewa adadin masu kamuwa da cutar a Italiya ya fi yadda aka zata.
Yawan yaduwar (R0) na COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka da Kula da Cututtuka ta Amurka ta fitar ya nuna cewa zai iya zama 5.7.
Yawancin masu cutar COVID-19 suna murmurewa.
Ga waɗanda ba su warke ba, lokacin bayyanar cututtuka da mutuwa tsakanin kwanaki 6 da 41, tare da matsakaicin kwanaki 14.
A ranar 10 ga Afrilu, 2020, mutane 97,000 sun mutu daga COVID-19.
A China, a ranar 5 ga Fabrairu, kashi 80% na waɗanda suka mutu sun kasance masu shekaru 60 ko sama da haka, kuma kashi 75% suna da wasu cututtuka kamar cututtukan zuciya da ciwon sukari.
Adadin ainihin mutuwar COVID-19 na iya zama mafi girma, amma ba ya nuna mutanen da ba a gwada su ba  kamar, gida, gidajen kula da tsofaffi, da ƙari.
Wani bincike na asali daga Italiya ya nuna cewa yawan mutuwar COVID ya ninka sau 4-5 fiye da yadda aka zata.
Ma'aikatar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta gano cewa ko kuma an san cewa (ƙididdigar yawan mutuwar jama'a) ba daidai ba ne saboda ƙananan ƙididdigar, in ji masu binciken rahotanni na Amurka. Irin waɗannan ƙananan ƙididdigar suna faruwa a cikin cututtukan cututtuka, kamar a cikin annobar 2009 ta H1N1 ta alade. Mutuwar ƙarshe a Wuhan ta kasance a ranar 9 ga Janairu, 2020.
Mutuwar da ta gabata a China ta faru ne a ranar 1 ga Fabrairu a Philippines, kuma mutuwar da ta faru a waje da Asiya ta faru ne a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga Fabrairu, a waje da China, mutane kusan 12 sun mutu a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, kasashe 40 sun ba da rahoton mutuwar, a duk nahiyoyi sai Antarctica. Ana ci gaba da aiki don tabbatar da adadin mutuwar.
Waɗannan ƙididdigar sun bambanta a wurare da yawa, kuma sun dogara da yanayin gwaji, da yanayin asibiti, da yanayin kulawa, lokacin da cutar ta fara, da kuma wasu abubuwan da suka shafi yawan jama'a kamar shekaru, jinsi, da yanayin lafiyar mutum.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan mutuwar a cikin masu kamuwa da cutar ya kai kashi 6.0% (97,039/1,617,204) tun daga 10 ga Afrilu 2020.
Yawan zai dangana ne a kan wannan.
A cikin kasar Sin, yawan mace-macen da ke cikin cutar ya kai kashi 17.3% (na waɗanda ke da alamun cutar daga 1 zuwa 10 ga Janairu 2020) zuwa 0.7% (na waɗanda ke da alamun cutar daga 1 ga Fabrairu 2020). Sauran ma'aunin sune ƙimar mutuwar (CFR), wanda ke nuna yawan mutanen da ke da cutar da suka mutu, da kuma ƙimar mutuwar (IFR) wanda ke nuna yawan mutanen da ke da cutar (wanda gwajin ya nuna) da kuma mutuwar cutar.
Wannan ƙididdigar ba ta da lokaci, ta dogara da yanayin ƙasa da yanayin yawan jama'a.
Yawancin masana kimiyya sun yi ƙoƙarin gano waɗannan ƙwayoyin cuta don yawancin mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta gano cewa yawan mutuwar cutar ya kasance tsakanin 0.1% da 0.39
Lambar da ke sama tana ɗaya daga cikin binciken COVID-19 na Jamus, kuma binciken ƙididdigar zai haɗa da gwajin CFR.
Hukumar Lafiya ta Duniya ta ce ana iya sarrafa annobar.
Ba a san lokacin da za a iya samun annobar ba kuma ya bambanta daga wuri zuwa wuri
Maciej Boni na Jami'ar Jihar Penn ya ce, Idan ba a fahimci cutar ba, za ta iya raguwa idan ba a ɓoye wuraren ɓoye ba.
Amma babu wata hanyar da za a sani a yau kamar yadda zai iya zama.
Gwamnatin 'yan takarar shugaban kasar Sin a Zhong Nanshan ta ce  zai iya karewa a watan Yuni idan dukkan kasashen duniya suka bi ka'idodin WHO kan yadda za a kula da cutar.
A ranar 17 ga Maris, Adam Kucharski na Kwalejin London don Tsabta &amp; Magungunan Yankin Gishi ya yi hasashen cewa SARS-CoV-2 zai ci gaba da rayuwa har tsawon shekara ɗaya zuwa biyu.
Bisa ga binciken da Neil Ferguson na Kwalejin Imperial ya yi, an gano cewa nisantar da mutane da sauran matakan da suka dace sun fi dacewa don yin allurar rigakafi (yana iya ɗaukar shekaru 18 ko sama da haka).
William Schaffner na Jami'ar Vanderbilt ya ce, "Ban tabbata ba ko cutar coronavirus ce ba  saboda za a manta da ita da sauri  za ta tafi har abada  kuma tana iya zama cuta mai saurin wucewa, mai iya dawowa a kowace shekara ".
Yadda za a iya yin amfani da shi a cikin jiki zai nuna ko jikin mutum yana da ƙarfi sosai.
Alamun cutar COVID-19 na iya zama masu yawa kuma waɗanda ke fama da cutar ba za su iya gane su ba.
Alamun cututtuka biyu da suka fi yawa sune zazzabi (88%) da tari mai bushe (68%).
Alamomin rashin ƙarfi kamar rashin ƙarfi, cututtukan numfashi, rashin ji, kashin baya, ciwon kasusuwa, motsi, ciwon kai, sanyi, hawan jini, zawo, ko cyanosis. WHO ta ce mutum ɗaya cikin shida zai kamu da rashin lafiya mai tsanani da wahalar numfashi.
A cikin Amurka Cibiyoyin Kula da Cututtuka da Kulawa (CDC) sun lissafa alamun cututtuka masu haɗari kamar wahalar numfashi, ciwon kirji ko ciwon kirji, rashin hankali, wahalar tafiya, zazzabi mai zafi; ana buƙatar asibiti da sauri idan waɗannan alamun sun bayyana. Hakanan cutar na iya haifar da ciwon huhu, cututtukan numfashi, sepsis da mutuwa.
Wasu masu cutarwa na iya zama marasa alamomi, ba tare da alamomi ba amma tare da gwajin gwaji, don haka masu binciken sun ba da shawarar cewa waɗanda ke kusa da waɗanda aka gano suna da cutar su fahimci su sosai.
China ta ce kashi 44 cikin ɗari na mutanen da ba su da alamun cutar.
Lokacin-zuwa-kwana-kwana don samun nasara (lokacin kamuwa da cuta da bayyanar cututtuka) yana tsakanin kwana ɗaya zuwa 14; yawanci kwanaki biyar. Saboda rashin sani, yawan mutanen da ke da cutar COVID-19 da ke fama da asarar ji ya ragu daga 30% zuwa 15%.
An san yadda cutar take yaduwa.
An yi imanin cewa za a iya yada cutar ta hanyar kusanci da ƙananan ƙwayoyin cuta da ke fitowa daga tari, ƙaiƙayi, ko magana; kusanci da mita 1 zuwa 2 (3 zuwa 6 ft).
Nazarin ya nuna cewa ƙwayar tari na iya tafiya daga mita 4.5 (15 feet) zuwa mita 8.2 (27 feet).
Wasu masana sun ce kwayar cutar za ta iya yaduwa ta hanyar ruwan jikin mutum wanda ke cikin iska na tsawon sa'o'i, wanda ke faruwa yayin magana.
Ruwan ruwa zai iya fitowa daga baki ko hanci na mutanen da ke kusa, kuma suna iya numfashi.
Yin amfani da na'urar CPR (Cardiopulmonary Resuscitation) na iya sa jijiyoyin numfashi su yi girma a cikin jiki.
Hakanan ana iya yaduwa ta hanyar taɓa tabo, fata, idanu, hanci da baki.
Wasu sun ce suna iya tafiya a cikin ƙura, amma wannan yana da ɗan tsoro.
Gwamnatin China ta musanta yiwuwar SARS-CoV-2 yana tafiya a cikin kumfa. Kwayar cutar tana da ƙarfi sosai a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma tana iya tafiya a cikin rashin bayyanar cututtuka a cikin kwanakin ƙarshe na cutar.
Mutane suna kamuwa da cutar bayan kwana uku bayan kamuwa da cutar, wanda ke nuna cewa mutum zai iya yada cutar daga wanda ba shi da alamun cutar.
Kawai wasu nazarin dakin gwaje-gwaje sun nuna cewa akwai marasa alamun cutar amma an gano masu alamun cutar a wasu ƙasashe yayin da ake bin diddigin waɗanda ke kusa da waɗanda ke da cutar.
Cibiyar Kula da Cututtuka ta Turai (ECD) ta ce ba a san yadda cutar ke yaduwa ba, kuma mutum ɗaya zai iya yadawa ga mutane biyu ko uku. Kwayar cutar na iya rayuwa na tsawon sa'o'i a kan abubuwa.
Saboda haka, an gano kwayar cutar a kan filastik (polypropylene) da kuma ƙarfe 304, don kwana ɗaya a cikin kwali, da kuma kwana huɗu a kan jan ƙarfe.
Koyaya, ya dogara da yanayin zafi ko yanayin zafi. Karnuka da sauran dabbobin gida na iya kamuwa da COVID-19.
Babu wani bincike da ya nuna cewa dabbobi na iya watsa kwayar cutar ga mutane, amma hukumomin Burtaniya a nan gaba sun bukaci wanke hannu bayan taɓa dabbobi, musamman bayan taɓa ƙwayoyin cuta na marasa lafiya.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin sabbin SARS-CoV-2 suna haifar da yanayin yanayi. A waje da jikin mutum, kwayar cutar na iya zama a saman sabulu sannan ta kamu da cutar kuma ta mutu. SARS-CoV-2 yana cikin dangin SARS-CoV.
An ce dabbobi ne suka samo su.
Gano kwayoyin halitta ya gano coronavirus a cikin abokan Betacoronaviruses, a cikin sarkar Sarbecovirus (sashi na B) tare da biyu daga jemage.
Wannan shine 96% na daidaito tare da wannan kwayar cutar coronavirus ta bat (batCov RaTG13).
A watan Fabrairun 2020, wani binciken da aka yi a China ya gano cewa kawai amino acid guda ɗaya ne ke raba su a wasu sassan kwayar cutar ta farko da ta ɗan adam.
An gano dukkanin kwayoyin halitta a cikin kashi 92% na asalin kwayar cutar coronavirus da SARS-CoV-2, wanda ba zai iya nuna cewa cutar ta samo asali daga asalin ba.
Ana iya gano cututtukan bayan kamuwa da cutar ta hanyar bayyanar cututtuka, amma dole ne a yi bincike don tabbatar da hakan ta hanyar nazarin polymerase mai kwakwalwa (rRT-PCR) na wuraren da ke da cutar a cikin CT.
Nazarin da aka yi don gano bambancin tsakanin PCR da CT a Wuhan ya nuna cewa CT ya fi PCR kyau, amma ba ta da cikakkiyar fahimta, saboda yawancin hotuna suna nuna cututtukan huhu da sauran cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa ba za a iya yin CT ba ga sabbin masu cutar COVID-19.
Hukumar Lafiya ta Duniya ta buga rubutun rubutun RNA da yawa don SARS-CoV-2, wanda aka fara buga shi a ranar 17 ga watan Agusta.
Gwajin ya taimaka wajen gano yanayin polymerase (rRT-PCR).
Ana iya gwadawa da jini ko kuma jini.
Za a sanar da sakamakon a cikin sa'o'i kadan ko kwanaki masu zuwa.
Amma gwaje-gwaje da aka yi na hanci da hanci da kuma na hanci. Yawancin dakunan gwaje-gwaje da kamfanoni suna yin gwaje-gwaje na serological don gano ƙwayoyin cuta.
A ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka tabbatar da inganci don amfani da su ga jama'a.
A Amurka, samfurin gwajin ƙwayar cuta wanda aka yi da Cellex an yarda da shi don maganin gaggawa don gwaje-gwaje kawai.
Hotunan radiyo da CT na marasa alamun cutar suna cikin gilashin opaque kuma ba a sami ƙarin jini ba.
Kamfanin Rediyo na Italiya yana samar da wani dandamali na intanet don ganin hotunan marasa lafiya.
Saboda yawan kamuwa da cututtuka kamar adenovirus, yanayin rashin gani ta hanyar PCR yana da iyakantacce don gano COVID-19.
Wani babban binciken da aka gudanar a China game da cututtukan kirji a cikin CT da PCR ya nuna cewa hotunan ba su da ƙarfi, ba su da sauri kuma ba su da inganci, don haka an yi la'akari da su a matsayin taimako a cikin yaƙin cutar.
Hanyoyin Artificial don gano jijiyoyin jiki na mutum don gano cutar ta hanyar radiyo ko CT.
Matakan da za a ɗauka don hana yaduwar cutar sun haɗa da tsabtace jiki, wanke hannu, guje wa taɓa fuska, hanci, ko baki da ƙwayoyin cuta da ba a wanke ba, da tari ko ƙaiƙayi a cikin tufafi da kuma zubar da su da wuri-wuri.
Ya kamata waɗanda ke da cutar su sanya abin rufe fuska a waje.
Hakanan, nisantar da jama'a. Gwamnatoci da yawa sun dakatar ko kuma dakatar da ayyukan da ba su da mahimmanci a cikin yankunan da ke fama da cutar.
Amma cutar ta zama cibiyar watsawa tsakanin mutane a duk duniya.
Wannan yana nufin cewa cutar tana yaduwa tsakanin mutane a cikin al'umma, wasu mutane ba su san yadda ko inda suka kamu da cutar ba. Ma'aikatan kiwon lafiya da ke kula da marasa lafiya suna buƙatar bin ƙa'idodin nisantar da kai da kiyaye ido. Kulawa da jama'a yana da mahimmanci ga hukumomi don gano asalin cutar don kawo ƙarshen ta.
Gwamnati ta taimaka wajen gano wurin da ake amfani da wayar hannu, Amnesty International da wasu kungiyoyi 100 sun yi barazanar yadda ake sa ido kan al'umma.
Yawancin aikace-aikacen wayar hannu da aka tsara don taimakawa, a ranar 7 ga Afrilu 2020, fiye da dozin dalibai suna aiki a kan ayyukan tsaro, kamar kunna Bluetooth don gano kusanci daga wasu wayoyin hannu.
Bayan haka, mutane za su sami saƙo cewa sun kasance kusa da mutumin da ke da cutar COVID-19. Bayanan da ke nuna yadda za a hana kamuwa da cutar, kamar wanke hanci da wanke baki da kiss na baki, ba gaskiya bane.
Babu riga-kafi ga COVID-19, amma ƙungiyoyi da yawa suna aiki don samar da shi.
Ana buƙatar wanke hannu don hana yaduwar cutar daga mutum zuwa wani.
CDC ta ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na tsawon sakan ashirin, bayan sun je bayan gida ko idan hannayensu sun ƙazantu; kafin cin abinci; da kuma bayan shafa hanci, tari, da ƙaiƙayi.
Wannan saboda a waje da jikin mutum, ana iya fitar da kwayar cutar ta hanyar sabulu na gida, wanda zai lalata ɓoyayyen wurin.
CDC ta kuma ba da shawarar cewa wanke hannu da maganin shafawa wanda ya fi ruwa da sabulu kashi 60% na ruwa.
Hukumar Lafiya ta Duniya ta ba da shawarar cewa mutane su guji taɓa idanu, hanci ko baki da hannayensu da ba a wanke ba.
Yanayin zai iya zama mai cutarwa da kuma maganin ƙwayoyin cuta (a cikin minti daya na maganin ƙwayoyin cuta na ƙarfe), da 62-71% na ethanol, 50-100% na isopropanol, 0.1% na sodium hypochloride, 0.5% na hydrogen peroxide, da kuma 0.2%-7.5% na povidone-iodine.
Sauran mafita, kamar benzalkonium chloride da chroxedine gluconate, ba su da ƙarfi sosai.
CDC ta ba da shawarar cewa duk wani asibiti da aka gano ko wanda ake zargi da cutar COVID, gami da wuraren aiki, makarantun yara, wuraren da ke da tsabta kamar shawa, wuraren zama, kayan lantarki, fuska, mabuɗan rubutu, sarrafawa ta nesa, da ATMs da ke riƙe da mai cutar, ya kamata a tsabtace su.
Kungiyoyin kiwon lafiya sun ba da shawarar mutane su rufe bakinsu da hancinsu da ƙwanƙolin hannu ko kuma da masana'anta don yin tari ko ƙaiƙayi, kuma su zubar da su da wuri-wuri.
Ana buƙatar abin rufe fuska na asibiti don marasa lafiya, saboda sanya abin rufe fuska na iya hana zubar da jini yayin magana, ƙaiƙayi ko tari.
Hukumar Lafiya ta Duniya ta ba da umarnin lokacin da za a sa abin rufe fuska.
Stephen Griffin, masanin ilimin cututtuka a Jami'ar Leeds, ya ce Sanya abin rufe fuska na iya hana mutane taɓa fuska, wanda shine babban dalilin yaduwar cutar. Ana iya sanya abin rufe fuska ga mai kula da mai cutar.
Hukumar Lafiya ta Duniya ta ce masu lafiya suna buƙatar sanya abin rufe fuska ne kawai idan suna cikin haɗarin kamuwa da cutar, kamar waɗanda ke kula da mai cutar COVID-19, amma sun kuma fahimci mahimmancin hana taɓa fuska.
Yawancin al'ummomi sun ba da umarnin sanya abin rufe fuska a waje.
A Amurka, CDC ta ba da shawarar yin amfani da abin rufe fuska na roba. Kasar Sin ta ba da shawarar yin amfani da abin rufe fuska na yau da kullun don marasa lafiya, musamman idan suna da kusan mita 1 (3ft ko ƙasa da haka) daga wasu mutane.
Hong Kong ta bukaci mutane su sanya abin rufe fuska na asibiti a cikin motocin jama'a ko kuma a cikin motocin jama'a.
Hukumomin kiwon lafiya a Thailand sun ba da shawarar cewa mutane su sanya abin rufe fuska a cikin gida kuma su wanke su kowace rana.
An kafa dokar hana fita daga gida a Jamhuriyar Czech da Slovakia idan ba a sanya abin rufe fuska ba.
A ranar 16 ga Maris, Vietnam ta bukaci mutane su sanya abin rufe fuska a waje don kare kansu da sauran mutane.
Gwamnatin Ostiraliya ta bukaci duk wanda ya shiga kasuwa ya sanya abin rufe fuska.
Isra'ila ta bukaci mutane su sanya abin rufe fuska idan suna waje.
Taiwan, wanda ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta bukaci duk waɗanda ke cikin jiragen ƙasa da bas su sanya abin rufe fuska daga 1 ga Afrilu.
Panama ta ba da umarnin yin amfani da abin rufe fuska a gida, kuma ta ba da shawarar yin abin rufe fuska na roba a gida ga waɗanda ba za su iya sayen abin rufe fuska ba.
Ana yin masks a Japan, Koriya ta Kudu da Malaysia da Singapore.
Nesa (ko nisantar) yana hana kamuwa da cuta wanda zai iya hana yaduwar cutar kuma ya lalata haɗin kan jama'a.
Sauran matakan sun haɗa da keɓewa; rufe hanyoyi; da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo, da manyan shagunan kasuwanci.
Mutane za su iya taimaka wajen nisanta kansu ta wajen kasancewa a gida, guje wa tafiya, guje wa zuwa wuraren da jama'a suke, guje wa taɓa mutane, da kuma nisanta kansu da mutane.
Gwamnatoci da yawa suna kafa dokar nisantawa a wuraren da cutar ta fi yaduwa.
Gwamnatin Amurka ta ce mutane 250 ko ƙasa da haka (idan ba su da cutar COVID-19 a cikin addininsu) ko 50, sannan a ƙayyade zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta dakatar da haɗuwa da mutane biyu ko fiye. Mutanen da ke da shekaru da yawa da kuma waɗanda ke fama da cututtukan cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da rashin ƙarfin tsarin garkuwar jiki na iya kamuwa da cuta mai tsanani. CDC ta ba da shawarar cewa su kasance a gida a wuraren da cutar ta fi yaduwa. A ƙarshen Maris, 2020, WHO da sauran cibiyoyin kula da ƙaura sun ba da shawarar Distance da Distance, wanda ke nufin cewa ya kamata a nisanta tsakanin mutane amma ya kamata a zauna a kan layi ko a nesa.
Maganar Distancing tana nufin cewa mutane su kasance tare da mutane, su kasance a cikin keɓaɓɓen wuri, amma mutane su kasance tare idan za su iya. Wasu gwamnatoci sun sanya takunkumin hana yin jima'i a lokacin annobar.
An haramta yin jima'i da wanda ke zaune tare da ku, wanda ba shi da cutar ko alamun cutar.
Ana buƙatar keɓewa a gida don waɗanda ke da cutar COVID-19 da waɗanda ake zargi da cutar.
Cibiyoyin kiwon lafiya sun ba da umarni don keɓewa mai kyau. Yawancin gwamnatoci sun ba da umarni ko kuma sun ba da umarnin keɓewa a cikin yankunan da cutar ta fi yawa.
An ba da ƙa'idodin keɓewa masu ƙarfi ga waɗanda ke cikin haɗarin kamuwa da cutar.
Waɗanda ke da kusanci da mai cutar COVID-19 da waɗanda suka dawo daga wuraren da ke da cutar ko kuma yankuna masu fama da cutar za su keɓe kansu na kwanaki 14.
Hanyoyin da za a bi don hana ko rage ko jinkirta yaduwar cutar.
An fara aiwatar da aikin rigakafin a farkon lokacin yaduwar cutar ta hanyar bin mutane da kewaye da marasa lafiya da kuma aiwatar da matakan hana yaduwar cutar da kuma allurar rigakafi don rage yawan kamuwa da cutar a cikin jama'a.
Lokacin da ya zama da wahala a hana yaduwar cutar, babban burin ya zama: rage yaduwar cutar a cikin al'umma.
Za a iya yin aikin da ke kawo ƙarshen jirgin tare.
Ragewa yana buƙatar ƙarin aiki don sauya Panama ta hanyar rage yawan kamuwa da cutar zuwa mutum 1. Kulawa da cutar yana rage saurin kamuwa da cutar, wanda ake kira rage tasirin cutar.
Wannan ya rage haɗarin ƙarancin wuraren kiwon lafiya kuma ya ba da lokaci don samar da allurar rigakafi da magani.
Abubuwan da ba na asibiti ba waɗanda ke taimakawa da kuma haifar da yaduwar cuta sun haɗa da wanke hannu, sanya abin rufe fuska, keɓewa; ƙa'idodin zamantakewar al'umma kamar rufe makarantu da hana taron jama'a; yarda da al'umma don yin waɗannan ayyukan; da tsabtace al'ummomin. An aiwatar da ƙarin ƙa'idodi masu ƙarfi a China lokacin da cutar ta yi tsanani, tare da keɓewa da rufe hanyoyin jama'a.
Wasu ƙasashe sun kafa dokoki don hana cutar.
Koriya ta Kudu ta fara aiwatar da gwaji mai tsanani da kuma sanya wuraren killacewa, tare da hana yawan zirga-zirga.
Singapore ta biya masu yin keɓewa da kuma hukunta waɗanda suka ƙi yin hakan.
Taiwan ta haɓaka samar da abin rufe fuska kuma ta yi yaƙi da masu samar da abin rufe fuska da yawa. Abin da Burtaniya da Amurka suka yi (don jinkirta amma dakatar da yaduwar cutar) ya kasance mai ƙarfi sosai.
Dokokin da aka tsara na iya taimaka wa ma'aikatan asibiti su rage yawan masu zuwa asibiti da kashi biyu cikin uku kuma rage mutuwar da rashin lafiyar ma'aikatan asibiti da kashi biyu.
Yin rigakafi na iya zama mai kyau amma ya kamata a ci gaba da shi idan kwayar cutar ta kasance a cikin mutane (ko kuma a ranar da za a iya samun allurar rigakafi), saboda yaduwar za ta sake komawa idan mutane ba su ci gaba da yin rigakafi ba.
Dokokin da ke da tsawo don kawo ƙarshen annobar za su kasance masu tsada ga al'umma da tattalin arziki.
Babu maganin COVID-19, amma akwai aikin yin amfani da shi, da kuma gwajin maganin da ake da shi.
Shan maganin tari da aka saya a kantin magani, shan ruwa, da samun isasshen barci na iya taimakawa wajen magance alamun.
Idan ya yi tsanani, ana iya yin amfani da iskar oxygen, na'urar numfashi, da kuma na'urar da ke taimaka wa mutum ya numfashi.
Yin amfani da kwayoyin steroid na iya haifar da mummunan sakamako.
Yawancin alamun cutar an amince da su don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
WHO ta kuma ce wasu magungunan gida da na gida na iya magance waɗannan alamun cutar SARS-CoV-19.
Ƙara yawan asibitoci da asarar su saboda yawan buƙatun marasa lafiya da ke fama da COVID-19 yana da mahimmanci a cikin yaƙin, in ji WHO.
ECDC da ofishin Turai na WHO sun ba da umarni ga asibitocin ƙwararru don samar da ƙarin kayan aikin kiwon lafiya, kamar samar da dakin gwaje-gwaje don gwajin COVID-19, hana ƙarin buƙatun marasa lafiya, keɓewa ko keɓewar masu cutar COVID-19, da haɓaka sabis na kulawa ta hanyar keɓewar lepial da samun ƙarin kayan aikin numfashi a gadaje.
Akwai wasu maganganu da yawa game da asalin wannan mutum na farko (wanda ake kira mai haƙuri zero).
An gano mutum na farko da ya kamu da sabon coronavirus a ranar 1 ga Disamba, 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu kamuwa da cutar coronavirus a Hubei ya karu sosai.
Sun kasance mutanen da ke kan titunan kasuwar Huanan, wanda ke sayar da dabbobi masu rai, kuma wasu maganganun sun nuna cewa cutar ta samo asali ne daga waɗannan dabbobi; wasu kuma sun nuna cewa ta samo asali ne daga dabbobin daji ko kuma ta zoonotic. Mutane da yawa sun kamu da cutar huhu a ranar 26 ga Oktoba kuma an kula da su daga Likita Zhang Jixian a asibitin Hubei, CDC na Jianghan ya sanar a Wuhan a ranar 27 ga Oktoba.
A ranar 30 ga Disamba, ƙungiyar likitoci a asibitin birnin Wuhan sun sanar da abokan aikin su cewa akwai cutar SARS-CoV-coronavirus.
Limamai takwas, da Li Wenliang, an kama su ne a kan zargin yin ƙarya, Ai Fen, an kore shi daga aikinsa a kan zargin sa da haddasa hatsarin.
Hukumar Kiwon Lafiya ta Wuhan ta ba da sanarwar a ranar 31 ga Oktoba kuma ta sanar da WHO.
Yawancin masu kamuwa da cutar nimoniya sun kai rahoto ga ma'aikatan kiwon lafiya a Wuhan don gano su a farkon watan Janairu. A farkon farkon barkewar cutar, yawan masu kamuwa da cutar ya karu sosai a cikin kwanaki bakwai zuwa rabin rana.
A farkon da tsakiyar watan Janairun 2020, cutar ta bazu zuwa wasu biranen China, wanda aka tallafawa da bikin sabuwar shekara da kuma kasancewar Wuhan babban tashar zirga-zirga.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton cewa ta samu mutum 140 a rana guda, da suka hada da mutum biyu a Beijing da daya a Shenzhen.
A ranar 26 ga Maris, Amurka ta zarce China da Italiya a matsayin mafi yawan masu kamuwa da cutar a duniya. A ranar 9 ga Afrilu, 2020, sama da mutane miliyan 1.61 ke fama da cutar a duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Ƙauyuka 200 da kuma wurare da na yi rashin lafiya.
A yayin annobar a Turai, yawancin ƙasashen yankin Schengen sun sanya takunkumin hana zirga-zirga da rufe hanyoyin.
An sanya mutane cikin keɓewa a duk faɗin duniya (wanda ake kira tsare-tsare na gida, tsare-tsare na gida, ko keɓewa) da kuma ƙuntatawa na fita waje. Ya zuwa 2 ga Afrilu, mutane miliyan 300 ko kashi 90% na yawan jama'a suna cikin keɓewa a Amurka, sama da mutane miliyan 50 a Philippines, sama da miliyan 59 a Afirka ta Kudu, da biliyan 1.3 a Indiya.
A ranar 26 ga Maris, an yi keɓewar tan biliyan 1.7 a duniya, wanda ya sa mutane biliyan 2.6 a duniya suka yi keɓewa a cikin kwanaki biyu da suka gabata  kusan yawan mutanen duniya.
An gano mutum na farko da ya kamu da cutar COVID-19 a cikin wani sabon yanayi a watan Disamba na 2019 a Wuhan, wasu kuma sun ce zai iya zama a ranar 17 ga Nuwamba.
Dr. Zhang Jixian ya gano yawancin masu cutar huhu a ranar 26 ga Disamba, sannan asibitin sa ya sanar da CDC na Jianghan a Wuhan a ranar 27 ga Disamba.
Gwaje-gwaje na farko na kwayoyin halitta da aka yi wa marasa lafiya a ranar 27 ga Disamba 2019 sun gano SARS-CoV-2.
Hukumar Kula da Lafiya ta Wuhan ta bayar da sanarwar a ranar 31 ga Nuwamba.
Hukumar Lafiya ta Duniya ta ba da wani limami a wannan ranar.
Yayin da ake gudanar da wannan taron, masu sihiri a Wuhan sun hana 'yan sanda yin ƙarya game da wannan hatsarin.
Hukumar Lafiya ta Kasa ta kasar Sin ta ce cutar ba ta yaduwa tsakanin mutane ko kuma babu wata alama ta hakan.
A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da kamfen da Babban Sakataren Siyasa na jam'iyyar kwaminis Xi Jinping ya kira "Yakin" don hana yaduwar cutar.
A cikin abin da aka kira mafi girman kulle-kulle a tarihin duniya, an fara aikin kiwon lafiya a ranar 23 ga Janairu don hana hanyoyin shiga da fita daga Wuhan, wanda aka yi a birane 15 a Hubei, don yawan mutane miliyan 57.
An hana zirga-zirgar jama'a shiga birnin.
An kammala bikin sabuwar wata na ƙasar Sin (Janairu 25).
Hukumomi sun kuma soma gina asibitin huoshenshan, wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti daga baya, asibitin leishenshan, don kula da marasa lafiya.
Baya ga sababbin asibitoci, kasar Sin ta kuma samar da wurare 14 a Wuhan, da suka hada da filayen wasa da wuraren wasanni da asibitoci.A ranar 26 ga watan Janairu, gwamnati ta fara gudanar da bincike kan yaduwar COVID-19, tare da samar da hanyoyin shiga ga masu halartar bikin bazara.
Jami'o'i da kwalejoji a cikin ƙasa sun rufe.
Manyan biranen Hong Kong sun kafa dokoki da dama, musamman game da dalibai da jami'o'i.
Aikin nesa ya samo asali ne daga birane a China.
An kafa dokar hana zirga-zirga a Hubei.
An canja motar bas, kuma an rufe wasu gidajen tarihi a ƙasar Sin.
An kafa dokar hana fita a birane da dama, kuma an ce an hana mutane miliyan 760 (fiye da rabin yawan jama'a) fita waje. Bayan barkewar cutar a watan Maris, gwamnatin China ta sanya tsauraran matakan hana yaduwar cutar zuwa wasu ƙasashe.
Alal misali, an sanya dokar keɓewa ta kwanaki 14 a Beijing don duk masu zuwa daga ƙasashen waje.A ranar 23 ga Maris, China ta sami mutum ɗaya kawai da ya kamu da cutar a cikin kwanaki biyar da suka gabata, wanda ya samo asali ne daga wani mutum da ya dawo Istanbul daga Guangzhou.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ce an samu nasarar dakile yaduwar cutar daga cikin gida kuma kasar Sin ta yi aiki da kyau.
A ranar ne aka rufe hanyoyin shiga da fita daga Hubei, bayan wata biyu da dakatar da Wuhan.Ma'aikatar Harkokin Wajen kasar Sin a Hubei ta sanar a ranar 26 ga Maris, 2020 cewa za a iya ba da biza guda goma a ranar 28 ga Maris da kuma gaba, ba tare da bayyana ranar da za a dakatar da dokar ba.
Masu son shiga China za su nemi takardar izinin shiga a Ofishin Jakadancin Sin ko Ofishin Jakadancin.
Gwamnatin kasar Sin ta ba da izinin yin aiki da gidajen wanka a ranar 30 ga Maris, tare da ba da wasu kudade ga masu mallakar gidajen wanka. Hukumomin birnin sun ba da umarnin ranar makoki da karfe 10:00 na ranar 4 ga Afrilu, wanda aka yi bikin Qingming, amma gwamnatin tsakiya ta bukaci mutane su yi amfani da intanet don kiyaye ƙa'idodin nisantar jama'a saboda annobar COVID-19.
An fara barkewar COVID-19 a Koriya ta Kudu a ranar 20 ga Janairun 2020 a China.
An ce an samu karuwar marasa lafiya a birnin Daegu a ranar 20 ga watan Afrilu, saboda taron da aka yi a Cocin Yesu na Shincheonji da ke Daegu.
Mutanen Shincheonji da suka yi tafiya daga Daegu zuwa Wuhan sun gano cewa su ne ke da alhakin yaduwar cutar.
A ranar 22 ga Fabrairu, mutane 9,336 na Iklesia, 1,261 ko 13% na mutanen da ke da alamun cutar.Koriya ta Kudu ta sami mafi yawan masu cutar a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, fiye da mutane 2,000 ne suka kamu da cutar a Korah, kuma sun ƙaru zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan mutanen da ke da cutar ta LMHD daga Koriya ta Kudu bayan an gwada su uku da cutar ta kamu da su.
Har ila yau, an yi wa tashoshin jiragen sama lahani.Koriya ta Kudu ta ƙaddamar da aikin farko da mafi girma a duniya don tantance yawan mutanen da ke fama da cutar, tare da keɓe masu kamuwa da cutar da kuma bin diddigin abokan hulɗarsu.
Ana gudanar da gwajin farko na mutum don masu ba da izinin shiga cikin ƙasa su iya yin rajistar ta hanyar aikace-aikacen wayar hannu, hanyoyin zirga-zirgar jama'a da kuma gwajin kwayar cutar kuma an haɓaka gwajin zuwa 20,000 a kowace rana.
An gano cewa shirin Koriya ta Kudu ya yi tasiri sosai wajen sarrafa cutar ko da ba a sanya biranen cikin keɓewa ba.
Yawancin 'yan Koriya sun yi kira ga korar ta saboda abin da suka kira rashin lafiya, ko kuma ba su yarda da abin da ta ce ba.
A ranar 23 ga Maris, an bayyana cewa Koriya ta Kudu ta kasance cikin iyakantaccen matsayi na makonni huɗu saboda mutum ɗaya ne kawai.
A ranar 29 ga Maris, an ba da sanarwar cewa daga ranar 1 ga watan Maris, duk masu shigowa daga ƙasashen waje za su shiga keɓewa na makonni huɗu.
A cewar kafofin watsa labarai a ranar 1 ga Afrilu, an aika da umarni daga Koriya ta Kudu don kayan gwaji daga ƙasashe 121.
Iran ta gano wani mutum mai dauke da cutar SRS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda a cewar ma'aikatar lafiya da kiwon lafiya, mutane biyu suka mutu a ranar.
Gwamnati ta fara aiki da gaggawa ta rufe kide-kide, wasanni, ayyukan ibada, da rufe jami'o'i da sauran cibiyoyin ilimi.
Iran ta kashe dala tiriliyan uku wajen magance cutar.
Sakatare Hassan Rouhani ya bayyana a ranar 26 ga Fabrairu, 2020 cewa ba za su sanya takunkumin killacewa a wuraren da aka sanya takunkumin cutar ba, amma za su iya yin hakan.
An fara aikin share hanyoyin a cikin birnin a watan Maris, amma an yi cunkoson ababen hawa kafin bikin farkon watan Ersian Nowruz.
Gidajen ibada na Shi'a sun karɓi mahajjata goma a ranar 16 ga Maris, 2020. Iran ta zama ƙasa mafi muni da cutar ta kamu da ita bayan China a watan Fabrairu.
Duk da cewa an ce sun ɓoye ɓoye game da yaduwar cutar a Iran, kasashe goma da suka gabata sun ba da rahoton mutum na farko da ya kamu da cutar daga Iran a ranar 28 ga Fabrairu, suna mai da cutar ta fi yawan mutane 388 da gwamnatin Iran ta bayyana.
Majalisar dokokin Iran ta rufe, saboda 23 daga cikin 290 na 'yan majalisun sun kamu da cutar a ranar 3 ga watan Maris.
A ranar 12 ga watan Maris, masu fafutukar kare hakkin dan Adam sun bukaci hukumomin kurkuku na Iran da su saki masu fafutukar kare hakkin dan Adam da kuma sakin wasu fursunoni na dan lokaci.
Ya ce haɗarin yaduwar cutar ya fi girma a cikin gidajen kurkuku, waɗanda ba su da isasshen asibitoci.
A ranar 15 ga Maris, Iran ta kai adadin mutuwar mutum 100 a rana ɗaya, mafi girma a ƙasar tun lokacin da annobar ta fara.
Mutane 12 daga cikin jami'an gwamnati na Iran sun mutu daga cutar a ranar 17 ga Maris.
A ranar 23 ga Maris, Iran tana da adadin kamuwa da cutar coronavirus 50 a kowace awa kuma mutum 1 yana mutuwa a cikin minti 10 daga cutar.
A cewar WHO, yawan mutanen Iran ya fi na da aka yi hasashen sau biyar.
An kuma ce takunkumin da Amurka ta sanya wa Iran ya shafi tattalin arzikin kasar a sakamakon annobar.
Hukumar kare hakkin bil'adama ta Majalisar Dinkin Duniya ta bukaci a dakatar da dokar hana fita ta hanyar cutar, kamar ta Iran.
Cutar ta barke a Italiya a ranar 31 ga Janairu, lokacin da aka gano wasu Sinawa biyu da ke da cutar SARS-CoV-2 a Rome.
Yawan masu cutar ya karu sosai har ya sa gwamnatin Italiya ta dakatar da zirga-zirgar jiragen sama daga China kuma ta bayyana lamarin a matsayin gaggawa.
An gano adadin mutane da suka kamu da cutar COVID-19, wanda ya fara da mutane 16 a Lombardy a ranar 21 ga Fabrairu.A ranar 22 ga Fabrairu, Majalisar Ministocin ta ba da sanarwar sabbin ƙa'idodi don magance cutar, tare da keɓe mutane sama da 50,000 a birane 11 a Arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, A yankunan da cutar ta fi tsanani, ba za a iya samun damar shiga da fita ba.
An fara dakatar da ayyukan da kuma wasanni a wasu daga cikin waɗannan yankuna. A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan jami'o'i a ƙasar bayan Italiya ta kai adadin mutane 100 da suka kamu da cutar.
Duk manyan wasannin, gami da gasar kwallon kafa ta Serie A, an shirya gudanar da su a cikin filin wasa a watan Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasannin har tsawon wata guda.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin rufe duk kasuwancin da ke sayar da kayayyaki a cikin kantin magani.A ranar 6 ga Maris, Cibiyar Nazarin Magungunan Magunguna ta Italiya, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta fitar da wani binciken kiwon lafiya game da yadda za a rarraba magunguna.
A ranar 19 ga Maris, Italiya ta zarce China a yawan mutanen da suka mutu daga cutar coronavirus kuma a duniya an samu adadin mutane 3,405 da suka mutu daga cutar.
A ranar 22 ga Maris, an ba da rahoton cewa Rasha ta aika da jiragen sama tara da ke dauke da kayayyakin asibiti zuwa Italiya.
A ranar 5 ga Afrilu, an samu mutane 128,948, mutane 15,887 da suka mutu, da kuma mutane 21,815 da suka warke a Italiya, yawancinsu a Lombardy.
Wani rahoto na CNN ya ce yawan mutuwar mutanen Italiya da ba su iya yin gwajin ba ya da nasaba da yawan mutuwar.
An fara aikin rigakafin cutar a cikin yankunan da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya ƙa'idodin nisantar jama'a ko keɓewa ba.
A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar cewa mutane za su dakatar da fita daga cikin gida sai dai idan akwai wata muhimmiyar bukata kuma su nisanta kansu da jama'a da kuma guje wa wuraren shakatawa, giya, da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta ba da sanarwar cewa duk wuraren nishaɗi kamar wuraren motsa jiki za su rufe, kuma za su biya ma'aikata kashi 80% na albashin su ko £2,500 a wata don hana mutane yin aikin yi. A ranar 23 ga Maris, Firayim Minista ya ba da umarnin tsauraran matakan nisantar jama'a, ya dakatar da duk wani taro na mutane sama da biyu kuma ya rufe hanyoyi kuma ya ba da izinin ayyukan waje masu mahimmanci.
Ba kamar na farko ba, 'yan sanda za su yi amfani da wannan dokar don su yi amfani da ita don yin faɗa da kuma ɓarkewar jama'a.
An umarci yawancin kamfanoni su rufe, sai dai manyan kamfanoni kamar su manyan kasuwanni, kantin magani, bankuna, shagunan kayan aiki, tashoshin jiragen sama, da wuraren ajiye motoci.
A ranar 20 ga Janairu, an gano mutum na farko da ya kamu da cutar COVID-19 a yankin Pacific Northwest na jihar Washington tare da wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa tawagar fadar White House a ranar 29 ga Janairu.
A ranar 31 ga watan, ofishin Trump ya bayyana wannan a matsayin haɗarin lafiya, kuma ya sanya takunkumi kan zirga-zirgar jiragen sama zuwa China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka  na Cibiyar Kiwon Lafiyar Jama'a ta Gwamnatin Amurka- ta sanar da cewa ta samar da kayan aikin gwajin ta.
Bayan haka, Amurka ta fara gwajin gwaji a baya, wanda ya girgiza gaskiyar cutar a wannan lokacin.
An samar da kayan aikin gwaji ta hanyar gwamnatin tarayya a watan Fabrairu, ba tare da amincewar gwamnatin tarayya ba don kayan aikin gwaji na baya (a cikin ilimi, kamfanoni ko asibitoci) har zuwa ƙarshen Fabrairu, kuma an ba da ƙarin shawarwari ga mutanen da za su iya yin gwajin kai tsaye a farkon Maris (ana buƙatar takardar shaidar likita).
A ranar 27 ga watan Fabrairu, jaridar Washington Post ta ruwaito cewa an gudanar da gwaje-gwaje 4,000 a Amurka.
A ranar 13 ga Maris, jaridar Atlantic ta ba da rahoton cewa an gudanar da gwaje-gwaje sama da 14,000.
A ranar 22 ga Maris, Associated Press ta ruwaito: Mutane da yawa da ke da alamun cututtuka da takardar shaidar likita sun jira na tsawon awanni ko kwanaki don yin gwaji. Bayan an bayyana mutuwar farko a Amurka a Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci ta gari, bayan da ƙasar ta bi sahun.
An rufe makarantu a Seattle a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an fara rufe makarantu a cikin gari. A ranar 6 ga Maris, 2020, an sanar da Amurka game da yanayin da ake ciki na cutar coronavirus a cikin kwalejin Imperial College a Ingila.
A wannan ranar ne Shugaba Trump ya sanya hannu kan dokar hana yaduwar cutar coronavirus, wanda ya kai dala biliyan 8.3 kuma ya zama babban haɗari ga hukumomin tarayya don magance cutar.
Kamfanoni sun hana ma'aikatansu yin aiki a kan titi, sun hana mutane yin taro, kuma sun umurci mutane su yi aiki daga gidajensu.
An kuma dakatar da wasannin kwaikwayo.A ranar 11 ga Maris, Trump ya ba da sanarwar cewa an rufe duk Turai, ba Burtaniya ba, na tsawon kwanaki 30, daga ranar 13 ga Maris.
Washegari, ya ba da umurnin a yi amfani da wannan dokar a ƙasar Ingila da kuma Ireland.
A ranar 13 ga Maris, ya ayyana shi a matsayin bala'i na ƙasa, wanda ya haifar da ƙarin kuɗin tarayya don magance cutar.
Tun daga ranar 15 ga Maris, yawancin kasuwancin Amurka sun rufe ko rage lokacin aiki don rage yaduwar cutar.
A ranar 17 ga Maris, annobar ta shafi birane 50 da Columbia, a ranar 23 ga Maris, New York ta sami ƙarin masu cutar coronavirus 10,700, mafi yawa a Koriya ta Kudu.
A ranar 25 ga Maris, gwamna ya ba da sanarwar cewa nisantar da jama'a yana da tasiri, yana sa yawan masu cutar ya karu daga 2.0 zuwa 4.7 a kowace rana.
A ranar 28 ga Maris, akwai mutane 32,308 da suka kamu da cutar a New York, kuma mutane 672 sun mutu daga cutar. A ranar 26 ga Maris, Amurka ta sami adadin masu kamuwa da cutar coronavirus mafi yawa a duniya, tare da China da Italiya. A ranar 8 ga Afrilu, akwai mutane 400,335 da suka kamu da cutar a Amurka, kuma mutane 12,841 sun mutu.
Rahotanni na 30 ga Maris sun ce a Amurka Shugaba Trump ya ba da umarnin tsaurara dokar nisantar jama'a a ranar 30 ga Afrilu.
A wannan ranar, asibitin jirgin ruwa mai gadaje 1,000 mai suna USNS Comfor ya isa New York.
A ranar 3 ga Afrilu, Amurka ta sami mutuwar mutum 884 a cikin awanni 24 da suka gabata sakamakon cutar coronavirus.
New York ta kai adadin masu cutar 100,000 a ranar 3 ga Afrilu. An yi tawaye ga fadar White House saboda rashin kula da shi da kuma mai da hankali kan maganganun da ke gudana tsakanin ɗaliban ilimin kimiyya da kimiyya game da abin da ake nufi da al'umma da kuma rubutun kwayar cutar a ofishin mataimakin shugaban ƙasa Mike Pence.
Wasu mutane sun yi shakkar amincewar da Trump ke da ita.
Wasu jami'an Amurka da masu ruwa da tsaki sun yi farin ciki da Amurka saboda ta dogara da kayayyakin da ake shigo da su daga China don kula da cututtuka masu mahimmanci.
An gudanar da binciken bincike don lura da yaduwar cutar a cikin mujallar Lafiya ta Lafiya a tsakiyar Janairu 2020.
A cewar Hukumar Kula da Jiragen Sama ta Duniya, a shekarar 2018, Bangkok, Hong Kong, Tokyo, da Taipei sun fi yawan masu zuwa daga Wuhan.
Dubai, Sydney, da Melbourne ma manyan wuraren da aka fi samun mutane daga Wuhan.
Bali ita ce birni mafi yawan mutane a cikin birane 20 da aka bincika don sake fasalin su, yayin da biranen Ostiraliya suka kasance cikin haɗari. Ostiraliya ta ƙaddamar da nata Tsarin Ayyuka don Cutar Cutar Cutar Kwayar cuta ta COVID-19 a ranar 7 ga Fabrairu.
Ya ce akwai ƙarin bukatar a san game da COVID-19, kuma Ostiraliya za ta ƙara tsaurara ƙa'idodin ƙaura da sanarwar annoba.
A ranar 21 ga Maris, an fara fuskantar matsalar tsaro ta mutum a Ostiraliya.
An kafa dokar hana zirga-zirgar bas a Wuhan da Hubei, inda aka shirya fitar da 'yan siyasa daga yankunan da ke kewaye da su, kafin jirgin sama na gida, tare da amincewar hukumomin kasar Sin.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostiraliya, Faransa, Argentina, Jamus, da Thailand ne suka fara kwashe mutanen da suka kamu da cutar.
Pakistan ta ce za ta fitar da jami'inta daga China.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko iyayensu tare da taimakon' yan Poland huɗu, ɗan China, da ɗan Indiya.
An shirya 'yan Poland, Sinawa, da Indiya a Poland, kuma an ɗauki 'yan Brazil a jirgin sama zuwa Brazil.
An killace mutanen Brazil da suka yi tafiya zuwa Wuhan a wani wuri kusa da yankin cutar ta cutar ta Brazil.
A wannan ranar, an kwashe 'yan Kanada 215 (176 a cikin jirgin sama, da 39 a cikin wani jirgin saman gwamnatin Amurka) daga Wuhan zuwa keɓewa na mako biyu a CFB Trenton.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a CB Trenton.
Hukumomin Australasia sun fitar da tan 277 a ranar 3 da 4 ga Fabrairu daga tsibirin Kirsimeti, wanda aka keɓe don keɓewa, don kwanaki 14.
Jirgin sama na ƙaura daga New Zealand ya isa ranar 5 ga Fabrairu, kuma fasinjojin (waɗanda suka haɗa da na Australiya da na Pacific) sun shiga keɓewa a Whangaparoa, Arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa da ke cikin jirgin ruwan Diamond Price.
A ranar 21 ga Fabrairu, jirgin sama mai fasinjoji 129 daga Diamond Princess ya isa Trenton, Ontario.
A farkon watan Maris, gwamnatin Italiya ta fara kwashe mutane daga Iran. A ranar 14 ga Maris, jirgin saman Afirka ta Kudu na gwamnatin Afirka ya kwashe 'yan Afirka ta Kudu 112.
An gudanar da gwaje-gwaje, kuma an bar mutane huɗu daga Afirka ta Kudu da ke nuna alamun cutar coronavirus don kare lafiyar wasu.
Sai dai mutanen Afirka ta Kudu da aka tabbatar ba su da cutar sun fita.
An yi gwajin ne don kare lafiyar mutanen Afirka ta Kudu da ma'aikatan jirgin da ma'aikatan otal, 'yan sanda, da ma'aikatan tsaro, duk an killace su na tsawon kwanaki 14 a Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara janye sojojinta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta sanar da cewa kasashe 21 (da suka hada da Delarus, Pakistan, Trinidad da Tobago, Masar, Iran da sauransu) sun aika da tallafi ga kasar Sin.
Wasu ɗaliban Sinawa a Jami'ar Amurka sun haɗa kai don aika taimako zuwa yankunan da cutar ta fi yaduwa a China, kuma wani taron a Chicago ya aika da abin rufe fuska 50,000 na N95 zuwa asibitoci a Hubei a ranar 30 ga Janairu.Kungiyar agaji ta Direct Relie, tare da haɗin gwiwar FedEX, ta aika da abin rufe fuska 200,000 da sauran kayan kariya, kamar su bagan, barbecue, ta hanyar jirgin gaggawa zuwa asibitin Wuhan Union a ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da cewa sun ba da kyautar dala miliyan 100 ga WHO don nazarin allurar rigakafi da ayyukan kulawa da tsaron al'ummomin da ke cikin haɗari a Afirka da Kudancin Asiya.
Interaksyon ta ce gwamnatin China ta ba da kayan rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta bayar da rahoton cewa ta shirya dala miliyan 2.26 don taimakawa kasar Sin.
Japan ta ba da kayan rufe fuska miliyan ɗaya ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta ba da tan 13 na kayan aikin likita ga Wuhan, Malaysia ta ba da sanarwar ba da kayan aikin likita miliyan 18 ga China, Jamus ta ba da kayan aikin likita na musamman kamar 10,000 na rigunan haɗari, kuma Amurka ta ba da tan 17.8 na kayan aikin likita ga China kuma ta ba da rahoton cewa an ba da dala miliyan 100 don ƙasashen da ke cikin haɗari. Bayan barkewar cutar a Wuhan, ƙasar ta rage don aika da agaji zuwa ƙasashe da yawa da ke fama da cutar.
A watan Maris, China, Cuba da Rasha sun aika da kayayyakin kiwon lafiya da likitoci don taimakawa Italiya wajen magance cutar coronavirus.
Wani ɗan kasuwa mai suna Jack MA ya aika da kayan bincike miliyan 1.1, abin rufe fuska miliyan 6, da kuma riguna 60,000 zuwa Addis Ababa, Habasha don ƙungiyar tarayyar Afirka ta rarraba su.
Daga baya ya aika da kayan bincike 5,000 da abin rufe fuska 100,000 da kuma na'urorin numfashi 5 zuwa Panama.
Mista Ma ya kuma ba da kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia, da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan bincike daga China.
Alal misali, Spain ta ƙi gwajin kwayar cutar coronavirus 58,000 daga China wanda ya nuna sakamako na gaskiya na kashi 30 cikin ɗari, sannan Netherlands ta dawo da masks 600,000 na China saboda sun lalace.
Belgium ta mayar da abin rufe fuska guda 100,000 da ba a yi amfani da su ba, da ake zaton an kawo su daga China amma a gaskiya an kawo su daga Kolombiya.
Duk da haka, wasu ƙasashen Latin Amurka da Afirka sun yi farin ciki da taimakon da China ta bayar.A ranar 2 ga Afrilu, Bankin Duniya ya ƙaddamar da ayyukan gaggawa don tallafawa ƙasashe masu tasowa.
Hukumar Lafiya ta Duniya ta yaba wa kokarin da hukumomin kasar Sin suka yi na lura da kuma hana yaduwar cutar.
WHO ta yi tsokaci game da bambancin da ke tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin kasar Sin da rashin bayyana gaskiya game da kokarin da suka yi na dakile cutar da kuma hana ta, da kuma halin da ake ciki yanzu, inda hukumomi za su samar da bayanai na yau da kullun don hana tsoro a gaban bikin Sabuwar Shekara.
A ranar 23 ga Janairu, bayan yanke shawarar hukuma ta dakatar da duk wata zirga-zirga daga Wuhan, wakilin WHO Gauden Galea ya ce duk da cewa ba shawarar WHO ba ce ta musamman, amma alamar da ta nuna cewa an yi aiki tuƙuru a cikin wani wuri kuma ya kira ta ƙaddara ta kiwon lafiya.A ranar 30 ga Janairu, bayan sanarwar watsa cutar daga wani mutum zuwa wani a wajen China da kuma karuwar yawan masu kamuwa da cutar a wasu ƙasashe, WHO ta ayyana cutar a matsayin Babban Lamarin Kiwon Lafiyar Jama'a na Duniya (USPPI), PHEIC na shida tun lokacin da aka fara aiwatar da matakan kawo ƙarshen cutar mura ta 2009.
Darakta Janar na WHO Tedros Adhanom ya ce PHEIC na iya yaduwa a duk duniya, musamman a ƙasashe masu tasowa waɗanda ba su da isasshen cibiyoyin kiwon lafiya.
Bayan ya dakatar da tafiye-tafiye, Tedros ya ce "babu bukatar sanya takunkumi kan tafiye-tafiye da cinikayya tsakanin ƙasashe" kuma "WHO ba za ta ba da izinin hana kasuwanci ko ba da izinin tafiya ba".
A ranar 5 ga Fabrairu, WHO ta nemi ƙasashe su ba da dala miliyan 675 don tallafawa shirye-shiryen ƙasashe masu tasowa, ta ce akwai buƙatar gaggawa a cikin ƙasashe waɗanda ba su da tsarin gano cutar, ko da kuwa akwai barkewar cutar.
Tedros ya ci gaba da cewa "Ƙarfi kamar yadda yake da sauƙi kamar yadda yake da sauƙi" kuma ya bukaci ƙasashe su "ba da kansu yanzu ko kuma su biya ƙarin daga baya".A ranar 11 ga Fabrairu, a wani taron manema labarai, WHO ta bayyana COVID-19 a matsayin sunan cutar.
A wannan ranar, Tedros ya ce Sakatare Janar na Majalisar Ɗinkin Duniya António Guterres ya amince da "ƙoƙarin da Majalisar Ɗinkin Duniya za ta yi don magance wannan matsalar".
An fara aiki da tawagar gaggawa ta Majalisar Dinkin Duniya, wanda ya ba da damar Majalisar Dinkin Duniya ta shiga cikin wannan yaƙi, wanda WHO ta ce zai taimaka wajen mayar da hankali kan kiwon lafiya yayin da sauran hukumomin ke ba da kwarewarsu don nazarin al'amuran zamantakewa, tattalin arziki, da ci gaban al'umma.
A ranar 14 ga Fabrairu, ƙungiyar WHO a China ta fara aiki tare don tallafawa ƙwararrun likitocin duniya da ƙwarewar WHO don taimakawa China wajen magance cutar da kuma duba ciwon cutar da kuma yadda ake yada ta  ta hanyar bita da tarurruka tare da manyan cibiyoyin duniya da ziyarar don fahimtar  tasirin ayyukan rigakafin cutar a yankin da ƙasashe, gami da birane da yankuna. A ranar 25 ga Fabrairu, WHO ta ce  duniya na bukatar ƙarin aiki don shirya cutar coronavirus, ta ce duk da cewa ba za a iya kiran ta da cutar ba, har yanzu ana bukatar  gyarawa.
Don magance cutar a Iran, WHO ta tura wata ƙungiya don bincika lamarin.A ranar 28 ga Fabrairu, jami'an WHO sun bayyana cewa haɗarin coronavirus na duniya yana da "ƙananan" amma ya kamata a ƙara shi zuwa "ƙananan", matakin tsaro da haɗari.
Mike Ryan, darektan kula da gaggawa na lafiya na WHO, ya yi gargadi a cikin kafofin watsa labarai cewa Wannan gaskiya ce da duniya ta kamata ta lura da ita: Ku farka.
Wataƙila cutar ta zo kuma ana buƙatar shirya, "in ji shi, yana buƙatar ɗaukar matakan da suka dace don hana" mummunan yanayi "a duniya.
Ryan ya kara da cewa bayanan da ake da su yanzu ba za su ba hukumomin kiwon lafiya damar yin la'akari da cutar ta zama mai cutarwa ba; ya ce hakan yana nufin cewa "za mu iya tabbatar da cewa kowa a duniya zai kamu da cutar".
A ranar 11 ga Maris, Hukumar Lafiya ta Duniya ta ayyana cutar coronavirus a matsayin cutar da ke ci gaba da yaduwa.
Darakta Janar ya ce WHO ta damu sosai game da yadda yaduwar cutar ta kasance da kuma yadda ta yi tsanani, da kuma yadda ba a yi wani abu game da ita ba. Mutane da yawa sun yi watsi da WHO saboda rashin kula da su, kamar yadda suka bayyana a matsayin gaggawa na kiwon lafiya da kuma cutar ta zama annoba.
A ranar 6 ga watan Afrilu, mutane 733,000 ne suka rattaba hannu kan takardar neman babban daraktan OM Tedros Adhanom ya yi murabus.
A ranar 26 ga Maris, 2020, manyan masana kan kare hakkin bil'adama na Majalisar Dinkin Duniya sun yi kira ga girmama haƙƙin ɗan adam a cikin lokacin annobar COVID-19.
Ƙungiyoyin masana sun ce dole ne a ceci kowa kuma gwamnatoci suna da wannan alhakin.
Masu zanga-zangar sun ce rashin kudi ko inshorar lafiya ya zama dalilin zaluntar wasu mutane.
Masana sun ce kowa yana da hakkin samun lafiya, har da nakasassu, 'yan tsiraru, tsofaffi, 'yan gudun hijira, marasa gida, matalauta, fursunoni, da 'yan gudun hijira da kuma waɗanda ba a san ko su wane ne ba.
Gwamnatocin ƙasashe sun ɗauki matakan magance matsalar tattalin arziki da zamantakewar da cutar COVID-19 ta haifar.
Kungiyar hadin gwiwa da ci gaban tattalin arziki ta samar da wani sabon tsari na ingantaccen tsarin kula da kasashen duniya don magance cutar, gami da shawarwari da shawarwari.
A matsayin cibiyar da ke da ikon ƙarfafa tsarin kiwon lafiya da tattalin arziki na duniya don magance tasirin kulle-kulle da ƙuntatawa na balaguro, cibiyar sadarwar tana da ikon sa ido kan manufofin ƙasa, kuma tana ba da damar ƙasashe su koya daga ƙasashen waje da kuma taimaka musu magance cutar coronavirus.
Amurka ta soki gwamnatin China, Ministan Ma'aikatar Burtaniya Michael Gove, da Edouardo Bolsonaro, ɗan Shugaban Brazil Jair Bolsonaro, kan yadda suka magance cutar, wacce ta barke a lardin Hubei na kasar Sin.
An kori wasu jami'an jam'iyyar kwaminis ta kasar Sin (CCP) daga aiki sakamakon kokarin da kasar Sin ke yi na killace mutane a tsakiyar kasar Sin, wanda ke nuna rashin amincewar jama'a da yadda hukumomi ke gudanar da al'amuran a yankunan.
Wasu 'yan jarida sun yi imanin cewa dalilin wannan lamari shi ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin da cutar korona ke jawowa.
Wasu jami'an kasar Sin, kamar Zhao Lijian, sun musanta cewa cutar coronavirus ta samo asali ne daga Wuhan, yayin da Amurka da Italiya ke zargin cewa COVID-19 ya haifar da hakan.
Gwamnatin Amurka ta Donald Trump ta bayyana cewa cutar korona Covid-19  ko Covid-19  kuma ta ce China ta mallaki asirin cutar da ta zama annoba ta duniya, wasu sun ce wannan magana ta nuna wariyar launin fata ce kuma ta ɗora wa gwamnatinsa alhakin rashin iya magance cutar.
Daily Beast ta samu wani sakon gwamnatin Amurka da ke nuna tattaunawar da aka yi da Kwamitin Tsaro na Kasa, kuma ta ce dukkan tattaunawar ta shafi kasar Sin ne.
Za a umarce mu da mu yi ƙoƙari mu kawar da wannan bayanin ta kowane hanya, ta hanyar taron manema labarai da kuma watsa shirye-shiryen talabijin. Politico, kafofin watsa labarai na ƙasashen waje, da Bloomberg sun ce ƙoƙarin da China za ta yi na aika da agaji zuwa ƙasashen da cutar ta shafa yana cikin ƙoƙarin da za ta yi don samun tasiri a duniya.
Kwamishinan harkokin wajen Tarayyar Turai Josep Borrell ya yi gargadin cewa wannan "ƙaddamarwa ce ta neman iko ta hanyar leken asiri da kuma dabarun ba da gudummawa".
Borell ya kuma ce China za ta yi amfani da wannan ikon ta wajen nuna cewa, ba kamar Amurka ba, tana da aminci da kuma abokantaka.
China ta kuma bukaci Amurka ta dage takunkumin da ta kakaba wa Syria, Venezuela da Iran, kuma ta ce ta tura tallafi ga kasashen biyu na karshe.
An kama abin rufe fuska 100,000 da Jack Ma ya aika zuwa Cuba a ranar 3 ga Afrilu a ƙarƙashin hukuncin Amurka.
Sun kuma tuhumi gwamnatin Amirka cewa ta kwace taimakon da ta aika wa wasu ƙasashe don amfanin kanta.
Ƙari ga haka, an yi nasara a wasu ƙasashe, kamar su Jamus, Austria, da Switzerland; da kuma Jamhuriyar Czech a Italiya.
Ƙari ga haka, Turkiyya ta hana masu ba da iska zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta yi rashin jin daɗin rashin haɗin kan Tarayyar Turai game da cutar coronavirus a Italiya.
Maurizio Massari, Jakadan Italiya a Tarayyar Turai, ya ce China ita kaɗai ce ta yi abin da ya dace.
Hakika, wannan ba alama ce mai kyau ba ga haɗin kan Turai.
A ranar 22 ga Maris, bayan tattaunawa ta waya da Firayim Minista Giuseppe Conte, Shugaban Rasha Vladimir Putin ya tura sojojin Rasha da ke dauke da likitoci, motocin kashe kwayoyin cuta, da sauran kayayyakin kiwon lafiya zuwa Italiya.
Jaridar La Stampa ta Italiya ta ce "wani babban jami'in siyasa" wanda ya ƙi a ambaci sunansa ya ce kashi 80 cikin ɗari na taimakon da aka ba Rissue "ba shi da amfani ko kuma ba shi da amfani ga Italiya".
Wannan mutumin ya zargi Rasha da yin yaƙi don cin ƙasashe da kuma samun nasara a siyasa.
Shugaban ƙasar Lombardy, Attilio Fontana, da Ministan Harkokin Waje Luigi Di Maio sun ce ba su yarda da wannan labarin ba kuma sun nuna godiyarsu.
Rasha ta kuma aika da kayayyakin kiwon lafiya zuwa Amurka.
Kakakin Kremlin, Dimitry Peskov, ya ce Lokacin da aka aika da taimako ga abokan aikinsa na Amurka, [Putin] ya yi tsammanin cewa idan kamfanonin Amurka suka dawo cikin al'ada, za su yi haka idan ya cancanta.
An sake shirya atisayen sojin NATO na Defender 2020 a Jamus, Poland, da Baltic, atisayen da suka fi girma da NATO ta yi tun bayan ƙarshen Yakin Cacar Baki.
Kate Hudson, Sakatariyar Janar ta Kamfen don Kawar da Makaman Nukiliya ta soki atisayen Defender 2020: A halin yanzu, matsalar kiwon lafiya ba wai kawai tana barazanar rayukan sojojin Amurka da na kasashen Turai da yawa da ke halartar taron ba amma har da na al'ummomin da ke halartar taron. Gwamnatin Iran ta sha fama da cutar a kwanan nan, tare da mambobin majalisar dokoki 12 da ke fama da cutar da wasu manyan 'yan siyasa 15 da suka gabata.
Shugaban Iran Hassan Rouhani ya rubuta wasiƙar neman taimako ga hukumomin duniya a ranar 14 ga Maris, 2020, yana mai cewa kasarsa ba za ta iya magance cutar ba saboda rashin samun damar shiga kasuwannin duniya saboda takunkumin da Amurka ta sanya wa Iran. Fitowar cutar za ta bukaci Amurka ta yi amfani da wasu hanyoyin da suka dace ga al'ummomin kasashe masu tasowa, gami da kiwon lafiya na duniya, kula da yara, izinin iyali da aka biya, da kuma buƙatar samun kuɗin shiga da kiwon lafiya ga jama'a.
Masu nazarin siyasa sun yi tsammanin zai iya rage damar da Donald Trump ke da ita na zaɓen 2020.
Koriya ta Kudu ta soki "ƙoƙarin keɓewa da ba a sani ba da kuma rashin amfani" na Japan lokacin da Japan ta ce duk waɗanda suka zo daga Koriya ta Kudu za a keɓe su na makonni biyu a wuraren da gwamnati ta tsara.
Da farko, mutanen Koriya ta Kudu ba su ji daɗin matakin da Shugaba Moon Jae-in ya ɗauka ba.
Yawancin 'yan Koriya sun sanya hannu kan takardar murabus daga aikin Moon saboda rashin iyawar sa na yaki da cutar, ko kuma don yaba wa nasarorin da ya samu.
Wasu sun nuna damuwa cewa hakan zai ba gwamnatoci zarafin riƙe ikonsu.
A Hungary, majalisar dokokin kasar ta kada kuri'ar amincewa da Firayim Minista Viktor Orbán ya ci gaba da mulki har abada, ta kori 'yan majalisa da kuma soke zaben, tare da hukunta wadanda ta ce sun yada labaran karya game da cutar da kuma yadda gwamnati ke kula da cutar.
Barkewar cutar coronavirus ta haifar da ƙarancin ƙarancin kayan aiki, daga buƙatar kayan aikin rigakafi, sayayya, da rashin kayan aiki a masana'antu da sauran wurare.
Ma'aikatar Abinci da Magunguna ta Amirka ta ba da gargaɗi game da rashin magunguna da kayan aiki saboda yawan buƙatu da kuma ƙarancin kayayyaki.
A wurare da yawa, mutane sun soma cin kasuwa, kuma hakan ya sa abinci da takardar bayan gida da kuma kwalaben ruwa da kayayyaki suka ƙare.
Masana'antar fasaha suna ba da gargaɗi game da jinkirin da ake samu a yin amfani da na'urorin zamani.
A cewar Darakta Janar na WHO Tedros Adhanom, bukatar tufafin kariya ta jiki ta ƙaru sau 100.
Wannan bukatar ta sa farashin kayayyaki ya ƙaru sau goma sha biyu kuma ta sa kayayyakin kiwon lafiya su yi jinkirin watanni huɗu zuwa shida.
Har ila yau, yana jawo rashin tufafin kariya na jiki a dukan duniya, kuma WHO ta yi gargaɗi cewa yana da haɗari ga lafiyar jiki.
A Ostiraliya, annobar ta ba da dama ga masu sayar da daigou su sayar da kayayyakin Australiya zuwa China.
Wannan ya haifar da karancin abinci ga jarirai a wasu manyan kasuwanni kuma gwamnatin Ostiraliya ta hana shi. Ko da yake an sami karuwar mutane da suka kamu da COVID-19 a arewacin Italiya da Wuhan, hakan na haifar da karancin abinci; duka yankuna biyu suna da karancin abinci.
Ƙungiyoyin da ke China da Italiya sun yi nasara wajen hana cin hanci da rashawa, kuma hakan ya sa Turai da Amirka ta Arewa ba su rasa abinci ba.
A arewacin Italiya, aikin noma ya ragu sosai, amma farashin zai iya ƙaruwa idan aka samu amfanin gona.
Ba a taɓa samun abinci a cikin gari ba, kuma hukumomin ƙasar sun kafa garken aladu don su tanadar da abinci ga dukan mutane.
Akwai irin wannan dokar a Italiya da ke buƙatar masana'antun abinci su adana abinci don gaggawa.
Matsalar tattalin arzikin duniya ta shafi China: Rahotanni na yau da kullun sun nuna cewa a ranar 16 ga Maris, tattalin arzikin China ya yi rauni sosai a farkon watanni biyu na 2020 saboda matakan gwamnati na hana yaduwar cutar, tare da hauhawar farashin kayayyaki da kashi 20.5%.
Kasashen da ke da yankin kasar Sin suna da muhimmiyar rawa a tattalin arziki da masana'antar ruwa, kuma barkewar cutar za ta yi mummunan tasiri ga tattalin arzikin duniya.
Agathe Demarais na Hukumar Kula da Tattalin Arziki ta Amurka ta ce har sai an samu sauki, kasuwar za ta ci gaba da zama cikin tsaka mai wuya.
A watan Janairun 2020, wasu masu bincike sun yi hasashen cewa koma bayan tattalin arzikin duniya zai iya zama mafi muni fiye da barkewar cutar SARS a 2002-2004.
Wani bincike da aka yi a Jami'ar Washington da ke St. Louis ya nuna cewa za a yi asarar fiye da dala biliyan 300 a duniya, wanda zai kai kuɗin da za a kashe a shekara biyu.
Kungiyar Kasashen da ke Sayar da Man Fetur ta ce, farashin man fetur zai ragu saboda bukatar kasar Sin.
Kasuwancin duniya ya yi rauni a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da COVID-19 a China.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, yawancin alamun kasuwancin Amurka ciki har da NASDAQ-100, S&amp;P 500, da Dow Jones sun faɗi mafi girma tun 2008, kuma Dow ya faɗi da maki 1,191, mafi girman koma baya na rana ɗaya tun rikicin 2007-08.
Dukkanin alamun uku sun ƙare mako a ƙasa da kashi 10%.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta amince da darajar gwamnatin China, amma har yanzu ba ta da kyau.
Har ila yau, an sake rage farashin kayayyaki saboda tsoron cutar coronavirus, tare da raguwa mai yawa a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai lalace.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa manyan bankuna da ƙasashe don matakan da suka ɗauka cikin sauri.
Bankunan tsakiya za su ɗauki mataki da sauri fiye da yadda suka yi a lokacin matsalar tattalin arziki ta shekara ta 2008.
Yawon shakatawa ne zai sha wuya sosai domin ƙuntatawa na tafiye-tafiye, rufe wuraren da ake yawan jama'a da kuma wuraren da ake son ziyarta, da kuma hana tafiye-tafiye a dukan duniya.
Sakamakon haka, yawancin kamfanonin jiragen sama sun soke zirga-zirgar su saboda ƙarancin masu tafiya, gami da British Airways, China Eastern Airlines, da Quantas, amma kamfanin jirgin sama na yankin Flybe na Burtaniya ya faɗi.
Tasirinsa a kan zirga-zirgar ruwa yana da ƙarfi a matakin da ba a taɓa gani ba.
An rufe tashoshin jirgin ƙasa da kuma tashar jiragen ruwa da yawa.
Cutar ta zo ne a lokacin da ake yin babban tafiyarsu na Sabuwar Shekara ta Sinawa, wato, Chunyun.
Gwamnatocin jihohi sun dakatar da yawancin abubuwan da ke tattare da jama'a, gami da bikin Sabuwar Shekara, kuma kamfanoni masu zaman kansu sun rufe shagunan su da wuraren shakatawa kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe bukukuwa da yawa na shekara-shekara da wuraren yawon bude ido don hana taron jama'a, gami da Forbidden City a Beijing da kuma bikin kakakin kakanninmu.
A larduna 24 daga cikin 31, gundumomi da yankuna da dama na kasar Sin, hukumomi sun dage bikin sabuwar shekara zuwa ranar 10 ga watan Fabrairu, kuma sun sanar da cewa yawancin wuraren aiki ba za su bude ba har zuwa wannan ranar.
Waɗannan yankuna suna da kashi 80 cikin ɗari na arzikin ƙasar kuma kashi 90 cikin ɗari na kuɗin da ake samu daga kayayyakin da ake sayar da su.
Hong Kong ta tsaurara matakan rigakafin cutar ta hanyar ayyana dokar ta baci, rufe makarantu har zuwa Maris da kuma dakatar da bikin Sabuwar Shekara.
Kasuwancin ƙananan kantuna ya ragu da kashi 40 cikin ɗari a Turai da Latin Amurka.
Kasuwancin da ke tsakanin Amirka ta Arewa da Gabas ta Tsakiya ya ragu da kashi 50 zuwa 60 cikin ɗari.
Hakan ya haifar da raguwar kashi 33 zuwa 43 cikin dari na masu tafiya a cikin shaguna a watan Maris idan aka kwatanta da Fabrairu.
Masu siyarwa a kasuwannin duniya suna fuskantar wasu ƙuntatawa, kamar tsabtace jiki, sanya na'urorin daukar zafin jiki, da rufe abubuwan da suka shafi zamantakewa.A cewar Ma'aikatar Tattalin Arziki ta Amurka don Latin Amurka, an kiyasta cewa cutar za ta jefa tsakanin mutane miliyan 14 zuwa 22 cikin talauci a Latin Amurka fiye da yadda ta kasance kafin barkewar cutar.
A watan Janairu da Fabrairun 2020, lokacin da cutar ta kai kololuwa a Wuhan, kusan mutane miliyan 5 a China sun rasa ayyukansu.
Yawancin ma'aikatan karkara miliyan 300 na kasar Sin sun makale a lardin Hubei ko lardin.A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Barkewar cutar coronavirus ta haifar da asarar ayyukan yi miliyan 47 a Amurka kuma rashin aikin yi ya karu da kashi 32%, a cewar alkaluma daga Bankin Tarayya na St. Louis. An dakatar da Indiya ta sanya miliyoyin ma'aikata (ma'aikata masu biyan albashi na yau da kullun) ba su da aiki. Binciken Cibiyar Angus Reid ya gano cewa kashi 44% na iyalai na Kanada ba su da aiki a wani fanni. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka fara kullewa a tsakiyar Maris 2020.
A rabin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi taimako na ɗan lokaci na rashin aikin yi kuma ma'aikata miliyan 1 na Burtaniya sun nemi tallafin kuɗi. Daga cikin kamfanoni miliyan ɗaya na Jamus, an nemi ma'aikatansu su nemi taimako ta hanyar tsarin ɗan lokaci da ake kira Kurzarbeit.
Faransa da Biritaniya sun amince da dokar Jamus ta biyan bashin nan da nan.
Ayyukan fasaha da al'adu sun lalace sosai ta hanyar cutar, suna shafar masu shan giya da kuma mutane, masu aiki da masu zaman kansu, a duk duniya.
Masu zane-zane da al'adu sun yi ƙoƙari su ci gaba da ayyukan su (wanda yawanci ana tallafawa da kuɗi) don su ci gaba da faranta wa al'ummomin su rai, su tabbatar da lafiyar ma'aikatansu da jama'a, kuma su tallafa wa masu zane-zane idan ya yiwu.
A watan Maris na 2020, a duk faɗin duniya da kuma a wasu ƙasashe, gidajen tarihi, dakunan karatu, wuraren wasan kwaikwayo, da sauran wuraren al'adu suna rufe; kuma baƙi, abubuwan da suka faru a can za a soke ko kuma a sake su.
Saboda haka, an yi ƙoƙari sosai don samun hanyar aiki ta hanyar Intanet. Wani ƙalubale kuma shi ne hana taron coci, wasanni, da sauran ayyukan zamantakewa, kamar bukukuwa da kide-kide, taron fasaha da nunin kayan kwalliya.
Vatican ta ce ba za a yi bikin mako mai tsarki na Roma ba, wanda ake yi a ƙarshen mako na azumi.
Yawancin majami'u sun bukaci tsofaffi Kiristoci su zauna maimakon halartar ibadar ranar Lahadi; wasu majami'u za su gudanar da tarurrukan su ta hanyar rediyo, streaming kai tsaye ko talabijin na kan layi, wasu kuma za su gudanar da tarurruka a kan titi.
Ikklesiya ta Roma ta rufe majami'unsu kuma ta kori Kiristoci daga St. Peter's Square, kuma wasu addinai sun hana su yin ibada kuma sun hana su yin taro a coci, masallatai, majami'u, haikali, da kuma majami'u.
Ma'aikatar Lafiya ta Iran ta ce za a dakatar da ayyukan ibada na ranar Juma'a a yankunan da cutar ta bulla kuma an rufe wuraren ibada daga baya, amma Saudi Arabiya ta umarci mazauna da baƙi su yi ibada a Makka da Madina.
Wannan annoba ta shafi wasanni a dukan duniya fiye da yadda ta taɓa yi tun bayan Yaƙin Duniya na Biyu.
Yawancin abubuwan wasanni da aka soke ko aka canza kwanan wata, kamar gasar zakarun Turai ta 2019-20, gasar cin kofin Ingila ta 2019-20, gasar zakarun Turai ta UEFA ta 2020, kakar NBA ta 2019-20, da kakar NHL ta 2019-20.
Barkewar cutar ta shafi jadawalin wasannin Olympics na bazara na 2020, wanda aka shirya fara da ƙare a ƙarshen Yuli; Kwamitin Wasannin Olympics na Duniya ya ba da sanarwar ranar 24 ga Maris cewa za a saita "sabon kwanan wata bayan 2020 amma zai kasance kafin bazara ta 2021".
Wannan ya haifar da karuwar kasuwancin kan layi, kuma yawancin shafukan yanar gizo na wasanni sun sami sabbin masu amfani da yawa. Masana'antar wasanni ma ta sha wahala, yawancin ƙungiyoyin kiɗa sun ɗauki hutu ko kuma sun dakatar da rangadin su.
Wasu manyan gidajen wasan kwaikwayo, kamar na Broadway, sun ce ba za a yi wasan ba.
Wasu masu fasaha suna neman hanyoyin da za su ci gaba da yin waƙoƙi da rarraba ayyukansu ta hanyar intanet maimakon yin wasan kwaikwayo na kai tsaye, kamar yin wasan kwaikwayo ta hanyar watsa shirye-shiryen kai tsaye ko yin bukukuwan kan layi don masu fasaha su yi wasan kwaikwayo, da kuma tallata ayyukansu.
Yawancin labaran da aka yi a kan intanet game da cutar coronavirus sun cika saboda wasu sun yi amfani da shi a matsayin abin dariya da kuma lokacin nishaɗi.
Tun bayan barkewar cutar COVID-19, akwai ƙiyayya, nuna bambanci, da nuna bambanci tsakanin Sinawa da mutanen da ke da asalin asalin Asiya ta Gabas, da kuma mutanen Turai, Amurka da sauran ƙasashe masu fama da cutar.
Rahotanni sun nuna cewa a ƙasashe da yawa, musamman a Turai, Asiya ta Gabas, Arewacin Amirka, da kuma Asiya Pacific, ana yawan nuna tsoro, wariya, da kuma ƙiyayya.
Rahotanni na watan Fabrairu (lokacin da yawancin masu cutar ke China) sun nuna ƙiyayya da ake nunawa ga Sinawa a duk faɗin duniya, kuma mutane da yawa sun yi jayayya cewa cutar ta dace da Sinawa don ɗaukar fansa.
A wasu ƙasashen Afirka ma, ana nuna bambanci ga Sinawa.
Yawancin mazauna Wuhan da Hubei sun ce za a raina su saboda yanayin da ke cikin yankin.
Mutane da yawa za su ba da tallafi ga jama'ar China, a kan layi da wajen layi, da kuma tallafawa waɗanda ke cikin yankunan da cutar ta shafa.
Dangane da yaduwar cutar a cikin ƙasashe masu tasowa, Italiya, ƙasar Turai da ta fi kamuwa da cutar COVID-19, na iya zama wuri mai saurin kamuwa da cutar da kuma nuna bambanci. Kasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun sanya hannu kan takardar hana baƙi daga China don magance cutar.
A Japan, za a yi amfani da Twitter don yin amfani da #BatoyaChinaBayoTenaJapon.
Wasu 'yan ƙasar Sin da wasu mutanen Asiya da ke zaune a Biritaniya da Amirka sun ce sun fuskanci ƙiyayya da kuma zalunci.
Shugaban Amurka Donald Trump ya kira coronavirus Covid-19 na kasar Sin, wanda ya zama mummunan kalaman wariyar launin fata da kuma nuna kyama.
A Ukraine, an kai hari kan bas da ke dauke da 'yan Ukraine da baƙi daga Wuhan, suna zuwa Novi Sanzhary.
Daliban da ke zaune a arewa maso gabashin Indiya, da ke iyaka da China, da ke karatu a manyan biranen Indiya sun ce za su iya fuskantar barazanar kamuwa da cutar coronavirus.
Shugaban jam'iyyar Bharatiya Janata na jihar West Bengal Dilip Ghosh ya ce Sinawa sun lalata duniya don haka Allah zai hukunta su.
Ofishin jakadancin kasar Sin a Kolkata, ya yi tir da wannan batu kuma bai ce ba  kuskure ne. A China, ƙiyayya da wariyar launin fata tsakanin mutanen da ba 'yan kasar Sin ba sun zama ruwan dare gama gari saboda cutar, kuma ana kiran baƙi  shara  kuma ana tunanin  zubar da su.
Yawancin mujallu da ke da bangon tallafi sun cire wasu ko duk bayanan da suka yi game da cutar coronavirus.
Yawancin kafofin yaɗa labarai na kimiyya sun wallafa littattafai da yawa game da wannan cuta kuma kowa zai iya karanta su kyauta.
Wasu masana kimiyya sun zaɓi su buga sakamakon su da sauri a cikin shafukan yanar gizo kamar bioRxiv.
Cutar da ke tasowa - cuta mai saurin kamuwa da cuta ta hanyar ƙwayoyin cuta, yawanci sabon nau'i ko kuma mai yaduwa
Duniya da Cututtuka - Yadda Cututtuka Suke Yaɗuwa a Duniya
Sunaye na cututtuka da kuma annoba - Lissafi na yawan waɗanda suka mutu
Cin Hanyoyin Daji - Hadarin Lafiya Daga Cinikin Daji
Gwaje-gwaje na cutar sankarar bargo ta coronavirus 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke da alaƙa sun haɗa da gano ƙwayoyin cuta da gano ƙwayoyin cuta da ke haifar da rigakafi.
Ana tabbatar da kasancewar kwayar cutar a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin yana da ƙwarewa sosai kuma yana da ƙwarewa don gano RNA na SARS-COV-2.
Ana amfani da su wajen gano sabon cuta ko kuma cuta da ta riga ta kamu da ita.
Ana iya yin binciken kwayoyin cutar don ganewar asali da kuma lura da mutane.
Gwajin rigakafi yana nuna yawan mutanen da ke da cutar, har da waɗanda ke da ƙananan alamun cutar ko marasa alamun cutar.
Sakamakon gwajin zai iya ƙayyade ainihin yawan mutuwar da kuma yawan rigakafi na al'umma.
Saboda ƙarancin gwajin, a watan Maris na 2020, babu wata ƙasa da ke da cikakken bayani game da yadda cutar ke yaduwa tsakanin al'ummomin su.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada kashi 3% na yawanta, kuma akwai bambance-bambance da yawa a cikin yadda yawancin ƙasashe ke yin gwajin.
Wannan bambancin zai iya shafar yawan mutuwar, wanda a yawancin ƙasashe ba shi da yawa.
Ta amfani da tsarin bincike na polymerase reverse transcription (rRT-PCR) ana iya yin gwajin tare da samfurori na numfashi da aka tattara ta hanyoyi da dama, ciki har da samfurin numfashi daga hanci ko samfurin tari.
Sakamakon yakan bayyana a cikin sa'o'i da yawa zuwa kwanaki biyu.
Gwajin RT-PCR na tari yana ba da sakamako mai kyau ne kawai a farkon makon kamuwa da cutar.
Daga nan kwayar cutar za ta iya ɓacewa daga bakin amma za ta ci gaba da ƙaruwa a cikin huhu.
Ga marasa lafiya da aka gwada a mako na biyu, ana iya yin wannan ta hanyar ɗaukar ruwa daga cikin cikin iska ta ciki ta hanyar catheter ko ruwan hanci.
An ƙaddamar da ɗayan gwajin PCR na farko a Charité a Berlin a watan Janairun 2020 ta amfani da tsarin kwafin kwayar halitta mai sauyawa (rRT-PCR), kuma ya haifar da samar da kayan aikin gwaji 250,000 da Hukumar Lafiya ta Duniya (WHO) ta rarraba.
Ƙasar Ingila ta ƙaddamar da kayan gwaji a ranar 23 ga Janairu, 2020. Kamfanin Kogenebioch na Koriya ta Kudu ya ƙaddamar da na'urar PC-da aka samo daga SARS-CoV-2 (PowerChek Coronavirusi) a ranar 28 ga Janairu, 2020.
Yana gano dukkanin kwayoyin halitta E da ke dauke da dukkanin kwayoyin beta-coronavirus da kuma takamaiman kwayoyin RdRp na SARS-CoV-2.A China, BGI ta kasance kamfani na farko da aka ba da izinin Hukumar Kula da Kula da Magunguna ta China don samar da na'urar PCR don gwajin SARS-COV-2.A Amurka, Cibiyoyin Kula da Cututtuka da Kulawa (CDC) suna rarraba kayan aikin gwajin sabon coronavirus-2019 (2019-nCoV) a ainihin lokacin RT-PCR Diagnostic Panel a duk dakunan gwaje-gwajen su ta hanyar amfani da International Reagent Resource.
A cikin gwaje-gwajen ƙwayoyin halittarmu guda uku da aka yi a cikin samfuran da suka gabata, kayan aikin gwajin ba su samar da sakamako mai kyau ba, kuma ƙarancin gwajin a CDC a Atlanta ya sa gwajin ya kai samfura 100 a kowace rana a watan Fabrairun 2020.
An tabbatar da rashin ingancin gwajin lokaci biyu a ranar 28 ga Fabrairu, 2020, bayan haka an ba da izinin fara gwajin a dakunan gwaje-gwaje na jihohi da na gida.
Ma'aikatar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin gaggawa. Dakunan gwaje-gwaje na Amurka sun fara samar da gwajin a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa za a iya fara gwajin COVID-19 ta hanyar RT-PCR a duk faɗin ƙasar.
Hakanan, Quest Diagnostics ta ba da shawarar fara gwajin COVID-19 a cikin al'umma daga 9 ga Maris, 2020.
Ba a ba da cikakken adadin ba; ana buƙatar yin samfurin da gwaji daidai da ƙa'idodin CDC.
A Rasha, an samar da kayan aikin gwaji na COVID-19 a Cibiyar Bincike da Fasaha ta VECTOR.
A ranar 11 ga Fabrairu, 2020, Ma'aikatar Kiwon Lafiya ta amince da gwajin gwaji. A ranar 12 ga Maris, 2020, an ba da sanarwar cewa Mayo Clinic ta ƙaddamar da na'urar gwajin COVID-19. A ranar 13 ga Maris, 2020, FDA ta amince da Roch Diagnostics don gudanar da gwaje-gwaje na tsawon sa'o'i 3.5 a matsakaicin lokaci, yana ba da damar na'urar guda ɗaya don gudanar da gwaje-gwaje kusan 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gwajin Abbott Laboratories a cikin tsarin Abbott m2000; FDA ta riga ta ba da izinin amfani da Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, an ba da izinin EUA ga Cepheid daga FDA don gwajin da ke ɗaukar minti 45 kawai.
FDA ta amince da gwajin da ke buƙatar amfani da hanyar isothermic nucleic acid maimakon PCR.
Ba a buƙatar zafin jiki na ƙafafun, wannan hanyar tana ba da sakamako ga masu cutar a cikin ƙasa da minti biyar da marasa lafiya a cikin ƙasa da minti 13.
A halin yanzu akwai na'urori 18,000 a Amurka kuma masu bincike na Abbott za su iya yin gwaje-gwaje 50,000 a kowace rana.An samar da gwajin da ke amfani da ƙwayoyin cuta na musamman tare da ƙwayoyin nuclecapsid (N-protein) na sabon coronavirus a Taiwan, tare da fatan samar da sakamako a cikin mintuna 15 zuwa 20 kamar yadda ake yi da gwajin mura.
A watan Maris na 2020, mujallar ta ba da rahoton cewa aikin radiyo na kirji ba shi da mahimmanci a farkon matakan, amma CT [digital tomography] na iya kasancewa tun kafin bayyanar cututtuka.
Abubuwan CT sun haɗa da madubai masu yawa masu sauƙi tare da ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Ƙashin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Wani bincike da ya kwatanta PCR da CT a Wuhan a farkon cutar ya nuna cewa CT ya fi ƙarfin PCR, amma ba shi da cikakkun sakamako, kuma wasu hotunansa sun wuce na ciwon huhu da sauran cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar ba za a yi amfani da CT don ganowa ko gwajin farko na COVID-19 ba. A watan Maris na 2020, CDC ta ba da shawarar PCR a farkon.
Don magance cutar, ana iya samar da ƙwayoyin cuta da kuma IgG da IgG.
Ana iya amfani da shi don gano cutar a cikin mutane daga kwanaki 7 ko fiye bayan bayyanar cututtuka, don tantance rigakafi, da kuma lura da mutane.
Tsarin atomatik mai rikitarwa a dakunan gwaje-gwaje na asibitoci da yawa na iya yin waɗannan gwaje-gwajen amma ƙwarewarsu ta dogara da yawan mutanen da kowane tsarin zai iya aiki.
CLT yawanci yana amfani da ƙananan jini, ko da yake ana iya amfani da samfurori da yawa don tantance tsarin rigakafi.
Don PoCT yawanci ana ɗaukar samfurin jini daga fata a cikin farji.
Ba kamar PCR ba, ba a buƙatar matakan gwaji kafin a fara. A ranar 26 ga Maris, 2020, FDA ta zaɓi cibiyoyin bayar da rahoto 29 waɗanda yanzu za su iya rarraba gwajin rigakafin su.
A ranar 7 ga Afrilu, 2020, FDA ta amince da gwajin gaggawa guda ɗaya kawai.A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don fara amfani da na'urorin gwajin su, wanda zai iya gano ƙwayoyin IgG da IgA a cikin samfurin jini mai dauke da kwayar.
Suna iya yin gwaje-gwaje da yawa a lokaci guda kuma suna da sauri fiye da PCR na yau da kullun don gwajin RNA na kwayar cuta.
Ana yawan gano ƙwayoyin cuta a cikin kwanaki 14 bayan kamuwa da cutar.A farkon watan Afrilu, Burtaniya ta gano cewa babu wani daga cikin na'urorin gwajin da aka saya da ke da inganci.
Hong Kong ta ƙaddamar da tsarin kula da marasa lafiya a gida, Ma'aikatar gaggawa za ta ba marasa lafiya bututun da za a yi musu, su yi amai a ciki, su sake dawowa, sannan a tura su don gwaji. NHS na Burtaniya ta ba da sanarwar cewa za a samar da tsarin kula da marasa lafiya a gida, wanda zai hana mai haƙuri ya cutar da wasu idan ya zo asibiti ko kuma ya yi aikin tsabtace motar asibiti idan an yi amfani da shi don mutum ɗaya.
Cibiyoyin gwaji na motoci sun ba Koriya ta Kudu damar yin gwaje-gwaje cikin sauri da kuma yawan jama'a a duk duniya.A Jamus, Hukumar Kula da Lafiya ta Kasa ta ba da rahoton ranar 2 ga Maris cewa tana da damar yin gwaje-gwaje kusan 12,000 a kowace rana a cikin motocin gaggawa kuma ta yi aiki da mutane 10,700 a makon da ya gabata.
Ana biyan kuɗin asibiti idan likita ya bukaci a yi wannan gwajin.
A cewar shugaban makarantar Robert Koch, Jamus na da damar yin gwaje-gwaje 160,000 a mako.
A ranar 19 ga Maris, an ba da izinin yin gwaji a manyan biranen da yawa.
A ranar 26 ga Maris, 2020, ba a san adadin mutanen da aka gwada a Jamus ba, saboda an ba da rahoton kawai game da yanayin.
Binciken farko na dakin gwaje-gwaje a makon 12/2020 ya nuna cewa an gwada kimanin samfura 483,295 kuma an bincika makon 12/2020 kuma samfurori 33,491 (6.9%) sun kasance masu cutar SARS-COV-2.A Isra'ila, masu bincike a Technion da Rambam Hospital sun kirkiro sabon tsari kuma sun gwada samfurori 64 a lokaci guda, ta hanyar sanya samfura da kuma gwada samfurori da yawa da ke dauke da cutar.A Wuham, an gina dakin gwaje-gwaje mai girman murabba'in mita 2,000 mai suna Huo-Yan (Cinese: 火眼 , ko 眼) wanda aka fara aiki a ranar 5 ga Fabrairu 2020 a BGI, wanda zai iya yin gwajin samfura 10,000 a rana.
A cikin aikin ƙididdigar da aka gudanar a ƙarƙashin jagorancin wanda ya kafa BGI Wang Jian kuma ya ɗauki kwanaki 5, samar da kayayyakin Hubei zai kasance da kashi 47% mafi girma kuma ya yi daidai da farashin keɓewa wanda zai ninka sau biyu idan ba a fara aikin gwajin ba.
Huo-Yan a Shenzehen, Tianjin, Beijing, da Shanghai, sun bi sahun dakin gwaje-gwaje na Wuhan, tare da birane 12 na kasar Sin.
A ranar 4 ga Maris, 2020, yawan gwaje-gwajen da ake gudanarwa a kowace rana ya kai 50,000. Wani samfurin, samfurin Multiplex da Origami Assays ya samar, zai iya gwada samfuran COVID-19 daga marasa lafiya 1,122 ta amfani da gwaje-gwaje 93 kawai. Za a iya amfani da ingantattun hanyoyin a cikin ƙananan dakunan gwaje-gwaje ba tare da taimakon mutum-mutumi ba.
A watan Maris, rashin maganin da za a yi amfani da shi wajen yin gwaji ya zama babban abin damuwa a Tarayyar Turai, Ingila da Amurka.
Wannan ya sa wasu masana suka ci gaba da haɓaka fasahar amfani da samfuran da ke buƙatar zafin jiki na mutum na 98 ° C (208 ° F) a cikin minti 5 don samar da kwayoyin RNA don ƙarin gwaji.A ranar 31 ga Maris, an ba da rahoton cewa Hadaddiyar Daular Larabawa tana gwada yawan jama'arta a kowace rana don coronavirus fiye da kowace ƙasa, kuma an riga an gwada yawan jama'arta.
An tsara shi ta hanyar fasaha mai mahimmanci, tare da sayen kayan aikin gwaji da yawa daga Group 42 da BGI (bayan Huo-Yan na Cibiyar Nazarin Cututtuka ta Kasar Sin).
An gina shi cikin kwanaki 14, dakin gwaje-gwaje na iya yin gwaje-gwaje na RT-PCR da yawa a kowace rana kuma shine farkon dakin gwaje-gwaje mai ƙarfi da aka yi amfani da shi a wajen China.
Za a gwada gwaje-gwaje masu yawa na gwaje-gwaje na coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta amince da yunƙurin Jamus na samar da na'urar gwaji don turawa ƙasashe masu tasowa waɗanda ba za su iya yin nasu ba.
An fitar da samfurin Jamus a ranar 17 ga Janairu, 2020; samfurin da Cibiyoyin Kula da Cututtuka na Amurka ba su samu ba har zuwa 28 ga Janairu; sakamakon haka, gwajin Amurka bai samu ba. China da Amurka sun damu da farko saboda rashin ingancin na'urorin gwajin su, kuma waɗannan ƙasashe da Australia ba su da ikon samar da isasshen na'urori don biyan buƙatun likita.
Akasin haka, likitoci sun ce, Koriya ta Kudu ta sami damar yin gwaji, wanda hakan ya rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta yi shekaru da yawa tana yin gwaji, musamman a dakunan gwaje-gwaje masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta bayyana cewa shirye-shiryen gwaji sune mafi inganci don hana barkewar cutar COVID-19. Babban buƙatar gwaji yayin da cutar ke yaduwa ya sa yawancin dakunan gwaje-gwaje na Amurka ba su da ƙarfin yin gwaji kuma ba su da kayan aikin ruwa da kayan aikin gwaji don gano cutar.
A watan Maris na 2020, kasar Sin ta ce na'urorin gwajinta ba su da inganci.
A Amurka, gwajin da aka yi da CDC ya kasance "mara kyau", saboda haka gwamnati ta soke dokar hana masu zaman kansu yin gwaji. Spain ta sayi gwajin daga kamfanin China, Shenzhen Bioeasy Biotechnology Co Ltd, amma sakamakon ya kasance ba daidai ba.
Kamfanin ya ce sakamakon da ba daidai ba na iya kasancewa sakamakon samfurin da ba daidai ba ko kuma rashin amfani da injin.
Ma'aikatar ta Spain ta ce za ta cire na'urorin da suka haifar da sakamako mara kyau, kuma za ta maye gurbin su da na'urori daga Shenzhen Bioeasy. Kashi 80% na na'urorin gwajin da Jamhuriyar Czech ta saya daga China sun ba da mummunan sakamako. Slovakia ta sayi na'urori masu gwaji miliyan 1.2 daga China amma ba su da kyau.
Firayim Minista Matovič ya ce an zubar da su a cikin Danube. Ministan Lafiya na Turkiyya Ates Kara ya ce na'urorin da Turkiyya ta saya daga China suna da "mummunan lahani" kuma ba a ba su don amfani ba. Burtaniya ta sayi na'urorin gwaji miliyan 3.5 daga China amma a farkon Afrilu 2020 ta ce ba za su iya amfani da su ba.
Yin gwaji, da keɓewar marasa lafiya da kuma lura da mutanen da suka taɓa saduwa da mutanen da ke da cutar SARS-COV-2, sun ba da sakamako mai kyau.
Masu binciken a Vò, Italiya, inda aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da gwaje-gwaje biyu a kan mutane kusan 3,400 a cikin kwanaki 10.
Kusan rabin mutanen ba su nuna alamun cutar ba, kuma an keɓe dukan waɗanda suka kamu da cutar.
An hana tafiya a wannan yankin, kuma hakan ya hana wasu kamuwa da cutar.
Tare da sa ido sosai kan lambobin sadarwa, ƙuntatawa na balaguro, gwaji, da keɓewa, coronavirus 2020 a Singapore ya fi sauran ƙasashe masu tasowa sauƙi, amma ba tare da takunkumi mai tsanani kamar rufe gidajen abinci da wuraren kasuwanci ba.
An rufe yawancin abubuwan da suka faru, kuma Singapore ta fara dokar hana fita a ranar 28 ga Maris, amma an buɗe makarantu a lokacin bikin ranar 23 ga Maris.
Yawancin ƙasashe sun ɗauki matakai masu ƙarfi don magance cutar, tare da saka idanu kan waɗanda ke hulɗa da marasa lafiya, ƙuntatawa na balaguro, gwaji, da keɓewa amma wasu ba su da ƙarfi kamar Iceland da Koriya ta Kudu.
Binciken da aka yi ya nuna cewa ƙasashe da ke da ƙarin gwajin cutar sun fi samun ƙananan mutuwar, wataƙila waɗanda ba su da alamun cutar ko kuma ba su da alamun cutar.
Hukumar Lafiya ta Duniya ta ce ƙasashe masu iya gwaji da dakunan gwaje-gwaje na gwamnati waɗanda ba su da cikakken bayani game da COVID-19 su aika sakamakon farko na marasa lafiya da sakamakon farko na marasa lafiya goma na COVID-19 zuwa ɗayan dakunan gwaje-gwaje 16 da Hukumar Lafiya ta Duniya ta amince da su don sake dubawa.
Daga cikin dakunan gwaje-gwaje 16 da aka amince da su, 7 suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka, da 1 a Ostiraliya.
A cikin teburin da ke ƙasa, an tsara adadin % na yawan kamuwa da cutar bisa ga tsarin gwajin da aka samu a ƙasashe.
Kasashen da ke ba da gwajin asibiti kawai za su sami kashi sama da kashi ɗaya na yawan masu kamuwa da cutar fiye da ƙasashen da ke ba da gwajin gaba ɗaya, ko suna da alamun cutar ko a'a.
Wanke hannu, wanda ake kira tsabtace hannu, yana nufin tsabtace hannu don kawar da datti, mai, ƙwayoyin cuta, da wasu abubuwa da ke gurɓata su.
Wanke hannuwanka da sabulu sau da yawa a wasu lokuta masu mahimmanci a rana yana hana yaduwar cututtuka ga mutane da yawa, kamar zawo, wanda ke zuwa ta hanyar ƙazanta da kuma wucewa ta baki.
Mutane na iya kamuwa da cututtukan numfashi kamar mura ko sanyi, alal misali, idan ba su wanke hannayensu ba kafin su taɓa idanu, hanci, ko baki (misali wuraren da ruwa ke gudana).
Sa'o'i biyar na musamman a rana da wanke hannu da sabulu yake da muhimmanci su ne: kafin da kuma bayan yin sayayya, bayan ka share wa jariri kwanon rufi ko kuma cire masa kwaskwarima, kafin ka ciyar da shi, kafin ka ci abinci da kuma bayan ka dafa abinci ko ka taɓa nama, kifi, ko kaza.
Idan babu sabulu da ruwa, zaka iya wanke hannayenka da ƙura. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin ka dafa abinci, sa'ad da kake dafa abinci da kuma bayan ka gama.
Kafin ka kula da marar lafiya da kuma bayan ka gama.
Bayan ka cire kuma ka sa wa jariri tufafi ko kuma ka wanke jariri daga bayan bayan gida.
Bayan ka taɓa hanci, tari ko kuma ka yi fitsari.
Bayan ka taɓa dabbobi ko naman dabbobi ko najasa.
Tsabtace hannu na likita ya ƙunshi tsabtace jiki a aikin likita.
Wanke hannu kafin a ba da magani ko kuma a kula da mai ciwo zai iya hana ko rage yaduwar cutar.
Babban dalilin wanke hannu don aikin likita shine don kawar da abubuwa masu cutarwa (ƙwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta masu cutarwa) da sauran abubuwa masu cutarwa ko masu cutarwa.
Yana da muhimmanci ga masu kula da abinci ko kuma likitoci, amma yana da muhimmanci ga dukan mutane.
Wanke hannu yana da fa'idodi masu yawa na kiwon lafiya, kamar rage yaduwar mura, coronavirus, da sauran cututtuka; hana abubuwan da ke haifar da zawo; da rage cututtukan numfashi;
kuma rage yawan mutuwar jarirai a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa wanke hannu yana iya shafan yadda yara 'yan kasa da shekara biyar suke girma.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara daga ciwon huhu da zawo idan aka canja salon rayuwarsu, kamar wanke hannu da sabulu.
Wannan mataki mai sauƙi zai iya rage mutuwar yara da kashi hamsin cikin ɗari.
Ayyukan da ke ƙarfafa wanke hannu suna da haɗarin kamuwa da gudawa sau uku, kuma suna da mahimmanci kamar samar da ruwa mai tsafta a ƙasashe masu tasowa.
48% na raguwar cututtukan gudawa na iya zuwa ta hanyar wanke hannu da sabulu. Wanke hannu da sabulu hanya ce mafi sauki kuma mafi arha don hana cututtuka kamar zawo da cututtukan cututtukan numfashi (ARI), yana da mahimmanci a cikin gidaje, makarantu, da sauran wurare a duniya.
Cutar huhu mai tsanani, wato ARI, ita ce sanadin mutuwa mafi yawa a cikin yara 'yan shekara biyar, kuma tana kashe yara miliyan 1.8 a kowace shekara.
Cutar gudawa da ciwon huhu suna kashe yara kusan miliyan 3.5 kowace shekara.
A cewar UNICEF, sanya wanke hannu da sabulu kafin cin abinci da bayan bayan gida al'ada na iya ceton rayuka fiye da allurar rigakafi ko magani, rage mutuwar gudawa da kashi biyu cikin huɗu na mutuwar cututtukan numfashi mai tsanani.
Wanke hannu yana da mahimmanci tare da sauran shirye-shiryen ruwa, tsaftacewa da tsabtace jiki.
Wanke hannu yana kuma hana kamuwa da cutar da ke tattare da taɓa jiki.
Abinda kawai ke kawo rashin amfani ga wanke hannu shine cewa wanke hannu sau da yawa na iya lalata fata kuma ya bushe ta.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu yana iya sa mutum ya yi rashin lafiya, wato, ya yi fama da cutar eczema ko kuma dermatitis na hannu.
Yin wanke hannu sosai yana ɗaya daga cikin alamun cutar da ake kira OCD.
Akwai lokuta guda biyar masu mahimmanci inda wanke hannu da sabulu ke da mahimmanci don rage yawan kamuwa da cuta daga ƙazamar baki: bayan bayan bayan bayan gida (wanka, yin sayayya), bayan wanke jariri (cire da kuma sanya sutura), kafin ciyar da jariri, kafin cin abinci da kafin / bayan dafa abinci ko taɓa nama, nama ko naman alade.
Sauran lokutan da wanke hannu da kyau ya zama al'ada don hana yaduwar cututtuka shine wanke hannu kafin da bayan kula da rauni; bayan yin fitsari, tari, taɓa hanci; bayan taɓa ƙazamin dabbobi ko dabbobi; da kuma bayan taɓa shara.
A ƙasashe da yawa, mutane da yawa ba sa wanke hannayensu da sabulu.
Wani bincike kan wanke hannu da aka gudanar a cikin kasashe 54 a 2015 ya nuna cewa, kashi 38.7% na gidaje suna wanke hannu da sabulu. A cikin binciken na 2014, Saudi Arabiya tana da kashi 97 cikin ɗari; Amurka tana da kusan kashi 77 cikin ɗari; kuma China tana da ƙasa da kashi 23 cikin ɗari. Yawancin ayyukan yanzu suna canza halaye na wanke hannu da ruwa da sabulu a lokuta masu mahimmanci. Wanke hannu tare da ɗalibai a lokacin da aka tsara a rana shine manufa a ƙasashe masu tasowa don shigar da shi cikin halayen yara.
Shirye-shiryen Kula da Lafiya na Lafiya wanda Ma'aikatar Ilimi ta Philippines ta gwada misali ne na ayyukan inganta lafiyar yara da ilimin su.
Yin fitsari sau biyu a shekara, tare da wanke hannuwan yau da kullun da sabulu, wanke haƙori yau da kullun da maganin hakori, sune manyan abubuwan da ke cikin shirin al'umma.
Mata a ƙasar Indonesia sun yi amfani da wannan dabarar kuma sun sami sakamako mai kyau.
Ana iya kawar da ƙwayoyin cuta daga fata ta wajen ƙara sabulu ko maganin kashe ƙwayoyin cuta a cikin ruwa.
Babban aikin sabulu da kayan tsabtace jiki shine samar da hanyoyin warkewa, da kuma inganta tasirin su.
Ruwa ne kaɗai zai iya taimaka wa mutum ya tsabtace fatarsa domin ruwa ba zai iya kawar da mai da kuma furotin da ke cikin jiki ba.
Amma, tsabtatawa tana da kyau idan aka ƙara ruwa sosai.
Sabulu mai ƙarfi, da yake ana iya sake amfani da shi, yana iya ƙunsar ƙwayoyin cuta da mutane suka samu daga amfani da shi.
Wasu bincike da aka yi game da yadda sabulu mai ƙarfi yake sa mutane su kamu da ƙwayoyin cuta sun nuna cewa ba zai iya sa mutane su kamu da ƙwayoyin cuta ba domin ana shafa su da kumfa.
Amma, CDC ta ce sabulu mai ruwa mai tsabta yana da tasiri sosai wajen hana yaduwar cutar.
Mutane da yawa sun ce sabulu da ke ɗauke da maganin kashe ƙwayoyin cuta yana da kyau ga masu kula da lafiyar jiki.
A yau babu wata hujja da ta nuna cewa ana ba da shawarar amfani da maganin kashe ƙwayoyin cuta ko maganin kashe ƙwayoyin cuta don kashe wannan cuta ta duniya
Amma sabulu yawanci yana dauke da maganin kashe kwayoyin cuta kamar triclosan, wanda shine mafi yawan kwayoyin cuta da ke cikin ƙasa.
Saboda haka, ko da maganin kashe ƙwayoyin cuta da aka yi amfani da su a cikin sabulu yana da ƙwayoyin cuta, ba zai yi tasiri sosai ba.
Baya ga kayan shafawa da kayan shafawa, magungunan da ke da rikitarwa na iya ƙunsar acid (acetic acid, ascorbic acid, rubber acid) da kuma pH mai daidaitawa, benzoic acid mai kashe ƙwayoyin cuta, da sauran kayan shafawa na fata (aloe vera, bitamin, menthol, kayan lambu).Binciken Jami'ar Lafiya ta Jama'a ta Oregon ya nuna cewa sabulu na jiki yana da tasiri kamar sabulu mai dauke da maganin kashe ƙwayoyin cuta na triclosan don magance cututtuka da kuma kawar da ƙwayoyin cuta daga hannayenmu.
Ruwan wanke hannu da ba shi da ƙarfi ba ya kashe ƙwayoyin cuta.
Kwayoyin cuta suna girma cikin sauri a yanayin zafin jiki na 37 ° C.
Amma, ruwan wanka da sabulu yana kawar da mai da datti da kuma ƙwayoyin cuta fiye da ruwan sanyi.
Amma, binciken da masana kimiyya suka yi ya nuna cewa wanke hannu da ruwa ba ya kawar da cututtuka.
Sanitizer na hannu ko maganin kashe ƙwayoyin cuta na hannu sanitizer ne na hannu wanda ba ya amfani da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, an yi amfani da maganin wanke hannu da ba ya amfani da ruwa (wanda ake kira maganin wanke hannu da barasa, maganin kashe ƙwayoyin cuta, ko kuma maganin wanke hannu).
Yawancin lokaci ana yin su da isopropyl ko ethanol da wani abu kamar Carbomer (polymer na acrylic acid) a cikin gel, ko kuma mai laushi kamar glycerin a cikin ruwa, ko kuma foda don ingantawa da kuma rage ƙarfin bushewar barasa.
Ƙara hydrogen peroxide mai ruwa yana haɓaka aikin maganin ƙwayoyin cuta. Magungunan ƙwayoyin cuta da ke da kashi 60 zuwa 95% na barasa suna da tasiri sosai.
Magungunan kashe ƙwayoyin cuta na barasa suna kashe ƙwayoyin cuta, ƙwayoyin cuta masu jurewa da ƙwayar cuta (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da AIDS, herpes, RSV, rhinovirus, allurar rigakafi, mura da hepatitis) da naman gwari.
Sanitizer na hannu mai dauke da kashi 70% na barasa yana kashe kashi 99.97% (rage log zuwa 3.5, da rage decibel zuwa 35) na ƙwayoyin cuta a hannu a cikin sakan 30 bayan amfani da shi da kuma kashi 99.99% zuwa 99.999% (rage log zuwa 4 zuwa 5) na ƙwayoyin cuta a hannu a cikin minti 1 bayan amfani. Sanitizer na hannu yana da tasiri sosai akan kashe ƙwayoyin cuta amma yana da rauni akan kashe wasu ƙwayoyin cuta.
Sanitizer na hannu mai shan giya ba zai iya magance cutar norovirus (ko Norwalk) ba, wanda yawanci ke yada ƙwayoyin cuta a cikin hanji. Ya kamata a yi maganin kashe ƙwayoyin cuta ko wanke hannu da yawa da ke da ruwa sosai ko kuma yana cike da hannu.
Kafin da bayan hannuwan biyu da na tsakiya kuma ka wanke ƙusoshin ƙusa na tsawon sakan 30 har sai ruwa, foda ko gel sun bushe.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka sun ba da shawarar cewa wanke hannu da kyau maimakon amfani da maganin wanke hannu, musamman idan hannuwan suna da datti sosai.
Ana amfani da maganin wanke hannu da yawa saboda sauƙin amfani da saurin kashe ƙwayoyin cuta, amma ba za a iya amfani da shi a madadin wanke hannu da ruwa mai kyau ba, amma kawai idan babu sabulu da ruwa.
Yin amfani da maganin wanke hannu da ke ɗauke da barasa a kai a kai zai iya sa fata ta bushe sai dai idan an ƙara kayan wanke hannu.
Ana iya rage ko rage ƙarfin ruwan sha na bushewa ta hanyar ƙara glycerin da / ko wasu kayan shafawa na hannu.
A lokacin gwajin rigakafin ɗan adam, kayan wanke hannu na giya da ke da kayan wanke hannu, sun haifar da ƙarancin ƙarancin fata kuma ba su bushe hannu sosai kamar sabulu ko maganin kashe ƙwayoyin cuta ba.
Sau da yawa, ba ta taɓa yin ja ko kuma ta yi sanyi ba, kuma ba ta taɓa yin rashin lafiyar da aka yi da giya ko kuma wasu ƙwayoyi ba.
An soma amfani da maganin shafawa don kawar da ja maimakon sabulu da ruwa don wanke hannu.
Ko da yake sun yi ƙarfi sosai, maganin wanke hannu da ruwa ba ya kawar da ƙwayoyin cuta daga hannayenmu, amma yana tsabtace su.
Saboda haka, maganin wanke hannu ba shi da tasiri sosai kamar sabulu da ruwa don hana yawancin ƙwayoyin cuta yaduwa, saboda ƙwayoyin cuta suna kan hannu.
Ingancin tsabtace hannu da ba shi da barasa ya dogara da kayan aiki da kuma yadda aka yi shi, kuma yana da alama ba zai iya wucewa da maganin wanke hannu mai shan giya da ke da kashi 70 na barasa ba.
A kwanan baya, maganin shafawa da ake amfani da shi da benzalkonium chloride yana kashe ƙwayoyin cuta bayan an shafa shi, ba kamar barasa ba, wanda aka gano cewa yana da lahani idan aka yi amfani da shi sosai, wataƙila domin yana da ƙwayoyin cuta da yawa a fata.
A wurare da ake talauci, mutane suna iya sayan sabulu kuma su yi amfani da ƙura ko kuma ƙasa a madadinsa.
Ƙura da ƙasa suna da ƙarfi fiye da ruwa, amma ba su da ƙarfi kamar sabulu.
Abin damuwa shi ne, gurɓataccen ƙasa ko ƙura zai iya sa cututtuka su yaɗu maimakon su hana su.
Kamar sabulu, turɓaya tana da tsabtace jiki domin idan ta haɗu da ruwa, tana samar da bayani mai alkaline.
Hukumar Lafiya ta Duniya ta ba da shawarar yin amfani da ƙura ko yashi maimakon sabulu idan babu sabulu.
Cibiyoyin Kula da Cututtuka na Amurka sun ba da shawarar yin wanke hannu yadda ya kamata don hana yaduwar cututtuka kamar haka:
Ka wanke hannuwanka da ruwan zafi ko ruwan sanyi.
An ce a yi amfani da ruwa mai gudana domin masu wasa da ke zaune tare suna iya kamuwa da ƙwayoyin cuta, kuma zafin ruwan ba shi da amfani.
Ka wanke hannayenka da sabulu mai yawa, har da bayan hannuwanka, tsakanin yatsun hannu, da kuma ƙarƙashin ƙusoshinka.
Sabulu yana kashe ƙwayoyin cuta a fata, kuma bincike ya nuna cewa mutane suna yawan wanke hannayensu sosai da kuma na dogon lokaci bayan sabulu ya bushe fiye da lokacin da aka yi amfani da ruwa.
Ka yi amfani da sabulu na aƙalla dakika 20.
Yin hakan yana kawar da ƙwayoyin cuta daga fata, kuma shafawa da aka yi na dogon lokaci yana kashe ƙwayoyin cuta da yawa.
Ka wanke hannayenka da ruwa mai gudana.
Goge hannu da kwanoni zai iya sa hannu ya sake kamuwa da ƙwayoyin cuta.
Ka bushe da tufafi masu tsabta ko kuma ka bar iska ta bushe.
Hannun da ke cikin ruwa suna da saurin kamuwa da ƙwayoyin cuta.Wuraren da ba a taɓa wanke su sosai ba sune babban yatsa, wuyan hannu, tsakanin yatsunsu, da ƙusoshin ƙafa.
Ƙunƙarar ƙusa da kuma kayan goge ƙusa na iya ƙunsar ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da man shafawa don hana bushewar hannu, domin bushewar hannu tana iya lalata fata kuma tana iya sa mutum ya kamu da cututtuka.
Ana iya amfani da man shafawa mai sauƙi don taimakawa wajen wanke hannu inda babu ruwa da / ko sabulu kamar zubar da ruwa daga tasa mai ɗorewa da ƙarancin ruwa da / ko amfani da ƙura idan ya cancanta a ƙasashe masu tasowa. Idan akwai ƙarancin ruwa (misali a makarantun ƙauyuka a ƙasashe masu tasowa), ba za a iya samun damar kiyaye ruwa ba, kamar tippy-taps da sauran hanyoyin da ba su da tsada.
Tippy-tap shine hanya mai sauƙi ta amfani da bututun ruwa wanda aka ɗora a saman kuma an haɗa shi da igiya, kuma an haɗa shi da igiya don zubar da ruwa a kan hannayen hannu da sabulu.
Wanke hannu da kyau yana da muhimmanci ga lafiyar jiki, amma akwai jayayya game da yadda za a wanke hannu da kyau a bayan gida.
Yawancin bincike sun tabbatar da cewa tawul ɗin wanke hannu yana da inganci fiye da na'urar busar hannu da ke cikin ɗakunan wanka da yawa.
A shekara ta 2008, an gudanar da wani bincike a Jami'ar Westminster, London, wanda aka ba da kuɗin ta hanyar taron tattaunawa na European Tissue Symposium, wanda ke samar da na'urar bushewa hannu, don fahimtar bambance-bambance tsakanin na'urar bushewa hannu, na'urar bushewa hannu da na'urar bushewa hannu.
Bayan wankewa da bushewa hannu da na'urar bushewa, ƙwayoyin cuta sun ƙaru a yatsunsu da kashi 194% da hannaye da kashi 254%.
Bayan wankewa da bushewa hannu da na'urar bushewa, ƙwayoyin cuta sun ƙaru a yatsun hannu da kashi 42% da hannaye da kashi 15%.
Bayan wankewa da bushewa da tawul ɗin hannu, ƙwayoyin cuta sun ragu da kashi 76% a yatsunsu da kashi 77% a hannayensu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano ko masu amfani da bayan gida da kuma bayan gida sun yada ƙwayoyin cuta bayan bushewa da yawa.
Na'urar busar hannu, wacce ke fitar da iska a saurin mita 180 a kowane dakika (650 km/h; 400 mph), na iya sanya ƙwayoyin cuta a hannaye zuwa wuraren da ke cikin bayan gida da kuma taɓa wasu mutane a bayan gida har zuwa mita 2.
Amfani da na'urar busar hannu yana yada ƙwayoyin cuta a nisan mita 0.25 daga na'urar.
A cikin binciken da aka yi a shekara ta 2005 da TÜV Produkt und Umwelt ya yi, an bincika hanyoyi da yawa na bushe hannu.
An gano bambance-bambance masu zuwa a cikin adadin ƙwayoyin cuta bayan bushe hannu:
Akwai masana'antun da yawa da ke kera na'urorin busar hannu, kuma suna da bambanci tsakanin na'urorin busar hannu da kuma na'urorin busar hannu.
Drying hannu da kayan wanke hannu shine madadin hanyar bushe hannu yayin tafiya idan sabulu da ruwa basu samuwa.
Ya kamata a ƙayyade adadin barasa a cikin kayan wanke hannu na giya zuwa kashi 60 cikin ɗari.
An soma amfani da maganin wanke hannu da yawa bayan da likitan Hungary Ignaz Semmelweis ya gano cewa yana da amfani wajen hana yaduwar cututtuka a asibitoci (a shekara ta 1846).
Akwai na'urori da yawa da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya nuna cewa yin amfani da maganin yana rage yawan kamuwa da cuta.
Ana amfani da maganin wanke hannu na tsawon dakika 15, tare da ruwa da sabulu da yawa ko man shafawa a duk wuraren da aka yi amfani da su.
Ya kamata a yi amfani da hannuwan da aka haɗa tare.
Idan akwai datti a ƙarƙashin ƙafar, za mu iya cire shi da wani abu mai ɗanɗano.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwa, yana da muhimmanci a cire ruwa daga hannu kuma a goge shi da zane mai tsabta.
Bayan bushewa, ya kamata a yi amfani da kayan bushewa don rufe ruwa (kuma buɗe ƙofar fitarwa idan akwai).
Hakan yana taimaka wajen hana cututtuka daga wannan wurin.
Manufar wanke hannu da kyau shine kawar da ƙwayoyin cuta da hana su yaduwa ga wasu.
Jaridar New England Journal of Medicine ta ce, a asibitoci, mutane da yawa ba sa wanke hannuwansu, kuma likitoci da ma'aikatan jinya da yawa suna manta su wanke hannuwansu kafin su taɓa marasa lafiya, kuma hakan yana sa su kamu da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran kayan aiki masu sauƙi na iya rage yawan kamuwa da cutar hawan jini da kashi 66%.
Ana iya samun shawarwarin farko na kungiyar game da wanke hannu kuma ana iya samun su a shafin yanar gizon ta don bayanin jama'a.
Whitby da abokansa sun yi bincike mai muhimmanci.
Na'urorin da ake sayarwa suna iya gwadawa da kuma nuna idan hannaye suna da tsabta, idan irin tsabta da ake buƙata ya isa.
Hukumar Lafiya ta Duniya ta ba da Abubuwa Biyar  don wanke hannu:
bayan ya taɓa jini/ruwan jikin mutum
kafin yin wannan aikin tsabtace hannu, da kuma
bayan kula da mai haƙuri. Ƙara maganin kashe ƙwayoyin cuta zuwa sabulu (sabulu mai magani ko sabulu mai kashe ƙwayoyin cuta) yana taimakawa wajen kashe ƙwayoyin cuta.
Goge hannu kafin tiyata ko a wuraren da akwai ƙwayoyin cuta da yawa. Goge hannu kafin tiyata, idan ya cancanta tare da famfo mai buɗewa ko rufewa wanda ba a taɓa shi da hannu, chlorhexidine ko iodine, zane mai tsabta don bushe hannu bayan wankewa, da kuma tawul mai tsabta don cire datti da sauran kayan aikin tsabta don cire datti daga kusoshi.
Dole ne a cire lu'ulu'u.
A cikin wannan yanayin, wanke hannuwan hannu da kuma gaban hannu har zuwa tsakiyar hannu, mafi yawa a cikin minti 2-6.
Ba a bukatar a yi jinkirin girki na minti 10.
Sa'ad da kake goge hannuwanka, ka hana ruwa daga gaban hannuwanka zuwa bayan hannuwanka.
Bayan wanke hannu, ya kamata a bushe hannuwanku da tawul da ba shi da ƙwayoyin cuta kuma a sa safar hannu ta likita.
Don hana yaduwar ƙwayoyin cuta, yana da kyau a wanke hannu ko amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da mai haƙuri.
Don nazarin cutar staphylococcal a asibitoci, an gano cewa mafi yawan fa'idodin wanke hannu sun zo bayan wanke hannu 20% na farko, kuma mafi ƙarancin fa'idar ta zo bayan wanke hannu 35%.
Wanke hannu da sabulu yana kara yawan kamuwa da cuta ta hanyar abinci sau uku idan aka kwatanta da wanke hannu da sabulu mai kashe ƙwayoyin cuta. Ya bambanta da wanke hannu da sabulu mai kashe ƙwayoyin cuta da barasa, wanke hannu da sabulu mai kashe ƙwayoyin cuta a cikin sakan 30 yana rage yawan kamuwa da ƙwayoyin cuta da kashi 26% fiye da sabulu mai kashe ƙwayoyin cuta.
Amma sabulu da ruwa sun fi maganin shafawa na barasa tasiri sosai wajen kamuwa da cutar mura ta H1N1 da kuma ƙwayar clostridium difficile. Ƙoƙarin inganta tsabtace hannu a asibitoci na iya buƙatar horar da ma'aikata kan wanke hannu, samar da wadataccen maganin wanke hannu mai shan giya, da kuma rubutaccen bayanin kula da ma'aikata.
Ana yin bincike sosai a kan hanyoyin da za su taimaka wajen magance cututtuka da yawa.
A ƙasashe masu tasowa, wanke hannu da sabulu yana da sauƙi, yana da muhimmanci ga lafiyar jiki, har ma yana da muhimmanci ga abinci mai gina jiki.
Amma, rashin ruwa da sabulu da kuma wuraren wanke hannu a gida, makaranta, da kuma wuraren aiki yana sa wanke hannu ya zama ƙalubale ga dukan mutane.
Misali, a yawancin ƙasashen Afirka, wuraren wanke hannu kusa da dakunan wanka na jama'a da na jama'a ba su da yawa, kodayake akwai zaɓuɓɓuka masu rahusa don samar da wuraren wanke hannu.
Amma, wanke hannu a kai a kai yana iya zama al'ada, ba don babu sabulu da ruwa ba.
Ƙaddamarwa da ƙarfafa wanke hannu da sabulu na iya sa a kafa dokoki, ƙarfafa ƙa'idodin wanke hannu da kuma taimaka wa mutane su yi canji mai kyau a halayensu.
Don a yi nasara, lura da kuma yin nazari suna da muhimmanci.
Binciken bincike 70 ya nuna cewa ƙarfafa wanke hannu a cikin ƙauyuka yana da mahimmanci a cikin LMICs, amma ƙuntatawa ga ɓarnatar da bayanai ba shi da tasiri sosai. Misali na ƙarfafa wanke hannu a makarantu shine "Matakai Uku" na UNICEF wanda ke ƙarfafa makarantu don yin ayyuka masu sauƙi, masu araha waɗanda ke sa ɗalibai su wanke hannu da sabulu, a tsakanin sauran ayyukan tsabta.
Idan makarantun sun yi nasara wajen koya wa ɗalibai wasu halaye masu kyau, za su iya canja zuwa waɗanda suka fi ƙarfinsu.
Gina wuraren wanke hannu na iya zama wani ɓangare na yaƙin neman zaɓe na wanke hannu don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya ita ce wani misali na aikin addini na taimakawa canjin halaye. A yayin barkewar cutar coronavirus ta 2019-20, UNICEF ta ƙarfafa ƙirƙirar emoji na wanke hannu.
Wasu nazarin sun bincika yawan wanke hannu a ƙasashe masu tasowa dangane da faɗakarwar DALYs.
Amma, wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu yana da sauƙi idan aka gwada da wasu hanyoyin tsabtace jiki kamar ruwa da kuma sauran hanyoyin tsabtace jiki.
Muhimmancin wanke hannu don lafiyar musamman ga mutane masu haɗari kamar mata masu haihuwa ko sojoji da ke asibiti  an fara amincewa da su a tsakiyar karni na 19 ta hanyar masu gabatar da aikin wanke hannu: Ignaz Semmelweis, likitan Hungary, wanda ke aiki a Vienna, Austria da kuma Florence Nightingale, mai kula da lafiya na Ingila".
A lokacin, mutane da yawa sun gaskata cewa ƙamshi ne ke kawo cuta.
A cikin shekarun 1980, ɓarkewar cututtuka na abinci da cututtuka na kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka su ƙara ƙarfafa tsabtace hannu kuma su ce yana da muhimmanci wajen hana yaduwar cuta.
Fashewar cutar mura ta 2009 da annobar COVID-19 a 2020, sun sa mutane a duniya su mai da hankali kan mahimmancin wanke hannu da sabulu don hana irin wannan annobar.
Alal misali, an saka allon tallace-tallace da ke ɗauke da "daidaitaccen hanyar wanke hannu" kusa da wuraren wanke hannu na jama'a da kuma wuraren wanka na ofisoshi da filayen jirgin sama a Jamus.
Furcin nan "wanke hannuwanmu" yana nufin ƙin ɗaukan hakki ko kuma ba da wani abu.
Ya bayyana a cikin nassin Matta cewa Bilatus Ba-Bunti ya wanke hannuwansa sa'ad da yake yanke shawarar rataye Yesu Kristi, amma ya zama sanannen magana a ƙasashen Turanci.
A cikin wasan Shakespeare na Macbeth, Uwar Macbeth ta fara wanke hannayenta don wanke ƙazantar da ke cikin tunanin, wanda ya nuna rashin fahimtar ta game da mummunan laifin da ta yi da kuma sa mijinta ya yi.
An lura cewa bayan an tuna wa mutane da wasu halaye marasa kyau ko kuma bayan an tuna musu da su, suna yawan wanke hannayensu fiye da wasu, kuma suna godiya sosai don kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba su damar wanke hannayensu bayan waɗannan abubuwan da suka faru sun rage yawan ayyukan tsabta, kamar aikin sa kai.
Yin wanke hannu a alamance, wato, wanke hannu da ruwa maimakon sabulu, koyarwar wanke hannu ce a addinai da yawa, kamar Baha'i, Hindu, Tevilah da Netilat Yadayim a addinin Yahudawa, Lavabo a addinin Kirista da kuma Wudhu a addinin Musulunci. Addinai suna bukatar mutane su wanke hannayensu don tsabta, musamman bayan wasu ayyuka.
Addinan Hindu, Yahudawa, da Musulmai suna bukatar mutane su wanke hannayensu bayan sun je bayan gida.
Ƙari ga haka, addinai kamar su Hindu, Buddha, Sikh, Yahudawa, da Musulmai suna bukatar a wanke hannu kafin a ci abinci da kuma bayan an ci abinci.
Kayan aikin kariya na COVID-19
Kayan aikin kariya na COVID-19 yana amfani da matakan lafiya da aminci don hana yaduwar cutar coronavirus 2019 (COVID-19).
Matsayin da ya dace na kiyaye lafiya ya dogara da yanayin aiki da aikin, haɗarin haɗari, yanayin kamuwa da cuta, da kuma haɗarin da ma'aikata ke da shi na kamuwa da COVID-19.
A cewar Ma'aikatar Tsaro da Lafiya ta Amurka (OSHA), aikin da ke da ƙananan haɗari shine aikin da ke buƙatar ƙarancin hulɗa da abokan aiki, wanda ke buƙatar amfani da matakan tsaro na yau da kullun, kamar wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, cututtukan numfashi, da kuma kiyaye tsabta da tsabta a wurin aiki.
Ayyukan haɗari masu haɗari sune ayyukan da ke buƙatar haɗuwa da mutane da kuka sani ko waɗanda ke da yiwuwar kamuwa da COVID-19, amma waɗanda ke da yiwuwar rashin lafiya saboda haɗuwa da mutane da yawa ko tafiya zuwa ƙasashe da yawa.
Wannan ya shafi ma'aikata da suke aiki tare da mutane da yawa, kamar su a makarantu da wuraren aiki da kuma wasu wurare da jama'a suke.
Don kare kai a cikin wannan rukunin, ban da matakan kariya na yau da kullun, ana buƙatar yin amfani da kayan aikin numfashi tare da matattarar iska mai ƙarfi, kariya ta ƙonewa, da kayan aikin kariya na mutum idan kun kasance cikin hulɗa da mai cutar COVID-19.
OSHA ta ɗauki likitoci da ma'aikatan asibiti da ke da alaƙa da waɗanda aka sani ko waɗanda za su iya haɗuwa da wani mai cutar COVID-19 a matsayin masu haɗari, kuma hakan yana haifar da haɗarin haɗari ga waɗanda ke aiki a cikin aerosol ko waɗanda ke taɓa ko karɓar samfuran mutane da ke da cutar ko waɗanda za su iya kamuwa da COVID-19.
Inganta kariya ga waɗanda suke aiki a cikin gidaje da ke da iska mai iska, da kuma samun kayan kariya masu dacewa don wannan aikin.
Fashewar COVID-19 na iya haifar da haɗari a wuraren aiki.
Ma'aikata ba za su iya zuwa aiki ba saboda rashin lafiya, kula da wasu, ko tsoron haɗuwa da mai cutar.
Yanayin kasuwanci na iya canzawa, yana iya zama da abubuwan da mutane ke so su saya, da kuma hanyoyin da za a samu waɗannan abubuwa (misali cin kasuwa a cikin babban taro ko ta hanyar sabis na isar da kaya).
A ƙarshe, ana iya hana jigilar kayayyaki zuwa wuraren da cutar COVID-19 ta fi yawa. Shirye-shiryen cutar na iya taimakawa wajen sanin abin da za a yi don kare kanmu.
Shirye-shiryen ya kamata su yi la'akari da haɗarin haɗari a wuraren aiki da wuraren aiki, da kuma abokan hulɗa, abubuwan da ke haifar da haɗari a gida da kuma sauran wurare, da kuma haɗarin da ma'aikata kamar tsofaffi ko marasa lafiya ke fuskanta.
Za a kuma tattauna yadda za a magance waɗannan haɗarin da kuma yadda za a magance matsalolin da za su iya tasowa.
Za a tsara shirye-shiryen yaduwar cututtuka da kuma matakan da za a ɗauka don magance su bisa ga dokokin ƙasa ko na ƙasa.
Hanyoyin da suka dace don magance su sun haɗa da abubuwan da suka shafi cututtuka kamar rage haɗarin yaduwar cututtuka tsakanin ma'aikata, kare waɗanda ke da haɗarin kamuwa da cututtukan da suka gabata, ci gaba da aiki, da kuma ɗaukar matakan da ba za su shafi ayyukan kamfanonin da kuke aiki tare ba.
Abin da za ka yi zai dangana ne a kan yadda cutar ta shafi hankalinka.
Sanin yadda kowa zai yi aiki don kare kansa yana da kyau don kare lafiyar ma'aikata da lafiyar mutane da yawa kamar yadda zai yiwu.
A wuraren da ba za a iya kawar da haɗarin COVID-19 ba, mafi kyawun hanyar magance shi shine ta hanyar amfani da kayan aiki, bayan binciken hukuma, kuma a ƙarshe samar da kayan aikin kariya na mutum.
Kula da injina yana nufin nisantar da ma'aikata daga haɗarin aiki ba tare da lalata ɗabi'ar aiki ba, kuma yana iya zama hanya mafi kyau.
Binciken da ake yi a wurin aiki yana kawo canji a yadda ake aiki, wanda ke bukatar ma'aikaci ko ma'aikaci ya yi gyara a yadda yake aiki.
Kayan aikin kare kai (PPE) ba su da ƙarfi kamar na'urori ko na'urori masu kulawa, amma suna iya taimakawa wajen hana wasu haɗari.
Ya kamata a zaɓi kowane irin PPE bisa ga haɗarin da ma'aikaci ke fuskanta, idan ya dace (misali kayan numfashi), sanya shi a hankali kuma a koyaushe, kiyaye shi, da maye gurbinsa, idan ya cancanta, da cire shi, wanke shi, gyara ko zubar da shi yadda ya kamata don hana cutar.
A cewar Ma'aikatar Lafiya da Tsaro ta Duniya (OSHA), ƙananan haɗarin aiki sune waɗanda ke buƙatar ƙarancin hulɗa da abokan aiki.
Hanyoyi mafi kyau don hana yaduwar kamuwa da cuta a wuraren aiki masu izini sune wanke hannu akai-akai, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, suna fama da cututtukan numfashi, rufe baki ko hanci idan sun tari ko ƙazanta, samun kayan shafawa da wuraren zubar da su, shirya kayan sadarwa ko wasu idan ya cancanta don hana ma'aikata amfani da kayan aikin wasu, da kiyaye ɗabi'un tsafta da tsabtace wurin aiki.
Gano mutane masu haɗari da kuma ware su daga wasu sune mafi kyawun hanyoyin da za a kiyaye ma'aikata, abokan ciniki, baƙi, da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka da Kula da Jama'a (CDC) na Amurka sun ba da shawarar cewa ma'aikata da ke da alamun cututtukan numfashi masu tsanani su kasance a gida har sai zazzabi, zazzabi, da sauran alamun sun wuce a cikin akalla awanni 24 ba tare da maganin zazzabi ko maganin cututtukan ba, da kuma tsara ƙa'idodin hutu masu dacewa, ba ma'aikata damar zama a gida don kula da dangin da ke fama da cutar, da kuma cewa ma'aikata su san waɗannan ƙa'idodin.
A cewar OSHA, matsakaicin haɗarin aiki ya danganta da yanayin da ya shafi mutane waɗanda ke hulɗa da mutane da yawa ko kusan mita 1.8 daga waɗanda ke da cutar COVID-19 ko kuma waɗanda ke da alaƙa da su, amma suna iya kamuwa da SARS-CoV-2 saboda yawan yaduwar cutar a wurin aiki, ko kuma saboda kwanan nan tafiya zuwa wasu ƙasashe inda yaduwar COVID-19 ke da yawa.
Yana shafar ma'aikata da ke fuskantar haɗari iri-iri kamar a makarantu, wuraren aiki masu cunkoso, da sauran wuraren taron jama'a. Kula da injuna don irin waɗannan ma'aikata ya ƙunshi sanya matattarar iska mai ƙarfi, sa masu iska su yi aiki da ƙarfi, kayan keɓewa da kayan hana ƙwanƙwasawa, da kuma sanya allon taga don masu karɓar baƙi. Kulawa na hukumomi don ƙungiyoyin haɗari mafi girma zai buƙaci ƙarfafa ma'aikata masu rauni su zauna a gida, gudanar da tarurruka ta hanyar yanar gizo maimakon kasancewa a wuri ɗaya, ƙa'idodin hana tafiya a wuraren da COVID-19 ke faruwa, samar da hanyoyin sadarwa da kuma dandalin tattaunawa don magance matsalolin jama'a, samar da sabbin masu amfani da kayan aikin da suka dace don kare kansu daga haɗarin COVID-19, yin abubuwan da suka dace don kiyaye su daga cutar, yin amfani da kayan aiki masu mahimmanci da kuma ba da kayan aikin da ake buƙata, kamar sanya tufafi masu kariya, sanya takunkumi, da kuma samar da horo ga masu aiki da kuma yin aiki a wasu lokuta, don tabbatar da cewa ba su da alamun COVID-19.
Ma'aikata a cikin wannan rukunin ba sa buƙatar yin amfani da kayan aikin numfashi.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, mafi kyawun hanyar kare lafiyar ma'aikata da sauran mutane shine nisantar da shi daga wasu a nesa da ƙafa 6, sanya ma'aikacin jirgin sama don kula da mai cutar, da sanya abin rufe fuska ko buƙatar mai cutar ya rufe bakinsa da hancinsa da zane lokacin da ya tari ko ya yi ƙaiƙayi.
Ma'aikatan jirgin suna buƙatar sanya rigar rigakafi lokacin da suke kula da matafiya marasa lafiya ko taɓa ruwa ko wani abu da zai iya haifar da cutar, kuma suna buƙatar ƙarin kariya idan mai haƙuri yana da zazzabi, tari mai ɗorewa, ko wahalar numfashi.
Ya kamata a zubar da kayan kwalliya da sauran kayan da aka zubar bayan amfani, kuma a tsabtace da kuma kashe ƙwayoyin cuta a wuraren da ke da cutar. Ga jirgin ruwa na kasuwanci, gami da fasinjojin jirgin ruwa da sauran fasinjojin jirgin, kariya ta kai tsaye tana nufin guje wa tafiya idan kun kamu da rashin lafiya, da keɓewa da sanar da likitocin jirgin nan da nan idan wani daga cikin fasinjojin ya kamu da zazzabi ko wasu alamun rashin lafiya.
Yana da kyau a kula da lafiyar mai haƙuri a wurin da aka sanya shi. Ga makarantu ko wuraren kula da yara, CDC na buƙatar rufe wurin na ɗan lokaci don tsabtace ko kashe ƙwayoyin cuta idan mai haƙuri ya kasance a harabar makarantar ko da cutar ta yadu ko a'a.
Idan akwai iyakancewar yaduwar cutar, ana iya amfani da matakan hana haɗuwa kamar hana tafiya, tarurruka, da sauran manyan tarurruka kamar ilimin motsa jiki ko wasan kwaikwayo a makarantu ko cin abinci a gidajen abinci, da kuma nisantar ofisoshi, jira a lokacin zuwa da fita, guje wa ziyarar da ba dole ba, da kuma amfani da ofisoshin likita daban-daban don yara masu alamun mura.
Idan akwai barkewar cutar a yankinku, ban da sanarwar da aka bayar, ana iya rufe makarantu na ɗan lokaci.Ga jami'an 'yan sanda da ke aiki a cikin al'ada, CDC ta ce haɗarin yana da ƙarancin gaske.
Jami'an 'yan sanda da ke hulɗa da mutanen da ke da cutar ko waɗanda za su iya kamuwa da cutar COVID-19 dole ne su bi ƙa'idodin kulawa na yau da kullun, gami da saka kayan kariya na musamman.
Idan ka taɓa wani yayin da kake riƙe shi, ya kamata ka tsabtace da kuma kashe ƙwayoyin cuta a kan kayan aikinka da kayan aikinka kafin amfani da su, ta hanyar amfani da injin tsabtace iska da bin ƙa'idodin kariya da zubar da kayan PPE da kuma kiyayewa da wanke tufafi.
OSHA ta ɗauki wasu ma'aikatan kiwon lafiya da na asibiti a matsayin masu haɗari ko waɗanda ke cikin haɗari.
Ayyukan haɗari sun haɗa da haihuwa, kulawa, dakin gwaje-gwaje, da kuma masu ɗaukar marasa lafiya da ke da cutar COVID-19 ko kuma waɗanda za su iya kamuwa da ita.
Suna fuskantar haɗarin haɗari idan suna aiki a cikin iska, ko kuma suna karɓar ko amfani da samfuran daga mutanen da ke da cutar ko kuma waɗanda za su iya kamuwa da COVID-19.
Ayyukan aerosol sune ayyuka kamar intubation, maganin tari, bronchoscopy, ko wasu ayyukan hakori ko gwaje-gwaje, ko ɗaukar ecchymoses.
Babban haɗarin aikin gawa yana da alaƙa da ma'aikatan da ke kula da gawawwakin waɗanda suka mutu daga COVID-19 a lokacin mutuwar ko waɗanda ake zargi da cutar; suna da haɗari sosai idan aka bincika su don gano cutar da ta kashe su. Wani haɗari a gare su shine idan suna kula da mutanen da ke da COVID-19 ko waɗanda ake zargi da cutar a cikin ɗakinsu, gami da ayyukan aerosol.
A wasu asibitoci da kuma dakunan ajiyar gawa, ana iya yin amfani da na'urar numfashi.
Ya kamata a yi amfani da samfurori bisa ga matakin tsaro na 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar rarraba marasa lafiya zuwa wuraren jira daban-daban dangane da ko sun kamu da cutar COVID-19.Baya ga shawarar samar da kayan aikin numfashi na PPE, OSHA ta ba da shawarar cewa mutane su yi aiki a tazarar ƙafa 6 daga mutanen da aka sani da SARS-CoV-2, waɗanda suka kamu da cutar, ko kuma waɗanda suka kamu da cutar, da kuma yin wasu ayyukan aerosol.
A cikin Amurka, kayan aikin N95 da aka amince da NIOSH ko mafi inganci ya kamata a yi amfani da su a cikin ayyukan rigakafin cututtukan numfashi kamar gwajin daidaitawa, horo, da gwajin likita.
Wasu nau'ikan kayan aikin numfashi suna da kariya da inganci. WHO ba ta ba da shawarar rufe fuska gaba ɗaya, saboda COVID-19 cuta ce ta numfashi kuma ba ta yaduwa ta hanyar ruwa na jiki.
Hukumar Lafiya ta Duniya ta bukaci a ci gaba da amfani da abin rufe fuska na likita don masu kula da lafiya.
Ga mutanen da ke ɗaukar samfurori na cututtukan numfashi daga marasa lafiya, kula da su, ko ɗaukar mutane da ke da cutar COVID-19 ba tare da yin aikin aerosol ba, WHO ta ba da shawarar yin amfani da abin rufe fuska na likita, tabarau na kariya, ko kayan kariya na fuska, riguna, da riguna.
Idan kuna aiki a cikin iska, maimakon abin rufe fuska na likita, yi amfani da kayan aikin numfashi na N95 ko FFP2.
Saboda rashin isasshen kayan aikin PPE, WHO ta ba da shawarar rage yawan amfani da PPE a cikin telemedicine, ƙuntatawa na hulɗa kamar buɗe windows, ba da izinin ma'aikatan lafiya su shiga ɗakin mai cutar COVID-19, amfani da PPE kawai wanda ya dace da takamaiman aikin, ci gaba da amfani da kayan aikin numfashi guda ɗaya ba tare da cire su ba yayin kula da mutane da yawa da ke fama da cutar ba, kiyayewa da amfani da wasu PPE, da kuma ba da shawarar amfani da abin rufe fuska ga marasa alamun cutar.
TASKAR: Katherine Maher, Shugaba na Gidauniyar Wikimedia
NA: Duk ma'aikatan Wikimedia Foundation
MAI SHAFI: [Covid-19] Haske da kuma Shirye-shiryen Nan Gaba
RANAR da aka buga: 14 ga Maris, 2020, 00:24 UTC
Ba a kiyaye haƙƙin mallaka ba
A wannan watan, mun ga abubuwa masu ban mamaki.
Cutar COVID-19 ta nuna mana yadda muke da haɗin kai da kuma alhakin juna.
Ba mu san irin matsalolin da ba za su haifar ba, amma mun san cewa ƙoƙarinmu na magance su yana dogara ne da ƙarfi, haɗin kai, da al'ummomin da ke da muhimmanci a cikin wannan ƙungiyar.
Abokantaka da kuma ƙauna da muka samu daga abokanmu ta hanyar imel, kira, da kuma tattaunawa sun tabbatar mana cewa muna aiki da mutane masu kyau.
Ina godiya sosai ga dukanku kuma ina farin cikin amincewa da ku.
A makon da ya shige, wani ya gaya mini yadda yake jin daɗin aikinmu.
Ya tunatar da ni yadda yake da muhimmanci mutane su shiga Wikipedia yanzu, kuma yana da matukar muhimmanci cewa ayyuka masu amfani su kasance a kan layi kuma kowa ya iya samun su.
Aikinku ne ke sa hakan ya yiwu, ko da kuna saka labarai a dandalin sada zumunta ko kuna biyan abokanmu ko kuma kuna kāre al'ummarmu.
A yanzu, duniya tana buƙatar bayanan da Wikipedia ke bayarwa.
Wannan lokaci ne da abin da zai zama da muhimmanci a duniya ba kawai abin da za mu yi ba ne, amma yadda za mu yi shi.
Saboda muhimmancin wannan aiki da kuma aikinku, za mu canza yadda muke aiki tare, daga wannan makon.
Canje-canjen Aikinmu da Tsarin Lokaci
Kamar yadda Robyn ta ambata, rukunin C sun yi taro a daren jiya don tattauna yadda za mu yi aiki da kuma tsarinmu na kwanaki da watanni masu zuwa.
A cikin waɗannan talifofin, mun tattauna abin da muke ganin zai fi dacewa mu yi don magance matsalolin da muke fuskanta da kuma yadda za mu ci gaba da ƙungiyarmu a wannan zamani.
Muna son mu daina damuwa kuma mu ci gaba da yin wa'azi.
Idan kana so ka kira mu, ba laifi.
Ga masu zartarwa, 'yan kasuwa da ma'aikata:
Aƙalla, za mu yi aiki na sa'o'i huɗu a rana, ko kuma sa'o'i 20 a mako har sai mun canja aikin.
Ba wai ka samu izini ba ne kawai - idan za ka iya yin aiki na tsawon lokaci, za a iya ba ka aiki.
Amma, a wannan lokacin da ba a san abin da zai faru ba, ya kamata lafiyar wanda kake ƙauna ta fi muhimmanci, ko kula da shi, ko zuwa cin abinci, ko kuma zuwa asibiti.
Ba za mu yi amfani da lokacinka ba.
Idan kana rashin lafiya, kada ka zo aiki.
Ya kamata a yi hakan ba tare da faɗin abin da muke so ba, amma za mu yi hakan.
Kada ka bukaci izinin rashin lafiya ko PTO - ka gaya wa shugabanka kuma ka taimaka wa abokan aikinka su san yadda za su tsara yadda za su ci gaba da yin ayyuka masu muhimmanci.
(Idan an gano cutar COVID-19, da fatan za a sanar da Bryan a cikin T&amp;C Ops don T&amp;C su iya tallafawa da kuma ba da taimako don kulawar da ta dace).
Za a biya su kuɗin aiki na tsawon sa'o'i.
Mun cika wannan alkawarin, kuma mun sake jaddada alƙawarinmu na yin aiki da yarjejeniyarmu tare da masu samar da kayayyaki da abokan aiki a kan sa'o'i da aka ƙayyade.
Ana biyan kowa bisa ga yawan sa'o'in da yake yi a lokacin da ake aiki.
Hakan ya dangana ga rashin lafiya ko kuma rashin iya aiki.
Idan kana son ka yi aiki, za mu taimaka maka.
Mutane da yawa suna amfani da aiki a matsayin zarafi na gaya wa mutane damuwarsu.
Abin da muke yi na iya taimakawa sosai, musamman a lokutan kamar wannan.
Za ka kuma yi la'akari da yadda kake kāre kanka.
Za mu nemi ka yi magana da shugabanka, don mu san abin da za mu yi kuma mu yi gyara da ya dace.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da za mu ci gaba da yi.
SRE, HR Ops, Trust &amp; Safety, da kuma Tallafin Kuɗi (ciki har da) suna gudanar da ayyuka masu mahimmanci waɗanda zasu iya buƙatar ƙarin tallafi.
Za mu yi aiki tare da dukan sassanmu don mu fahimci sababbin makasudai kuma mu mai da hankali yanzu ga tallafa wa muhimman sassan aikinmu.
Ko da yake dukanmu muna da aiki da yawa, amma za mu mai da hankali ga ayyuka masu muhimmanci.
Idan muka yi sanyin gwiwa yanzu, ba za mu yi baƙin ciki ba a nan gaba.
Ba mu da niyyar aiki sau biyu don murmurewa idan cutar ta ƙare.
Ba za mu bukaci ku yi aiki na tsawon lokaci ba don kammala aikin a ranar da ba ta da muhimmanci a yanzu.
Za mu amince da canji, kuma mu daidaita abubuwa don mu kafa sababbin makasudai da kuma kwanan wata a inda ya fi muhimmanci.
Menene zai faru da APP (Tsarin Shekara-shekara)?
Don daidaitawa da sabbin abubuwan da suka faru da kuma lokutan aiki na yau da kullun, muna son canza lokacin buga shirinmu na shekara-shekara na 2020-2021.
Manufarmu ita ce mu nemi ƙarin lokaci a cikin tsarinmu na shekara ta 2019-2020 don mu sami damar tsara tsarin kuɗi wanda zai ba ma'aikatanmu damar mai da hankali kan ayyuka masu mahimmanci, kare kansu, da kuma kula da ƙaunatattunmu yayin da muke la'akari da waɗanda suke buƙatar ko son yin ƙarin sa'o'i a cikin makonni masu zuwa.
Ƙaddamar da lokaci zai haifar da ƙarin aiki da matsin lamba a cikin ƙungiyar.
Za mu gabatar da shawarwarinmu ga hukumomi a mako mai zuwa kuma mu sanar da wakilanmu da ƙungiyoyinmu abin da za su yi idan muka sami amsa daga hukumomi.
Muna godiya ga ƙungiyar APP don gudanar da waɗannan ayyukan.
Matsayin Ofishi, Hadarin Cutar, da Tsabta
A makon da ya gabata, an sanar da mu cewa wataƙila wani abokinmu ya kasance cikin haɗuwa da wani mai cutar COVID-19.
Amma, don mu kāre kanmu, mun yi amfani da maganin kashe ƙwayoyin cuta don mu tsabtace ofishin Francisco.
An yi amfani da maganin kashe ƙwayoyin cuta na asibiti don tsabtace dukan wurin, har da filin shiga da kuma lif da ke kai ofishinmu.
Ana amfani da wannan gidan bisa ƙa'idodinsa.
Muna farin ciki cewa za mu koma wurin da yake da kyau.
Ofishinmu na DC yana da WeWork, wanda ke sanar da mu ƙa'idodin rigakafin COVID-19 kuma yana ba da su ga duk ma'aikatan DC.
A makon da ya gabata, an sake fasalin ofishinmu na DC don yin aiki daga nesa bisa ga shawarar da aka bayar daga San Francisco.
Kamar yadda wasu abokanmu a birnin New York suka sani, mun tattauna batun neman gida a Brooklyn.
Za a tattauna wasu talifofi a gaba.
Wasu daga cikin abokanmu suna hidima a wani wuri mai nisa a karon farko.
Abokanmu da suke hidima a nesa sun san cewa hakan zai iya kawo canji, kuma muna so mu ba ku wasu shawarwari:
Ka sa taron ya ɗauki awa ɗaya ko biyu.
Idan hakan zai ɗauki lokaci, ka yi ƙoƙari ka yi hakan a hankali.
Ku fahimci manufar taron da kuma abin da za a tattauna, kuma ku aika da abin da za ku rubuta a gaba.
Bayyana bidiyon da za a yi amfani da shi, ta hanyar kayan aiki kamar Google Doc da Zoom don inganta tattaunawar kai tsaye da haɗin kai.
Ka kasance da mai gudanarwa don gudanar da kowane taro, wanda zai amsa tambayoyin da aka yi da kuma jerin masu magana, da kuma wanda zai taimaka wajen yin rubutu (ko kuma taimaka wa juna).
Aika da imel zuwa ga masu goyon bayan IT idan kuna buƙatar belun kunne masu kyau.
Ku kashe kuɗin lafiyarku a kan abinci.
Shiga cikin Slack ta hanyar #remoties don tattaunawa da abokanka game da aiki
HR Team za ta ci gaba da gudanar da taron kan layi don jagorantar da za ta taimaka wajen kula da ayyukan da ke gudana a kan Gidauniyar.
A makon da ya gabata, mun sanar da cewa za a dakatar da duk wani taron da aka tallafawa ta hanyar Wikipedia, kamar su editan edita, har sai WHO ta bayyana cewa annobar ta ƙare.
Za mu bayyana cewa mun fahimci cewa bukatar a soke wannan taron da kuma wasu ƙuntatawa na iya sa yin yarjejeniyar ta kasance da wuya kuma ba za mu ɗauki alhakin wani ba idan muka jinkirta kwanan wata ko kuma muka canja wannan shirin.
A cikin makonni masu zuwa, za mu ƙara wasu dokoki a Wikimania da sauran taron yanki da kuma taron kafofin watsa labarai.
Abokanmu na duniya suna baƙin ciki da dakatar da waɗannan ayyukan amma sun sami kwanciyar hankali game da ma'anoni da damar da za su iya ba da hankali ga ƙungiyoyin su, Wikimedia, da sauran abubuwan da suka shafi.
Don cimma wannan, CRT tana shirin ƙirƙirar shafukan Meta-Wiki don ba wa ƙungiyoyi wuri don lura da tasirinmu da tattaunawarmu da juna.
Ci gaba da samun bayanai game da COVID-19
Za mu aika da gayyata zuwa kalandarmu a ranar Alhamis, 14:00 UTC/07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don mu gaya muku sababbin abubuwa, mu amsa tambayoyinku kuma mu tattauna da juna.
Muna tare da ku a wannan batun kuma muna taimaka muku yadda za mu iya.
Yayin da kuke jira, za ku iya ci gaba da samun saƙonnin imel da ke cikin wannan adireshin, da kuma ƙarin bayanai masu mahimmanci game da COVID-19, a cikin Office Wiki.
CRT za ta ci gaba da ɗaukaka waɗannan shafuka da kuma haɗa su.
Za mu kuma yi iya ƙoƙarinmu don mu ci gaba da tuntuɓar 'yan'uwanmu da ke ƙasashen da cutar ta fi tsanani.
Idan kuna da tambayoyi game da tafiya, taro, aiki, ko yadda za ku magance matsaloli, ko duk wani abu da kuke buƙatar taimako, kada ku yi jinkirin sanar da CRT kuma ku sami nasara.
Muna shirye mu ba da taimako da taimako idan ana bukata.
Idan kana da wata matsala ta sirri ko ta musamman, ka tuntuɓi Bryan Judan - Daraktan Ayyukan Ƙasa na HR.
Babu wanda ya kamata ya ga wannan canji kamar barin aikinmu da kuma aikinmu.
Amma, ya san cewa a wannan zamani, aikinmu da kuma hakkokinmu za su canja a hanyoyi da ba su taɓa canjawa ba.
Waɗannan matakai ne da muke ganin suna da muhimmanci don tallafa wa juna don ci gaba da aiki, ba wa ƙungiyarmu tallafin da take buƙata, da kuma ba duniya sabis na amincewa.
Aikin da muke shirin yi zai jira har sai lokacin da ya yi.
Yanzu lokaci ne da za mu taimaki juna kuma mu shirya wuri don aiki mai muhimmanci da za a yi a makonni da wata-wata masu zuwa.
Muna son ku duka ku tabbata cewa hakan zai faru, saboda haka muna roƙonku ku kāre kanku da iyalanku don ku kasance da ƙarfi a lokacin bala'i.
Yanzu, don Allah - ku wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da kuma dukan ƙungiyar gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
Angiotensin converting enzyme 2 (ACE2) wani enzyme ne wanda yake cikin ƙwayoyin cuta na ƙwayoyin cuta, jijiyoyi, zuciya, koda da hanji.
ACE2 yana hana aikin enzyme mai canza angiotensin (ACE) ta hanyar rage yawan angiotensin-II da haɓaka ang ((1-7) yana mai da shi magani mai ƙarfi don magance cututtukan zuciya. ACE2 kuma yana taimakawa wajen shiga cikin coronavirus.
An samo enzyme a jikin mutum da ake kira hACE2.
Angiotensin mai canzawa enzyme 2 shine enzyme wanda aka samo a cikin zinc a cikin endothelial da sauran ƙwayoyin halitta.
Protein ACE2 yana da N-terminal peptidase M2 da kuma C-terminal mai karɓar amino acid.
ACE2 ya zama nau'in membrane na furotin guda ɗaya, tare da aikinsa na enzyme a waje da ƙwayoyin halitta da sauran kwayoyin halitta.
Ƙungiyar ACE2 ta fito daga cikin ƙwayoyin cuta da kuma wani enzyme da ake kira sheddase, sannan furotin ya shiga cikin jini kuma ya fita daga cikin fitsari.
ACE2 yana cikin kwayoyin halitta da yawa: ACE2 yana haɗuwa da membrane na ƙwayoyin cuta na huhu na nau'in II na ƙwayoyin alveolarenterocytes na ƙananan hanji, jijiyoyi da jijiyoyin jini da ƙwayoyin jijiyoyin jiki masu sauƙi.
Ana kuma samun ACE2 mRNA a cikin ƙwayar ƙwayar cuta, striatum, hypothalamus, da kuma ƙwaƙwalwar ƙwaƙwalwa.
Aikin farko na aCE2 shine aikin ACE.
ACE yana haɗuwa da hormone na angiotensin I zuwa angiotensin II vasoconstriction.
ACE2 yana ɗaurewa zuwa amino acid phenylalanine na carboxyl-terminal a cikin angiotensin II (Asp-Arg-Tyr-Ile-His-Pro-pPhe) kuma yana haɓaka shi cikin angiotensin (1-7), mai saurin jijiyoyin jini (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana iya ɗaure kansa ga peptides da yawa kamar su [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana daidaita ƙuntatawa na membrane na amino acid mai tsaka tsaki wanda ke ɗaukar SLC6A19 kuma yana da cutar Hartnup.
A cikin ƙwayoyin cuta na transmembrane, ACE2 shine farkon hanyar shiga cikin kwayoyin cutar coronavirus, da HCoV-NL63; SARS-CoV (kwayar cutar SARS); da SARS-CoV-2 (kwayar cutar COVID-19).
A cikin mafi kyawun yanayin, haɗuwa da ƙwayar furotin S1 na SARS-CoV da SARS-CoV2 zuwa enzyme ACE2 a saman sel zai haifar da endocytosis da sarrafa kwayar enzyme tare da ɗayan endosomes a cikin sel.
Wannan hanyar shiga tana buƙatar inganta furotin S tare da protease na serine TMPRSS2, wanda ke cikin binciken magani mai tasiri. Wannan ya sa wasu mutane suka rage ACE2, a cikin ƙwayoyin halitta, don ƙoƙarin magance kamuwa da cuta.
Koyaya, ƙananan ƙungiyoyin ilimi da shari'a sun ba da shawarar ci gaba da ACE da ake buƙata da kuma maganin ARB.
Wani bita na tsarin da nazarin meta da aka buga a ranar 11 ga Yuli, 2012 ya gano cewa Maganin ACE yana rage haɗarin cutar huhu da kashi 34%.
Amma, haɗarin ciwon huhu ya ragu a cikin mutanen da aka kula da ACE waɗanda ke da haɗarin kamuwa da ciwon huhu, kamar waɗanda ke da ciwon zuciya.
Hakanan maganin ACE yana da alaƙa da rage yawan mutuwar ciwon huhu, amma sakamakon bai yi tasiri sosai ba a cikin haɗarin ciwon huhu.
Abubuwan da ke tattare da mutum ACE2 (rhACE2) sabon magani ne don ciwon huhu, kuma an yi amfani da shi don magance cutar haemodynacy na huhu da kuma oxygenation a cikin aladu tare da lypopolysaccharemia a cikin ciwon huhu.
Rashin rayuwa na rhACE2 a cikin mutane shine awanni 10 kuma yana aiki a cikin minti 30 da rabi a cikin awanni 24.
Yawancin nazarin sun nuna cewa rhACE2 na iya zama magani mai tasiri ga masu hanawa na RAS (Renin-angiotensin inhibitors) ko kuma masu cutar angiotensin mai tsanani. rhACE2 ana nazarin asibiti don magance cututtukan numfashi.
Aikace-aikacen BCOVID-19 aikace-aikacen wayar hannu ne da aka tsara don bin diddigin mutanen da ke da yiwuwar kamuwa da cutar coronavirus ta 2019-20. Misali, gano (mutanen) waɗanda ke da yiwuwar kasancewa tare da mutumin da ke da cutar.
An yi aikace-aikace da yawa, kuma tare da taimakon gwamnati a wasu wurare.
An yi amfani da manhajojin wayar hannu wajen yin amfani da hanyoyin sa ido da yawa.
Mutane ba su da masaniya game da yadda ake lura da asirin mutane, kamar tsarin bin sawun mutane.
Wani abu da ya fi sa mutane damuwa shi ne siginar Bluetooth da ke nuna cewa mutum yana kusa da wasu wayoyin.
A ranar 10 ga Afrilu 2020, Google da Apple sun sanar da cewa za su haɗa tsarin tallafi na Bluetooth a cikin Android da iOS.
A China, gwamnatin kasar Sin, tare da haɗin gwiwar Alipay, sun kirkiro wata manhaja da ke taimaka wa mazauna yankin su gano idan sun kasance kusa da wani mai cutar COVID-19.
Ana yin hakan a birane 200 a China, a Singapore, ana yin aikace-aikacen da ake kira TraceTogether.
Masana IT na gari sun kirkiro wannan aikace-aikacen, sun samar da shi don amfanin kowa kuma za su samar da shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da StopKorona!, aikace-aikacen Bluetooth wanda ke gano idan wani ya kamu da cutar a kusa da mai cutar kuma yana tallafawa yakin lafiyar gwamnati.
An samar da manhajar ne ta Ma'aikatar Sadarwa da Fasaha ta Ma'aikatar Lafiya.
A ranar 14 ga Afrilu 2020, aikace-aikacen yana jiran amincewa daga Google Play da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta sanar da cewa an kammala aikin bin sawun jama'a, kuma za a iya amfani da shi a cikin makonni masu zuwa. Ana aiwatar da irin wannan aikace-aikacen a Ireland, da Faransa (StopCovid).
Australia da New Zealand suna son amfani da aikace-aikacen da ke cikin yarjejeniyar TraceTogether da BlueTrace ta Singapore. Rasha tana haɓaka aikace-aikacen da ke gano mutanen da ke da COVID-19 da ke zaune a Moscow, wanda za a tsara don bin diddigin su don hana su fita daga gida.
Ross Anderson, Farfesa a fannin Tsaro a Jami'ar Cambridge, ya bayyana wasu abubuwa da yawa da za a iya yi da waɗannan tsarin aikace-aikacen, ciki har da ƙarancin sakamako mai kyau, da kuma ƙalubalen ingantaccen aiki saboda aikace-aikacen kawai zai iya amfani da ƙananan mutane.
Dangane da damuwa game da tasirin tasirin cutar coronavirus, Apple ya iyakance adadin ƙungiyoyi da za su iya shigar da aikace-aikacen a cikin App Store, yana iyakance su ga ma'aikatan gwamnati ko wasu manyan ƙungiyoyi.
Google da Amazon sun kafa irin wannan doka.
Mutane da yawa da ke neman magance matsalar ɓoye sirri na sirri suna mamakin ko akwai hanyoyin da za a bi don yin hakan da kyau kuma ko za a iya lalata su bayan cutar coronavirus.
Ƙungiyoyin Amnesty International da kuma wasu ƙungiyoyi 100 sun yi kira ga mutane su kafa dokoki game da yiwuwar sa ido.
Ƙungiyoyi sun tsara shawarwari bakwai da gwamnati za ta iya bi:
Za a yi tsaro ta hanyar sadaukarwa da kuma yadda ya kamata.
Lalle ne akwai wani lõkaci da ake ƙãre farillai.
Za a yi ƙididdigar ne kawai saboda COVID-19;
Dole ne su yi amfani da bayanan mutane da sunayensu kuma kada su nuna cewa suna yin haka;
Kulawa ta hanyar kwamfuta ba za ta kasance cikin ƙiyayya ba;
Rarraba yawan jama'a a waje da aikin da ya kamata a tsara ta hanyar rubutaccen doka;
Dole ne a sami hanyar kare jama'a da taimako idan wani ya sha wahala saboda wannan ma'aikacin;
Dukan mutane su shiga cikin aikin don dukan mutane ana buƙatar su, gami da ma'aikatan kiwon lafiya da waɗanda ba su da masu kula da su.Kungiyar Kwamfuta ta Baƙin Ciki ta Jamus (CCC) da kuma Masu Ba da Labarai Ba tare da Iyaka (Reporter ohne Grenzen) (RSF) suma sun ba da shawarwari.
Shirye-shiryen Google da Apple sun nuna cewa za a cire tsarin idan ba a buƙatarsa.
Wasu ƙasashe sun ba da damar bin sawun mutane ta hanyar yanar gizo maimakon aikace-aikace, wanda ke ba da damar amfani da aikace-aikacen kuma yana ba da damar kauce wa saka idanu.
A Isra'ila, an yarda da bin hanyar sadarwa.
Idanunmu suna iya kasancewa a kan wani abu da ba shi da muhimmanci.
Duk da haka, ba duk tsarin da ake buƙatar gano wurin mutum ba; yawancin tsarin kula da tsaro na al'umma suna da alaƙa da sadarwa (duba sashe na ƙasa).
A Koriya ta Kudu, an yi amfani da aikace-aikacen da ba a buƙatar aikace-aikacen mutum.
A cikin aikace-aikacen, an samo bayanai daga wurare da yawa kamar wayar hannu, katunan kuɗi, da kuma amfani da su don sanar da mutane ta hanyar saƙon rubutu game da yiwuwar kamuwa da cuta.
Kuma an sanar da su cewa sun wuce wannan hanyar, kuma gwamnati ta tabbatar da cewa an sanar da yankin, wanda ya dace da doka saboda cutar MERS ta shiga cikin ƙasar.
Bayanai da kowa zai iya samu a cikin aikace-aikace da shafukan yanar gizo da yawa. Ƙasashe kamar Jamus suna son yin amfani da tsarin kula da tsaro na cikin gida.
Har zuwa 6 ga Afrilu 2020, ba a sake buga shi ba.
Kulawa sananne ne, tare da nazarin da yawa tun daga 2013.Kamar yadda 7 ga Afrilu 2020, fiye da ɗalibai dozin suna haɓaka tsarin kula da kulawa na zamantakewa, kamar Bluetooth Low Energy (BLE) don faɗakar da wayar hannu idan tana kusa.
Duk da haka, PEPP-PT yana da ƙarfin aiki na ciki da na waje, kuma babu wata ƙa'ida ta amfani da shi. Ka'idojin waje sun dace da Decentralized Privacy-Preserving Proximity Tracing (DP-PPT/DP-3T), Temporary Contact (TCN. fka Contact Event Numbers, CEN) Privacy Sensible Protocols da kuma Tsarin Kula da Wayar Hannu.
A cikin waɗannan hanyoyin, ba za a ɓoye bayanan sirri ba, kuma za a yi amfani da wayar tarho kawai.
Ƙungiyar Masu zaman kansu da MIT Media Lab suna haɓaka SafePaths, hanyar da za a iya amfani da ita don kiyaye bayanan sirri yayin samun bayanai da kuma taimakawa wajen kula da wuraren taruwa don kiyaye yaduwar COVID-19.
An samo asali ne daga binciken takardar farin Apps Gone Rogue: Kare Bayanai a cikin Cutar  An fitar da shi a watan Maris 2020. Wani aikin SafeTrade na Enigma MPZ, wani kamfani ne wanda ke haɓaka fasahar kare bayanai wanda ya fara aiki a MIT Media Lab.
SafeTrade yana ba da damar fasahar sarrafa bayanai ta atomatik don mutane su zaɓi ko za su ba da bayanan su na asali da na kiwon lafiya ga wasu mutane da hukumomin gwamnati, ba tare da keta dokokin adana bayanai ba.
A ranar 5 ga Afrilu, 2020, an ƙaddamar da Ƙungiyar TCN ta Duniya tare da ƙungiyar masu ba da shawara don samar da hanyoyin da za a bi don rage wahala, da haɓaka haɗin kai na duniya ta hanyar bin diddigin aikace-aikace da aikace-aikace, wanda ya zama dole don amfani da duniya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta ba da sanarwar cewa akwai wasu ƙa'idodin BlueTrace da ma'aikatan gwamnatin ta ke amfani da su.
A ranar 10 ga Afrilu 2020, Google da Apple, kamfanonin da ke samar da Android da IOS, sun ba da sanarwar cewa an ƙaddamar da wani aiki don tallafawa sa ido na sirri da kuma kiyaye sirrin sirri, wanda za a yi ta hanyar fasahar Bluetooth Low Energy da kuma ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓoyayyen ɓ
An kuma wallafa wata takarda da ta bayyana fasahar da za a yi amfani da ita.
Ga Apple da Google, tsarin zai kasance cikin matakai uku:
Ƙirƙirar kayan aikin da za su yi amfani da su don tallafa wa gwamnati wajen kare bayanan sirri.
Shigarwa zuwa iOS da AndroidGoogle da Apple suna son magance matsalolin sirri ta hanyar shigar da wannan tsarin a cikin tsarin aiki, sannan cire shi a hankali
Gyara magani (wanda ake kira magani) shine inganta magani don magance cuta ko yanayin da aka yi amfani da shi.
Wannan kalma ce ta binciken kimiyya da ake ci gaba da yi don samar da ingantaccen magani don COVID-19.
Wasu nazarin sun bi hanyar binciken allurar rigakafi don COVID-19 da kuma ƙarin jini. SARS-CoV-2 yana da magunguna 66, dukansu suna da ligand mai tasiri.
Gano wuraren da aka yi amfani da su ya ba da damar yin aiki don tabbatar da ingancin maganin COVID-19.
A cikin SARS-CoV-2, sunadarai masu mahimmanci sune protease papain, RNA polymerase, helicase, S protein, da ADP ribophosphatase.
A cikin binciken da aka gudanar a cikin watan Agusta, an gano cewa cutar SARS-CoV-2 ta kamu da cutar a cikin mutane da yawa.
Chloroquine magani ne na asali wanda aka yi amfani da shi don magance cututtukan tsarin garkuwar jiki.
A ranar 18 ga Maris, WHO ta sanar da cewa Chloroquine da Hydroxychloroquine za su kasance cikin magunguna huɗu a cikin Ƙungiyar Gwajin Magunguna.
Gwamnan New York Andrew Cumo ya ce gwajin gwaji na birnin New York na chloroquine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da hydroxychloroquine sulfate da chloroquine phosphate a cikin Hadarin Amincewa don Kulawa (EUA).
FDA ba ta amince da gwajin magani ba amma an amince da shi a Amurka a matsayin gwaji don marasa lafiya masu haɗari waɗanda ke asibiti amma ba za su iya samun magani ba.
CDC ta ce amfani, sashi, da tsawon lokacin amfani da hydroxychloroquine don maganin SARS-CoV-2 ba a sani ba.
Likitoci sun ce suna amfani da wannan magani ne kawai idan babu wata hanyar magani.
Nazarin turkey da ake gudanarwa a Istanbul yana nazarin tasirin chloroquine a cikin cakuda zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan bincike a Jami'ar Duke da Jami'ar Oxford.
Cibiyar Nazarin Magunguna ta NYU Langone tana ƙoƙarin gano inganci da ingancin hydroxychloroquine.
A China, gwajin maganin a Wuhan da Shenzhen sun nuna favipavir yana da "ƙarfi sosai".
An gano marasa lafiya 35 a Shenzhen marasa lafiya a cikin kwanaki 4, amma tsawon lokacin cutar ya kai kwanaki 11 a cikin marasa lafiya 45 da ba a warke ba.
A cikin binciken da aka yi a Wuhan, an yi amfani da kashi 240 na marasa lafiya da ke fama da cutar huhu, rabin su sun karɓi favipiravir da sauran umifenovir.
Hukumar Kula da Magunguna ta Italiya ta ba da shawarar a fara gano sakamakon maganin.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan, ta hanyar amfani da ruwa don jigilar magungunan zuwa asibitocin jami'a, inda za a samar da maganin don kula da marasa lafiya na COVID-19.
A cewar rahoton jaridar South China Morning Post, Shinzo Abe ya gargadi ofishin Trump da ya sayi maganin. Wannan maganin yana iya zama mai rauni a cikin marasa lafiya masu tsanani kuma yana da ƙwayoyin cuta da yawa.
Ba zai dace da mata masu ciki ko waɗanda suke ƙoƙarin yin ciki ba.
Wani samfurin lopinavir/ritonavir (Kaletra), haɗin lopinavir da ritonavir ya haifar da Ba mai tsanani ba.
An tsara maganin don hana kwayar cutar HIV daga yaduwa cikin jiki.
Wani rukunin masu bincike a Jami'ar Colorado suna haɓaka maganin don samar da maganin SARS-CoV-2 mai tasiri. Wasu ba su da farin ciki saboda ana amfani da kayan aikin don maganin HIV / AIDS.
Hukumar Lafiya ta Duniya ta haɗa lopinavir/ritonavir a cikin gwajin gwaji na duniya.
Kamfanin Gilead Sciences ne ya kirkiro maganin Remdesivir don maganin cutar Ebola da cutar Marburg. Gilead Sciences ta gano cewa remdesivir yana da tasiri a cikin vitro don magance yawancin cututtukan filato, pneumonia, paramyzoid, da coronaviruses.
Wani fasalin maganin shine ƙarfinsa na sarrafawa idan kwayar cutar ta zama mai saurin kamuwa da cuta da kuma yaduwa tsakanin mutane.
Wani binciken farko ya nuna cewa Remdesivir na iya zama mai tasiri sosai. Ana gudanar da gwaje-gwaje da yawa, kamar biyu da Jami'ar Cleveland ke gudanarwa; ɗaya don marasa lafiya masu sauƙi da ɗaya don masu rauni.
Ana gudanar da gwaje-gwaje uku na maganin cutar don gano bitamin C a cikin marasa lafiya masu fama da cutar COVID-19; biyu a cikin placebo (China, Kanada) da ɗaya a cikin marasa lafiya (Italiya).
New York ta fara gwajin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Japan (NCGM) tana shirye-shiryen gwajin maganin Teijin mai suna Alvesco (ciclesonide), maganin numfashi don asma don kula da marasa lafiya da sabon coronavirus.
Wani gwaji na kashi na biyu na wani nau'in enzyme mai suna angiotensin 2 wanda aka fara a cikin marasa lafiya 200 masu fama da cutar a asibitoci a Denmark, Jamus da Austria don tantance tasirin maganin.
Nazarin da aka yi a Cibiyar Nazarin Kanada ta Montreal wanda ya gano cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Cutar, da aka sani da COLCORONA, ta ƙunshi mutane 6,000 da suka haura shekaru 40 da suka kamu da COVID-19 kuma suna da alamun rashin lafiya da ba sa buƙatar asibiti.
Mata masu ciki ko masu shayarwa ko kuma waɗanda ba su da maganin hana ɗaukar ciki da ya dace ba za su iya shiga ba.
Ana gwada magungunan hana jini da yawa a Italiya.
Ana samar da ƙananan kwayoyin halitta don maganin marasa lafiya, wanda ya sa Hukumar Kula da Magunguna ta Italiya ta ba da shawarar yin amfani da su.
An fara nazarin marasa lafiya 300 da ke da alaƙa da maganin rigakafi da maganin enoxaparin sodium a Italiya a ranar 14 ga Afrilu.
A cikin yanayin SARS-CoV-2 da ke cikin kwayar cuta, ana iya gano su don sake fasalin su, sun kasance magungunan da aka yi amfani da su a lokacin annobar MERS, SARS da West Nile.
Ribavirin: ribavirin ya fi dacewa da COVID-19 bayan shawarar 7 ta kasar Sin
Umefenovir: Umifenovir ya fi dacewa da COVID-19 bayan shawarar 7 na kasar Sin
Wasu magunguna da aka tabbatar sun fi dacewa don magance COVID-19:
Tocilizumab (Anti-IL-6 receptor): An amince da shi a ƙasar Sin.
Kuma gwaji a Italiya da China. Ka kuma duba Tocilizumab#COVID-19.
Allurar rigakafin bCOVID-19 ba ta da inganci don cutar 2019 (COVID-19).
Babu wani allurar rigakafi da ta wuce gwajin gwaji, kuma ana ci gaba da aiki don samar da allurar rigakafi da za ta wuce.
A ƙarshen Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba a tsammanin allurar rigakafin SARS-CoV-2, cutar da ke haifar da cutar, za ta kasance a cikin makonni 18 ba.
An yi allurar rigakafi biyar a cikin kashi na farko na aikin a watan Afrilu.
An gano COVID-19 a watan Disamba na 2019.
Cutar ta yadu sosai a duniya a cikin 2020, ta ɗauki kuɗi da albarkatu masu yawa don samar da allurar rigakafi.
Yawancin kungiyoyi suna tallafawa kwayoyin halittar da aka samar don binciken allurar rigakafin SARS-CoV-2.
A watan Afrilu, sun ce ƙarfin CEPI na binciken allurar rigakafi shine saurin sa, ƙarfin samarwa mai yawa, gudanar da shi a wurare da yawa, da kuma samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa ana nazarin fasahohi 10 a farkon 2020 don samar da allurar rigakafi mai ƙarfi da za ta iya magance COVID-19.
Yawancin wurare sun shiga cikin gwajin gwaji na kashi na 1:
Kwayar nucleic (DNA da RNA) (Safari na I da gyaran maganin rigakafi: Moderna, mRNA-1273)
masu ɗaukar hoto (Shirin bincike na Phase I da Candida: CanSino Biology, adenovirus mai ɗaukar hoto 5)
A cewar masana kimiyya na CEPI a watan Afrilu, an riga an samar da alluran rigakafi 115 a cikin 78 da aka amince da su a matsayin shirye-shirye (79, in ji Cibiyar Milken), da kuma wasu 37 da ba a san su sosai ba (a shirye-shirye ko a kan aiki).
A cikin gwajin gwaji na I-II, ana gwada ingancin magani da gwajin rigakafi, tare da mutane da aka zaɓa, placebo mai kulawa, da wurare da yawa, da kuma ƙayyade yawan kashi.
Gwajin gwaji na Mataki na III ya ƙunshi mutane da yawa da ƙungiyoyi masu lura, da kuma gwaji don tabbatar da tasirin maganin a cikin cututtukan, duk suna lura da tasirin allurai.
Daga cikin alluran rigakafi 79 da ke cikin aiki tun farkon Afrilu 2020, 74 ba su kai ga ɗan adam ba (suna cikin gwajin gwaji na clinic).
A Ostiraliya a ranar 24 ga Janairun 2020, Jami'ar Queensland ta ba da sanarwar cewa tana nazarin ko kwayar cutar rigakafin za ta iya aiki tare da furotin na kwayar cutar don haifar da amsawar rigakafi.
A ranar 24 ga Janairun 2020 a Kanada, Cibiyar Alurar riga kafi ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta ba da sanarwar cewa ta fara aikin samar da allurar rigakafi, tare da yiwuwar fara gwajin mutum a 2021.
Cibiyar Kula da Cututtuka ta kasar Sin ta fara gwajin rigakafin a ranar 26 ga Janairu, 2020, kuma Jami'ar Hong Kong ta fara a ranar 28 ga Janairu.
A ranar 29 ga Janairun 2020, Kamfanin Janssen Pharmaceutical, wanda Hanneke Schuitemaker ya jagoranci, ya sanar da cewa ya fara aikin samar da allurar rigakafi.
Janssen yana samar da allurar rigakafi ta ciki tare da abokin aikinsa na fasahar halittu, vaxart.
A ranar 18 ga Maris, 2020, kamfanin samar da magunguna na Emergent BioSolutions ya sanar da cewa shi da abokin aikinsa Vaxart suna neman allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, OncoGen Laboratory a Romania ya rubuta rubutun rigakafi tare da fasahar da ke cikin ci gaba don allurar rigakafi da maganin cutar kansa.
A ranar 25 ga Maris, shugaban cibiyar binciken ya sanar da cewa an kammala aikin hadawa kuma an fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani kamfani na Generex, NuGenerex Immuni-Ongology, ya ba da sanarwar cewa suna fara aikin samar da allurar rigakafi don samar da babban peptide na allurar rigakafin COVID-19.
Sun so su samar da allurar rigakafin cutar Candida da za a iya gwadawa a cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da cewa ta fara aikin samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Kula da Lafiya ta Amurka da Kwamitin Kayan Aiki a Fort Detrick da Cibiyar Kula da Lafiya ta Walter Reed, duka a gabashin Maryland, sun ba da sanarwar cewa suna yin allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta shiga cikin kamfanin Novavax Inc.
A cikin bincike da kuma samar da allurar rigakafi.
Sun kuma ce za su fara gwajin asibiti da gwajin gwaji na farko a watan Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta ce suna aiki a kan kashi 11 na gaba, kuma ko da sun ci gaba da sauri, zai ɗauki tsawon shekaru 1.5 zuwa 2 don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar halittu a Quebec City, Quebec ya ba da sanarwar cewa yana haɓaka kwayar cutar coronavirus tare da tallafin kuɗi daga Cibiyar Nazarin Kiwon Lafiya ta Kanada.
An ƙaddamar da gwajin gwajin mutum a cikin watan Yuli ko Agusta 2020.
A farkon wannan makon, Jaridar Guardian ta ruwaito cewa Shugaban Amurka Donald Trump ya ba da gudummawar kuɗi mai yawa ga CureVac don samun allurar rigakafin COVID-19  gwamnatin Jamus ta hana shi.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya ba da sanarwar cewa yana haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
BNT162 Candida, allurar rigakafin mRNA, tana cikin gwajin asibiti wanda za a fara a watan Afrilu 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfanin fasahar halittu na Italiya ya ce za su sami sakamakon gwajin asibiti na farko a watan Afrilu na 2020 kuma za a iya gwada allurar rigakafin ta ƙarshe a kan ɗan adam a lokacin bazara.
A Faransa a ranar 19 ga Maris, 2020, Coalition for Epidemic Preparedness and Innovation (CEPI) ta ba da rahoton cewa ta ba da dala miliyan 4.9 don nazarin ƙungiyar rigakafin COVID-19 a Insitu Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimlar kuɗin CEPI don COVID-19 zuwa dala miliyan 29.
Sauran membobin ƙungiyar CEPI don allurar COVID-19 sun haɗa da Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, hukumomin kiwon lafiya na Rasha sun ba da sanarwar cewa masana kimiyya sun fara gwajin alluran rigakafi shida akan dabbobi.
Masana kimiyya na Kwalejin Imperial na London sun ce za su fara samar da allurar rigakafin RNA don COVID-19 a ranar 20 ga Maris, 2020.
An samar da allurar rigakafin cutar Candida a cikin kwanaki 14 bayan shawarar da aka bayar daga China.
A ƙarshen Maris, gwamnatin Kanada ta ba da dala miliyan 275 na C $ don nazarin 96 don yaƙar COVID-19, da kuma takarar allurar rigakafi da yawa a kamfanonin Kanada da jami'o'i, kamar Medicago da aikin a Jami'ar Saskatchewan.
A lokaci guda, gwamnatin Kanada ta ba da sanarwar kashe dala miliyan 192 na C$192 musamman don samar da allurar rigakafin COVID-19, tare da niyyar samar da "Bankin allurar rigakafin" na ƙasa don samar da sabbin alluran rigakafi da yawa don sake fashewar cutar coronavirus.
A ranar 2 ga Afrilu 2020, masu bincike a Makarantar Kiwon Lafiya ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, mai yuwuwar allurar COVID-19 a cikin beraye, suna cewa "MNA ya haifar da SARS-CoV-2 S1 subunit na allurar rigakafi wanda ya nuna cewa ƙwayoyin rigakafi na musamman na antigen-specific na ƙarfin jiki a cikin martani [a cikin beraye] sun kasance masu inganci makonni 2 bayan allurar".
A Kanada a ranar 16 ga Afrilu, 2020, Makarantar Pharmacy na Jami'ar Waterloo ta sanar da shirye-shiryen rigakafin DNA don maganin hanci.
Ta amfani da masu cin kwari, DNA za a iya daidaita shi don yin kwafi a cikin kwayoyin halittar mutum don samar da ƙwayoyin cuta masu ƙarancin ƙwayoyin cuta, wanda zai iya motsa tsarin garkuwar jiki don samar da ƙwayoyin cuta don yaƙar cutar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗa albarkatu don samun damar manyan kwamfutocin IBM, tare da haɗin gwiwar ayyukan girgije na Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da tasirin heterologous, wanda ake kira cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Wannan yana nufin za su iya samun fa'idodi bayan cutar ta ƙare.
Gwajin cutar sankarar bargo a Ostiraliya yana neman daukar ma'aikatan lafiya 4,170.
Zai yiwu cewa alluran rigakafin da aka yi amfani da su ba za su kasance masu aminci da inganci ba.
Binciken farko don kimanta ingancin alluran rigakafi ta amfani da samfurin dabbobi na musamman na COVID-19, kamar ƙwayoyin ACE2-transgenic, wasu dabbobin gwaji, da kuma manyan dabbobi, ya nuna alamar aminci na matakan matakin 3 na keɓewa don sarrafa ƙwayoyin cuta masu rai, da kuma haɗin gwiwar ƙasashen duniya don amfani da matakan aminci na yau da kullun.
An gwada alluran rigakafin SARS da MERS a cikin samfuran ɗan adam.
Har zuwa 2020, babu magani ko allurar rigakafi don kawar da ko hana SARS da kuma samar da lafiya da nasara ga mutane.
Bayan da aka buga takardun shaida a cikin 2005 da 2006, ci gaban sababbin alluran rigakafi da magunguna don magance SARS ya zama babban fifiko ga hukumomin kiwon lafiya na duniya. Babu sauran alluran rigakafi da aka amince da su don MERS.
A lokacin da cutar MERS ta ci gaba da ƙaruwa, an yi imanin cewa binciken SARS da aka yi a baya zai iya samar da samfurin da ya dace don ci gaban alluran rigakafi don maganin cutar MERS-CoV.
Har zuwa Maris2020, an kammala gwajin gwaji na mutum na farko na allurar rigakafin MERS (wanda aka yi amfani da DNA), kuma wasu uku suna kan hanya, dukansu alluran rigakafin kwayar cutar, biyu adenoviral-vector (ChAdOx1-MERS, BVRS-GamVac), da ɗaya MVA-vector (MVA-MERS-S).
An wallafa wasu hotunan a shafukan sada zumunta da ke nuna cewa an gano cutar da ke haifar da COVID-19 kuma an samar da allurar rigakafi.
Takaddun shaida na kafofin watsa labarun na wannan nau'in suna nuni ne ga takaddun shaida na baya don jerin kwayoyin halitta da alluran rigakafi don wasu nau'ikan coronavirus kamar SARS coronavirus.
Cutar kwayar cutar Coronavirus ta 2019 (COVID-19) cuta ce ta kamuwa da cuta ta cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Alamomin da ake yawan samu sun hada da zazzabi, tari, da kuma numfashi.
Sauran alamun cututtuka na iya haɗawa da gajiya, ciwon tsoka, fitsari, ciwon murya, ƙonewa, ciwon ciki.
Farkon lokacin bayyanar cututtuka shine kwanaki biyar amma zai iya ƙaruwa daga kwana biyu zuwa goma sha huɗu.
Yawancin lokuta suna da alamun rashin lafiya, amma wasu suna haifar da ciwon daji da kuma lalacewar gabobin jiki.
Zuwa 17 ga Afrilu 2020, an bayar da rahoton sama da mutane miliyan 2.24 a cikin ƙasashe da yankuna 210, wanda ya kai ga mutuwar mutane sama da 153,000.
Fiye da mutane 568,000 sun kamu da cutar. Ana yada kwayar cutar ne ta hanyar mutane da ke fama da cutar, galibi ta hanyar ƙananan fitsari da ke fitowa daga tari, fitsari ko magana.
Ƙwayoyin wannan ruwa suna fitowa daga cikin iska, amma yawanci suna sauka ne a ƙasa ko kuma a inda akwai kamuwa da cuta ta ƙura.
Mutane za su iya kamuwa da cutar ta hanyar taɓa gurɓataccen abu sannan su taɓa idanunsu, hanci, ko bakinsu.
Kwayar cutar na iya rayuwa a cikin sararin samaniya har zuwa awanni 72.
Yana da matukar damuwa a cikin kwanaki uku na farko na bayyanar cututtuka, amma ana iya samun yaduwa kafin bayyanar cututtuka da kuma bayan kamuwa da cuta. Hanyoyin bincike na yau da kullun sune hanyar sake dawo da sarkar lokaci na polymerase reverse transcriptase (rRT-PCR) a cikin hanci.
Ana amfani da abin rufe fuska don mutanen da ake zargi da cutar da kuma masu kula da su.
Dokar amfani da abin rufe fuska a cikin jama'a ta bambanta, saboda wasu hukumomi sun hana amfani da shi, wasu sun ba da umarnin, wasu kuma sun ce ya kamata a yi amfani da shi.
A halin yanzu, babu allurar rigakafi ko magani don COVID-19.
An riga an rubuta yankin cutar a cikin ƙasashe da yawa a cikin dukan cibiyoyin WHO.
Mutane da ke fama da cutar za su iya zama marasa alamun cutar ko kuma su sami alamun cutar kamar mura, kamar zazzabi, tari, rashin ƙarfi, numfashi.
Alamun rashin jin daɗi sun haɗa da numfashi mai raɗaɗi, ciwon kirji ko matsin lamba, rashin hankali, jin zafi, da launin shuɗi a fuska ko baki; ana buƙatar kulawar likita da sauri idan akwai irin waɗannan alamun.
A wasu lokuta, alamun numfashi na sama kamar su ciwon ciki, hanci mai zafi ko ciwon makogwaro na iya faruwa.
Alamomin cututtukan hanji kamar tashin zuciya, amai da gudawa sun bayyana a cikin kashi daban-daban.
Wasu daga cikin cututtukan a China sun fara nuna ciwon kirji da kuma ciwon zuciya.
A wasu mutane, rashin lafiya na iya zama ciwon zuciya, lalacewar gabobin jiki, har ma da mutuwa.
Wannan shine ake kira lokacin incubation.
Lokacin ɗaukar hoto don COVID-19 yawanci kwanaki biyar zuwa shida ne amma yana tsakanin kwanaki biyu zuwa 14.
Kashi 97.5% na mutanen da ke kamuwa da cutar suna nuna alamun cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duk mutanen da ke kamuwa da cutar ba ne ke nuna alamun cutar.
Dalilin da ya sa masu dauke da cutar ba su da alamun cutar ba a san su ba tukuna; amma alamun farko sun nuna cewa suna da alaƙa da cutar.
Ba a san adadin mutanen da ke fama da cutar ba a halin yanzu kuma ana ci gaba da nazarin su, cibiyar Kula da Cututtuka da Cututtuka ta Koriya ta Kudu (KCDC) ta ba da rahoton cewa kashi 20% na duk masu cutar da aka tabbatar ba su da alamun cutar a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara rarraba masu cutar da ba su da alamun cutar zuwa masu cutar da ke da alamun cutar a ranar 1 ga Afrilu; daga cikin jimillar masu cutar 166 a ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Ƙarƙashin ƙura na iya ɗaukar nauyin kwayar cutar.
Magana mai ƙarfi ta fi yawan murya a cikin magana ta al'ada.
Wani bincike da aka yi a Singapore ya nuna cewa tari ba tare da murfi ba zai iya ɗaukar ruwa zuwa mita 4.5 (ƙafa 15).
Kodayake yawancin ƙwayoyin cuta ba sa haifar da cutar ta hanyar iska, Cibiyar Nazarin Kimiyya ta Kasa ta ce za a iya yin amfani da shi ta hanyar amfani da iska ta hanyar amfani da iska da kuma yin amfani da iska a cikin wuraren da ke waje da wuraren wanka na jama'a ya ba da samfurori masu kyau don RNA na kwayar cutar.
Wasu ayyukan likita kamar su allurar rigakafi da CPR na iya haifar da numfashi mai numfashi da kuma numfashi mai numfashi.
Damuwar ita ce cewa ana iya yaduwa ta hanyar dusar ƙanƙara, wanda shine haɗarin da aka yarda da shi a matakinmu. Kwayar cutar tana da ƙarfi sosai a cikin rarrabuwa idan mutane suna da alamun bayyanar cututtuka; yayin da yaduwar zata iya faruwa kafin bayyanar cututtuka, haɗarin yana da ƙanƙantacce.
Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC) ta ce ba a san yadda cutar ke yaduwa ba, yayin da mutum ɗaya ke cutar da mutane biyu ko uku. Kwayar cutar na iya rayuwa na tsawon sa'o'i a saman abubuwa.
Musamman, an gano kwayar cutar a kan kwali na kwana ɗaya, har zuwa kwana uku a kan filastik (polypropylene) da ƙarfe mai ƙarfe (AISI 304), da kuma har zuwa awanni huɗu a kan jan ƙarfe 99%.
Amma, wannan ya bambanta da yanayin zafi da zafi.
Sabulu da kayan wanki suna da ƙarfi idan aka yi amfani da su yadda ya kamata; kayan sabulu suna yanke ƙwayoyin cuta, hana ƙwayoyin cuta, da kuma kawar da su daga akwatunan ko wasu wurare.
Sauran magungunan, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe ƙwayoyin cuta na tiyata), sun fi sauƙi.A cikin binciken Hong Kong, an cire samfuran fitsari a cikin kwanaki biyu bayan shigar da su asibiti.
Daga cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna ƙaruwa a cikin nauyin kwayar cutar a ƙarshen, yayin da na shida ya nuna ƙaruwa a cikin nauyin kwayar cutar a rana ta biyu ta gwaji.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Dukkanin nau'ikan SARS-CoV-2 suna da kwayar cutar coronavirus a cikin ƙasa.
A waje da jikin mutum, ana kashe kwayar cutar ta hanyar sabulu mai laushi, wanda ke kare ta ta hanyar fashewar ƙwayoyin cuta.
Fuka-fukan sune gabobin da ke da haɗari ga COVID-19 saboda kwayar cutar tana shiga cikin ƙwayoyin mai karɓar ta hanyar enzyme angiotensin-convertant enzyme 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar nau'in II na huhu.
Kwayar cutar tana amfani da wani ƙwayoyin glycoprotein na musamman da ake kira "spike" (peplomer) don ɗaure kansa ga ACE2 kuma ya shiga cikin ƙwayoyin mai karɓar.
An gano mummunan ciwon zuciya a kashi 12% na masu cutar da ke asibiti a Wuhan, China, kuma suna da yawan kamuwa da ciwon zuciya.
Yawan cututtukan zuciya yana ƙaruwa, wanda ke haifar da halayen kumburi na tsarin jiki da kuma ciwon tsarin rigakafi yayin da cutar ta ci gaba, amma ciwon jijiyoyin zuciya na iya haɗuwa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna da yawa a cikin zuciya kuma suna taimakawa wajen aikin zuciya.
Yawan kamuwa da cutar ta hanyar jini (31%) da kuma kamuwa da cutar ta jini (25%) an lura da su a cikin marasa lafiya na ICU da ke fama da cutar COVID-19 kuma yana iya kasancewa da alaƙa da mummunan hangen nesa. Gwajin COVID-19 ya nuna lalacewar alveoli mai yaduwa (AAD), da kuma ƙwayoyin lymphocytes tare da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Kodayake SARS-COV-2 yana da ƙwarewa ga ƙwayoyin epithelial na numfashi na ACE2-expressing, marasa lafiya masu cutar COVID-19 masu tsanani suna da alamun alamun cutar kumburi.
A cikin bincike, an nuna alaƙa tsakanin kwayoyin halittar T-cell na GM-CSF-producing pathogens da kuma daukar IL-6 mai haifar da kumburi da cututtukan hanta mai tsanani a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton maganin cututtukan lymphocytic.
Hukumar Lafiya ta Duniya ta wallafa wasu ka'idojin gwaji don cutar.
Hanyar da aka saba amfani da ita don maganin gwaji ita ce rikodin ainihin lokacin da aka yi amfani da shi na polymerase chain reaction (rRT-PCR).
Ana yin gwajin musamman tare da samfurori na numfashi da aka samo ta hanyar hanci da hanci; amma za a iya amfani da samfurin hanci ko samfurin ƙura.
Sakamakon zai kasance sananne a cikin sa'o'i kadan ko kwana biyu.
Ana iya amfani da gwaje-gwajen jini, amma wannan yana buƙatar samfurin jini biyu da ke da makonni biyu da juna da kuma sakamakon da ba shi da inganci.
Masu bincike na kasar Sin sun sami damar ware kwayar cutar coronavirus kuma sun buga jerin kwayoyin halitta don dakunan gwaje-gwaje na duniya su iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano cutar.
A ranar 4 ga Afrilu, 2020, gwajin rigakafi (wanda zai iya gano cutar mai aiki da cutar da aka riga aka kamu da ita) ya kasance mai haɓaka, amma ba a yi amfani da shi sosai ba.
Kwarewar Sinawa a gwajin gwaji ya nuna cewa daidaito na gwajin ya kasance tsakanin kashi 60 zuwa 70 cikin dari.
Hukumar Kula da Abinci da Magunguna ta Amurka ta amince da gwajin farko na gwaji a ranar 21 ga Maris, 2020 don amfani da mutane a ƙarshen watan.Kayan aikin bincike na asibitin Zhongnan na Jami'ar Wuhan ya ba da shawarar hanyoyin gano duk wani rikice-rikice na asibiti da haɗarin cututtukan cututtuka.
Rashin haske mai yawa na gilashin ƙasa a gefen gefe, asymmetrical da kuma rarraba siminti suna da yawa a cikin matsalolin farko.
Dominance na subpleural, shimfidawa na ƙwayoyin cuta (ƙumburi na ƙwayoyin cuta na ƙwayoyin cuta na alveoli ya bambanta), da kuma ƙarfafawa na iya faruwa yayin da cutar ta ci gaba.
Ba a sami bayanai da yawa game da lalacewar microscopic da ilimin cututtukan COVID-19 ba.
Abubuwan da aka lura a cikin binciken da aka yi a kan gawa sune:
Macroscopy: pleurisy, pericarditis, ƙarfafawar hanta da ƙonewa na huhu.
Akwai nau'i hudu na ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon ciwon
Ƙananan ƙwayoyin cuta: ƙwayoyin cuta, hyperplasia na pneumocyte, pneumocytes masu girma, ƙwayoyin cuta tare da infiltration na lymphocytic da kuma samar da kwayoyin halitta masu yawa
Ƙarƙashin ƙarancin ciwo: ƙarancin ƙwayar alveolar (DAD) ƙarancin ƙwayar alveolar.
DAD shine tushen ciwo mai saurin ciwo na numfashi (ARDS) da kuma ciwon hypoxemia mai tsanani.
Rashin ƙwayar cuta: gyaran ƙwayoyin cuta a cikin alveolar da kuma fibrosis na ƙwayoyin cuta.
Jini: DIC (Divisional Intravenous Circulation) da kuma maganin leukoerythroblastic
Matakan rigakafi da rage haɗarin kamuwa da cutar sun haɗa da kasancewa a gida, guje wa wuraren taron jama'a, wanke hannuwanku da sabulu da ruwa sau da yawa na tsawon dakika 20, amfani da tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannuwan da ba su da tsabta.
Dokar CDC ta ba da umarnin rufe baki da hanci da kuma hanci a lokacin aikin tiyata kuma ta ba da shawarar yin amfani da kayan aiki na hannu idan ba a sami kayan aiki ba.
Ana bukatar tsabta ta gaskiya bayan an yi alkawari.
CDC ta ba da umarnin yin amfani da abin rufe fuska a cikin jama'a, a gefe don rage yaduwar mutanen da ba su da alamun cutar. An tsara dabarun nisantar da jama'a don rage yawan masu kamuwa da cutar da rufe motoci da wuraren aiki, hana zirga-zirga da rufe wuraren taron jama'a.
Taimakon nisantar da hankali kuma ya ba da shawarar cewa mutane su kasance aƙalla ƙafa 6 (1.8 m) nesa da juna.
Babu wani abu da aka sani don hana cutar COVID-19 da gaske. Yayin da ba a sa ran samar da allurar rigakafi a cikin 2021 ba, ana fatan, babban mahimmin mataki don magance COVID-19 shine ƙoƙarin rage ƙimar cutar, wanda ake kira "ƙaddamar da layin kwance".
CDC ta ba da shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla dakika 20 bayan sun je bayan gida ko idan hannayensu sun kasance da datti, kafin cin abinci; da kuma bayan shafa hanci, tari, da fitsari.
Ya ci gaba da ba da shawarar amfani da kayayyakin tsabtace hannu na giya na kashi 60% don tsabtace hannu, amma kawai idan sabulu da ruwa ba su da samuwa.A wuraren da aka saba siyan kayan tsabtace hannu da ba a sayar da su ba, WHO ta maye gurbin su da kayan aikin hana haihuwa.
A cikin waɗannan ƙwayoyin, maganin kashe kwari yana tasowa daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta daga cikin barasa; "wani magani ne mai amfani da maganin kashe ƙwayoyin cuta na hannu".
Ana ƙara glycerol don yin ƙwanƙwasa.
Ana ba da taimako na gaggawa ga mutane ta hanyar amfani da ruwa, taimakon oxygen, da kuma taimakon ga wasu gabobin da suka lalace.
CDC ta ba da shawarar cewa mutanen da ke da alamun cutar su sanya abin rufe fuska mai haske.
Ana amfani da maganin ECMO don magance ciwon numfashi mai tsanani, amma har yanzu ana nazarin ingancinsa.
Ana amfani da salon rayuwa da abinci mai tsabta don inganta rigakafi.
Taimako na magani na iya zama dole ga mutanen da ke da alamun rashin lafiya a farkon lokacin kamuwa da cutar. Hukumar Lafiya ta Duniya da Kwamitin Kiwon Lafiya na Kasa na kasar Sin sun ba da umarni don kula da mutanen da ke kwance a asibiti saboda COVID-19.
Mata masu kula da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
A watan Afrilu na 2020, babu takamaiman magani don COVID-19.
Don bayyanar cututtuka, wasu likitoci sun ba da shawarar yin amfani da paracetamol (acetaminophen) a matsayin magani a cikin maganin farko.
Dole ne a ɗauki matakan kariya don rage haɗarin yaduwar kwayar cutar, musamman a wuraren da ke ba da sabis na likita wanda zai iya haifar da aerosols kamar su bututun ruwa ko iska mai iska.
Don ma'aikatan kiwon lafiya da ke kula da marasa lafiya na COVID-19, CDC ta ba da izinin keɓewa na mutum a cikin Rukunin Keɓewa na Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar Cutar
Abubuwan da aka ba da shawarar don amfani da su sune: PPE, kayan aiki na numfashi ko abin rufe fuska, kariya ta ido, da kayan aikin likita.Idan akwai, ana buƙatar kayan aikin numfashi (maimakon abin rufe fuska).
An amince da kayan numfashi na N95 don masana'antu, amma FDA ta ba da izini don amfani da kowane abin rufe fuska na Amurka.
An tsara shi don kare mutum daga iska amma ba a tabbatar da lafiyarsa a cikin yanayin da ake amfani da shi ba.
Lokacin da babu abin rufe fuska, CDC ta ba da shawarar yin amfani da abin rufe fuska ko, a mafi ƙarancin, abin rufe fuska na gida.
Ba a san yawan adadin masu kamuwa da COVID-19 da ke buƙatar yin amfani da iska mai tsafta ko wasu hanyoyin ba, amma kashi ɗaya cikin ɗari na masu kamuwa da cutar suna buƙatar hakan.
Nau'in suturar numfashi don marasa lafiya da ke fama da cutar COVID-19 ana nazarin su sosai don marasa lafiya a asibiti, tare da alamar cewa shigar da bututun zai iya tserewa ta hanyar iska mai ƙarfi ta hanyar cannula ta hanyar numfashi ko matsin lamba mai kyau.
Amma ba a san ko ɗayan yana ba da fa'idodi iri ɗaya ga marasa lafiya masu tsanani ba.
Wasu likitoci sun fi son injin numfashi na ciki idan ya cancanta, saboda haka ana iya yin amfani da wannan fasaha ta hana yaduwar ƙananan abubuwa a cikin iska ta hanyar amfani da bututun iska mai ƙarfi a cikin hanci.
Yawancin ƙasashe masu tasowa ba su da isassun gadajen asibiti na mutum, wanda ke ƙuntata tsarin kiwon lafiya don magance yawan adadin masu cutar COVID-19 da ke cikin asibiti.
Wani bincike a China ya gano cewa a cikin kashi 5% na waɗanda aka kula da su a sashen kulawa mai tsanani, kashi 2.3% sun kamu da cutar numfashi, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30 cikin dari na waɗanda aka kwantar da su a asibiti don COVID-19 sun ƙare a cikin ICU.
Samun iska ta atomatik ya zama da wahala sosai saboda ciwon rashin lafiyar numfashi (ARDS) wanda ya haɓaka tare da COVID-19 kuma samar da iskar oxygen ya zama da wahala sosai.
Ana buƙatar masu numfashi masu aiki tare da yanayin da za a iya sarrafa matsa lamba a cikin PEEP mai girma don haɓaka isar da iskar oxygen tare da rage haɗarin rauni na iska da na kirji.
Ƙarfin PEEP zai iya ɓacewa a cikin tsoffin masu motsa jiki.
An fara binciken magani mai warkewa a watan Janairun 2020, kuma yawancin magungunan rigakafin cutar suna cikin gwaji na asibiti.
Remdesivir ya kasance mafi alkawurra a cikin maganin.
Duk da cewa ana iya samun sabbin magunguna a cikin 2021 don yin rajista, yawancin magungunan gwaji an riga an amince da su don amfani da su a wasu cututtuka ko kuma suna kan hanyar gwaji.
Za a iya gwada maganin rigakafin cutar a jikin mutane masu fama da cutar.
Hukumar Lafiya ta Duniya ta tura masu aikin sa kai don gwaji kan ingancin da amincin kayan aikin allurar rigakafi. Hukumar ta FDA ta ba da izinin ɗan gajeren lokaci don amfani da plasma na waɗanda suka tsira daga gwajin a cikin yanayin da aka tabbatar da cewa rayuwar mutum tana cikin haɗari ko kuma yana fuskantar mutuwa.
Har yanzu ba a gudanar da nazarin asibiti da ya cancanta ba don tabbatar da cewa yana da lafiya da kuma tasiri wajen kawar da cutar.
A watan Fabrairun 2020, kasar Sin ta ƙaddamar da wata manhajar wayar hannu don magance cutar.
Ana buƙatar ma'aikata su sanya sunayensu da lambar ID.
Aikace-aikacen yana da tarihin gano abokan hulɗa na ɓoye ta amfani da bayanan kulawa don gano haɗarin haɗari.
Kowane mai amfani na iya bincika matsayin wasu masu amfani uku.
Idan akwai yiwuwar haɗari, aikace-aikacen ba kawai zai ba da umarnin keɓewa ba amma kuma zai sanar da hukumomin kiwon lafiya na gida.Ana samar da manyan bayanan wayar salula, fasahar gano fuska, bin diddigin wayar salula, da kuma hanyoyin kula da lafiya don bin diddigin masu kamuwa da cutar a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba da izinin hukumomin tsaro su bi diddigin bayanan wayar hannu na mutanen da ake zargi da cutar coronavirus.
An tsara wannan tsari don ƙarfafa keɓewa da kuma kare waɗanda ke da alaƙa da jama'a masu cutar.
Bugu da ƙari, a cikin Maris 2020, Deutsche Telekom ta ba da damar rarraba bayanan wayar hannu tare da hukumar tarayya ta Jamus, Cibiyar Robert Koch, don ganowa da hana yaduwar cutar.
Rasha ta kirkiro fasahar gane fuska don gano masu keta dokar killacewa.
Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce ya samu sanarwar daga masu amfani da wayoyin salula cewa "kashi 40% na yawan jama'a suna ci gaba da tafiya".
Gwamnatin Jamus ta kammala aikin hackathon na tsawon sa'o'i 48 tare da mahalarta sama da 42,000.
Shugaba Kersti Kaljulaid na Estonia ya kuma yi kira ga duniya da ta nemi hanyoyin da za a iya amfani da su wajen kawo karshen yaduwar cutar korona.
Mutane za su sha wahala daga rashin jin daɗi na keɓewa, ƙuntatawa na tafiya, sakamako na magani ko kuma tsoron cutar.
BBC ta ambaci Rory O'Connor yana cewa, "ƙara nisantar jama'a, keɓewa, tsoron rashin lafiya, damuwa da rashin arziki sune abubuwan da ke haifar da mummunan tasiri ga rayuwar mutane".
Cutar na iya zama mai sauƙi tare da alamun bayyanar cututtuka kamar rashin lafiyar numfashi, kamar sanyi.
Yawancin lokuta masu sauƙi suna wucewa cikin makonni biyu, amma waɗanda ke da ciwon kirji mai tsanani suna ɗaukar makonni uku zuwa shida don wucewa.
Mata masu juna biyu suna da haɗarin kamuwa da cutar COVID-19 ko kuma wasu ƙwayoyin cuta masu kama da su, kamar SARS da MERS, amma babu cikakkun bayanai game da COVID-19. A wasu mutane, COVID-19 na iya shafar ƙwayoyin cuta da ƙwayoyin cuta.
A cikin waɗanda ke da mummunan rauni, COVID-19 na iya haɓaka zuwa ciwon numfashi mai saurin kamuwa da cuta (ARDS) wanda ke haifar da rashin ƙarfi, damuwa ko lalacewar gabobin jiki da yawa.
Matsalolin da ke tattare da COVID-19 sun haɗa da cutar sauro, cutar jini da kuma ciwon zuciya, koda da hanta.
An lura da cutar hawan jini, musamman haɓakar prothrombin, a cikin kashi 6% na mutanen da aka kwantar da su a asibiti don COVID-19, amma an lura da cutar sankarar bargo a cikin kashi 4% na yawan jama'a.
Kusan kashi 20-30% na mutanen da ke da cutar COVID-19 suna nuna ƙaruwa a cikin ƙwayoyin enzymes na jini (transaminases).
Bisa ga wannan rahoton, matsakaicin lokacin farawa da bayyanar cututtuka da mutuwa ya kai kwanaki 10, biyar daga cikinsu asibiti.
Don haka, marasa lafiya da aka aika zuwa ICU suna da matsakaicin lokacin kwana bakwai daga lokacin asibiti zuwa mutuwa.
A cikin binciken farko, matsakaicin lokacin daga bayyanar cututtuka na farko zuwa mutuwa ya kasance kwanaki 14, tare da jerin sunayen kwanaki shida da 41 a jere.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta gudanar, maza sun sami kashi 2.8% na mace-mace da ke mutuwa yayin da maza suka samu kashi 1.7%.
Binciken ilimin lissafi na ƙwayar ƙwayar cuta na ƙwayar cuta ya nuna yaduwar alveoli a cikin fibromyxoid cell exudate na ƙwayoyin cuta biyu.
An gano canjin kwayar cutar a cikin ƙwayoyin huhu.
Hoton da ke cikin kwakwalwar mutum yana kama da ciwon numfashi mai saurin tashi (ARDS).
A cikin kashi 11.8 cikin dari na mutuwar da aka ruwaito daga Hukumar Lafiya ta Kasa ta kasar Sin, an gano cutar zuciya ta hanyar hawan matakan troponin ko bugun zuciya.
Dangane da bayanan Maris daga Amurka, kashi 89% na waɗanda aka kwantar da su a asibiti suna da ciwon da ya gabata.
Ƙididdigar yawan mutuwar da ke faruwa ta hanyar cututtuka sun bambanta saboda canjin yanayi, amma kuma saboda rashin amfani da hanyoyin.
Karanta waɗannan ƙananan ƙididdiga na iya haifar da ƙididdigar yawan mutuwar.
Amma, tun da yake mutuwar ta kasance ne daga waɗanda suka kamu da cutar a dā, wannan yana nufin cewa an rage yawan mutuwar a cikin shekarun nan.
Masu shan sigari suna da haɗarin sau 1.4 na ciwo mai tsanani na COVID-19 da kuma sau 2.4 na haɗarin mutuwa a cikin kulawa mai tsanani ko mutuwa idan aka kwatanta da waɗanda ba sa shan sigari. Tsoron ci gaba da cutar zai haifar da cutar.
Babban asibitin Hong Kong ya lura da raguwar kashi 20 zuwa 30 cikin dari na ƙarfin hanta a cikin mutanen da suka warke daga cutar, kuma hotunan hanta sun nuna lalacewar gabobin jiki.
Hakanan yana iya haifar da ciwon sukari na baya wanda ya fi tsanani bayan warkewa.
Har zuwa Maris 2020, ba a san ko ƙarin cutar za ta iya samar da rigakafi mai inganci da na dogon lokaci ga mutanen da suka warke daga cutar ba.
An yi la'akari da cewa rigakafi yana da inganci, kamar yadda yake a cikin wasu cututtukan coronavirus, amma an bi mutane da suka warke daga COVID-19 tare da gwajin tabbatacce na coronavirus a kwanan wata bayan an ba da rahoton.
Ana ganin irin waɗannan cututtukan sun rage mummunan yanayin cutar ba kawai don ci gaba ba amma don sabon rikici.
Kwayar cutar ta kasance ta duniya kuma ta samo asali ne daga dabbobi, ta hanyar kamuwa da cuta.
Ba a san ainihin asalin cutar ba, amma a watan Disamba na shekarar 2019 an yi la'akari da yaduwar cutar ta hanyar mai watsawa.
Wani bincike na farko da aka tabbatar da 41 na COVID-19 da aka buga a cikin Janairu 2020 a cikin The Lancet, ya nuna cewa farkon farawar alamun cutar ya kasance 1 ga Disamba 2019.
Rahotanni na WHO sun ba da rahoton bayyanar cututtukan farko a ranar 8 ga Disamba, 2019.
Ana amfani da watanni da yawa don yawan mutanen da suka mutu.
Wadannan ƙididdigar sun bambanta a wurare da yawa kuma a tsawon lokaci kuma suna da alaƙa da yawan cututtukan cututtuka, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokacin farawa, da kuma yanayin alƙaluma kamar shekaru, jinsi, da lafiyar mutum gaba ɗaya.
A ƙarshen 2019, WHO ta ba da lambar ICD-10 ta musamman don lambobin U07.1 don waɗanda suka mutu daga gwajin gwaji na cutar SARS-CoV-2 da U07.2 don waɗanda suka mutu daga asibiti ko kuma cutar COVID-19 ba tare da gwajin gwaji na cutar SARS-CoV-2 ba.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan adadin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
Yawan zai iya bambanta daga mutum zuwa mutum. Wasu ma'auni sun haɗa da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan mutuwar (IFR), wanda ke nuna yawan mutanen da ke da cutar (ko da an gano su ko ba a gano su ba) da suka mutu daga cutar.
Waɗannan ƙididdigar ba su da lokaci, suna bin takamaiman alƙaluma daga ci gaban kamuwa da cuta zuwa ƙarshen yanayin.
Ko da yake ba kowa ba ne ke da ƙwayoyin cuta, ƙwayoyin cuta na iya ba da bayani game da yawan mutanen da za su iya kamuwa da cutar.
A tsakiyar annobar a Italiya, Castiglione d'Adda, wani ƙaramin gari mai yawan mutane 4,600, 80 (1.7%) sun mutu kwanan nan.
A Gangelt, cutar ta bazu daga bukukuwan Carnival, ta shafi yara, ta jawo ƙananan mutuwar kuma ba duka mutuwar COVID-19 aka rarraba ta haka ba.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ya kasance cikin yanayi mai wuya.
A Netherlands, kashi 3 cikin ɗari na iya samun ƙwayoyin rigakafi, kamar yadda masu bayar da jini suka kimanta.
An tabbatar da mutuwar mutane 69 (0.004% na yawan jama'a) daga COVID-19.
Sakamakon annobar cutar da yawan mace-mace ya bambanta tsakanin maza da mata.
Yawan kisan kai a cikin maza ya fi na duka nazarin da aka yi a China da Italiya.
Hadarin yana ƙaruwa ga maza a shekara ta 50, kuma bambancin tsakanin maza da mata yana ƙaruwa a shekara ta 1990.
A China, yawan mace-macen ya kai kashi 2.8 cikin ɗari ga maza da kashi 1.7 cikin ɗari ga mata.
Dalilin bambancin tsakanin maza da mata ba a sani ba, amma zai iya zama na asali da kuma halayyar mutum.
Bambancin tsarin rigakafi tsakanin jinsi, ƙarancin shan taba a cikin maza da kuma ƙaruwar yanayin haɗuwa don kashewa kamar hauhawar jini a cikin matasa fiye da maza na iya ƙara yawan mutuwar maza.
A Turai, 57% na masu kamuwa da cutar maza ne kuma 72% na waɗanda suka mutu daga COVID-19 maza ne.
A watan Afrilu 2020, gwamnatin Amurka ba ta samar da wani ƙididdigar COVID-19 ba.
Bincike ya nuna cewa cututtukan da ke tattare da cutar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, sun yi yawa, wanda ke haifar da haɗarin haɗari don kasancewa kusa da kwayar.
Hukumar Lafiya ta Duniya ta tabbatar a ranar 11 ga Fabrairun 2020 cewa sunan hukuma na cutar zai zama "COVID-19".
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana wakiltar corona, VI yana wakiltar kwayar cuta, D yana wakiltar cuta, kuma shekara ta 19 da aka fara gano cutar: 31 ga Disamba 2019.
An zaɓi sunan don hana nuna yatsan hannu a takamaiman yanayin ƙasa (misali, China), musamman na dabba ko al'umma, a cikin jerin sunayen da aka ba da izini a ƙasashe don sanya sunan don hana ƙyama. Kwayar cutar da ke haifar da COVID-19 ana kiranta cutar sankarar bargo ta coronavirus 2 (SARS-CoV-2).
WHO ta ƙara amfani da "kwayar cutar COVID-19" da "kwayar cutar da ke da alhakin COVID-19" a cikin watsa labarai.
Dukansu cututtuka da ƙwayoyin cuta ana kiransu da yawa "coronavirus".
A lokacin barkewar cutar a Wuhan, China, an kira kwayar cutar da cutar "coronavirus" da "Wuhan coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar cewa 2019-nCov da 2019-nCoV cutar sankarar bargo a matsayin sunayen da aka ba da izini don cutar da cutar bayan sabuntawar 2015 maimakon sunayen cutar da cutar.
An ƙaddamar da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
A cikin iyakar ƙa'idodin samar da kayan aikin likita, wasu masana'antun dijital suna buga kayan aikin asibiti kamar su hanci da kuma kayan aikin numfashi.
A wani misali, lokacin da asibiti a Italiya ke buƙatar bawul ɗin iska mai ƙarfi, kuma ma'aikacin ba zai iya aikawa a lokacin da ake so ba, wani kamfani na gida ya yi amfani da injin injin kuma ya buga bawul 100 da ake buƙata a cikin dare ɗaya.
Bayan barkewar COVID-19, ra'ayoyin maƙarƙashiya da bayanan karya game da asalin, sikelin, rigakafi, magani da sauran bayanan cutar sun bazu cikin sauri akan Intanet.
An gano cewa mutane suna da tarihin yada kwayar cutar daga wasu dabbobi.
Binciken bai yi nasarar gano alamun cutar a aladu, ducks, da sauransu ba.
Babu magani ko allurar rigakafi da aka amince da ita don magance cutar.
An fara gudanar da bincike na duniya game da alluran rigakafi da alluran rigakafin COVID-19 ta hanyar ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da wani gwaji da ake kira "Study SOLIDARITE" don nazarin tasirin maganin maganin cutar B wanda ke ba da kyakkyawan fata na magani.
Har yanzu ba a samu allurar rigakafi ba, amma hukumomi da yawa suna aiki tuƙuru don samar da alluran rigakafi masu inganci.
An fara yin aiki don gano SARS-CoV ta hanyar yin amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin mutum.
Akwai dabarun rigakafi guda uku da ake nema.
Da farko, masu bincike sun mai da hankali kan samar da allurar rigakafin cutar gaba ɗaya.
Yin amfani da irin wannan kwayar cutar, ko mai saurin yaduwa ko mai kashewa, yana ƙoƙarin saurin amsawar rigakafin mutum ga sabon kamuwa da COVID-19.
Dabara ta biyu, allurar rigakafin subunit, tana ƙoƙarin samar da allurar rigakafin da ke sa tsarin garkuwar jiki ya zama mai saukin kamuwa da ƙwayoyin cuta na asali.
A cikin yanayin SARS-CoV-2, waɗannan binciken sun mai da hankali kan sunadarai na S-spicules waɗanda ke taimakawa ƙwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Dabara ta uku ita ce rigakafin nucleic acid (DNA ko RNA rigakafi, sabuwar fasaha don inganta allurar rigakafi).
Alluran rigakafin da aka gwada ta amfani da waɗannan dabarun dole ne a gwada su don aminci da ingancin amfani.A ranar 16 ga Maris, 2020, gwajin farko na asibiti na allurar rigakafi ya fara tare da masu sa kai huɗu a Seattle.
A cikin allurar rigakafi ba a haɗa da lambar halittar cutar ba ta hanyar kwafin kwayar cutar da ke haifar da cutar. An yi tunanin cewa haɓakar ƙarfin ƙwayoyin cuta da ke dogara da ƙwayoyin cuta a cikin yanayin yaƙi na iya zama sanadin haɓakar allurar rigakafin SARS-COV-2, amma wannan har yanzu batun muhawara ne.
An gudanar da gwaji na asibiti sama da 300 a watan Afrilu 2020.
Guda bakwai na gwajin suna nazarin maganin da aka riga aka amince da shi don zazzabin cizon sauro, hudu daga cikinsu suna nazarin hydroxychloroquine ko chloroquine.
Magungunan rigakafin cutar sun sake zama wani ɓangare na nazarin kasar Sin, tare da gwaji tara na III na gwaji a kan remdesivir da aka gudanar a ƙasashe da yawa waɗanda za su bayar da rahoto a ƙarshen Afrilu.
An ƙaddamar da gwajin gwaji na ci gaban asibiti na allurar rigakafin COVID-19 tare da maganin da za a iya yarda da shi a watan Afrilu 2020.Ana nazarin magungunan riga-kafin cutar da yawa don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir/ritonavir da lopinavir/ritonavir a hade tare da interferon beta.
Alamar farko ta bayyanar da amfani da remdesivir, a cikin Maris 2020.
An lura da haɓaka lafiyar asibiti a cikin marasa lafiya waɗanda suka karɓi maganin jinƙai na remdesivir.
Ana gudanar da gwajin asibiti na Mataki na III a Amurka, China da Italiya. An fara nazarin chloroquine a China a watan Fabrairun 2020, a cikin bugu na farko.
Amma, ana tsammanin cewa masana za su iya gano tushen wannan ƙwaƙwalwar.
Hukumomin kiwon lafiya na Koriya da China sun ba da shawarar amfani da chloroquine.
A cewar Cibiyar Kwayoyin Cutar Wuhan, a cikin kashi ɗaya na gamma a kowace rana, kashi biyu cikin ɗari na cutar suna da haɗari kuma suna iya zama masu kisa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da maganin hydroxychloroquine da chloroquine a cikin asirin likita don kula da marasa lafiya na COVID-19.
Bayanai na farko sun nuna cewa manyan allurai na ribavirin suna da mahimmanci don hana SARS-CoV-2 a cikin vitro.
An riga an ba da umarnin Nitazoxanide don ƙarin nazarin in vivo bayan nuna ƙananan matakan hanawa na SARS-CoV-2. Nazarin ya nuna cewa haɓakar ƙwayoyin cuta na asali ta hanyar amfani da ƙwayar ƙwayar cuta ta ƙwayar cuta ta 2 (TMPRSS2) yana da mahimmanci ga shigar SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine tare da hydroxychloroquine tare da ko ba tare da azithromycin ba yana da iyakancewa mai ƙarfi wanda ya sa ƙungiyar likitoci ta ƙi yarda da magunguna ba tare da ƙarin bincike ba. Oseltamivir ba ya cutar da SARS-CoV-2 a cikin vitro kuma ba shi da wani aiki da aka sani a cikin maganin COVID-19.
Cytokin raunin na iya zama mummunan rauni na ƙarshen lokacin COVID-19 mai tsanani.
An nuna cewa hydroxychloroquine na iya samun kaddarorin hana cutar cytokine. Tocilizumab an riga an sanya shi cikin taimakon magani ta Hukumar Kiwon Lafiyar Kasa ta China bayan kammala wani karamin bincike.
A halin yanzu ana gudanar da gwajin gwaji na 2 a matakin ƙasa a Italiya bayan an nuna kyakkyawan sakamako a cikin marasa lafiya.
An haɗa shi da gwajin jini na ferritin na magani don ganewa, wanda aka yi don hana ci gaba, wanda ake zaton shine dalilin mutuwar ga kashi daya cikin dari na mutanen da ke fama da cutar.
An amince da samfurin farko na interleukin-6 ta FDA bayan binciken da aka yi a baya don maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan CART, a cikin shekara ta shekara ta 2017.
A yau, babu wata hujja ta bazuwar da aka sarrafa don tabbatar da cewa tocilizumab magani ne mai inganci don CRS.
Bayar da ƙwayoyin cuta da aka tace da kuma ƙwayoyin cuta daga tsarin rigakafin mutane da suka tsira daga kamuwa da COVID-19 ga waɗanda ke buƙatar su ana bin su ne don tabbatar da cewa sun kasance hanya ce ta rigakafi da rigakafi.
An gwada wannan na'urar amma ba ta yi nasara ba.
Ana tsammanin kawar da kwayar cutar ta hanyar amfani da maganin rigakafi na wucewa wanda zai iya rage kariya daga cutar SARS-CoV-2.
Sauran hanyoyin, kamar cytotoxicity da / ko phagocytosis na ƙwayoyin cuta masu dogara da ƙwayoyin cuta na iya aiki.
Ana ci gaba da wasu hanyoyin maganin rigakafi na wucewa, misali, amfani da rigakafin monoclonic na inji.
Ana iya ƙara yawan ƙwayar ƙwayar cutar ta marasa lafiya da suka warke, wanda ya ƙunshi jini mai ruwa daga masu warkewa kuma yana da ƙwayoyin cuta na musamman ga kwayar cutar, don rarraba shi ta hanyar maye gurbin.
Cutar coronavirus, tarin cututtuka masu alaƙa da juna
Li Wenliang, likita a babban asibitin Wuhan, wanda ya kamu da cutar COVID-19 a baya ya mutu bayan an sami ƙarin bayani game da yaduwar cutar.
